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Abstract 
 
 
Iron oxide magnetic nanoparticle synthesis and their surface functionalization hold a crucial 
position in the design and fabrication of functional materials for a variety of biomedical 
applications. Non-uniform nanoparticles with poor crystallinity, prepared by conventional 
methods, have only limited value in biological areas. Large scale synthesis methods that are able 
to produce high quality, mono-dispersed iron oxide nanoparticles using low cost and 
environment friendly chemicals are highly desirable. Following synthesis, appropriate surface 
functionalization is necessary to direct the dispersibility of nanoparticles in aqueous solution in 
order to provide them with acceptable colloidal stability against the ion strength and many 
biomolecules that nanoparticles may encounter under physiological conditions. Poorly stabilized 
nanoparticles that easily aggregate and form large size agglomerates would be quickly cleared by 
the liver and other organs and are not suitable for clinical purposes. Additionally, many 
interesting functionalities such as fluorescence, targeting and anti-cancer properties can be 
immobilized onto the surface of iron oxide magnetic nanoparticles during the surface 
functionalization process so as to build multifunctional platforms for disease diagnosis and 
treatment. 
Polyol method can be an effective way to prepare magnetite nanoparticles that are suitable 
for biological applications. In a polyol system, selected surface functionalities were introduced to 
the nanoparticle surface via a hot injection technique. The morphology, uniformity, crystallinity 
and magnetic properties were examined to understand the effect of different ligand molecules on 
the final product. Their surface chemistry, colloidal properties and surface reactivity were also 
studied to evaluate their practicability in different applications.  
A high efficiency in-situ method for the preparation of magnetite nanoparticles attached to 
silica nanospheres was also developed in a polyol system. This approach eliminates several 
time-consuming processing steps that are in the conventional fabrication route and directly 
produces water-stable magnetite-silica hybrid materials with surface availability for subsequent 
modifications.  
In addition to polyalcohol, the potential of polyamine in the preparation of water-soluble 
magnetite nanoparticles with amine surface functionalities was also evaluated. And it is 
suggested that polyamine acts as solvent, stabilizing agent and reducing agent simultaneously 
during the synthesis. The characterization of polyamine coated nanoparticles, their surface 
functionalization, and subsequent application for bioseparation and drug delivery were reported. 
 
 
 
Iron oxide magnetic nanoparticles, Water-dispersible, One-pot synthesis, Drug delivery, Surface 
functionalization, Bioseparation. 
1 
 
Chapter I: Introduction 
 
Magnetic iron oxides, especially magnetite have been used extensively in many areas such 
as magnetic recording, catalysis and surface coating for steel, based on their naturally occurring 
magnetism and high temperature stability. When the size of a single magnetite crystal is 
decreased from bulk to micro or nano-meter range, their applications are greatly expanded. 
Ferrofluid technology, water purification and magnetic inks for jet printing all benefit from the 
small size of magnetite nanoparticles. It is suggested that in water treatment, when the size of 
magnetite nanoparticles was decreased from 300 nm to 12 nm, the adsorption capacities for both 
As(III) and As(V) increased nearly 200 times.1 Despite the excellent properties of nanosized 
magnetite crystals, some of their applications are strongly limited by the low quality of the 
product. Due to the lack of control in conventional preparation methods, the as-prepared 
nanoparticles usually have poor morphology, broad size distribution and a large amount of 
impurities. Therefore, it is necessary to develop new synthesis techniques that are suitable for 
large scale production of high-quality, mono-dispersed magnetite nanoparticles.  
Because small magnetite crystals present size dependent magnetic behavior and very low 
cytotoxicity compared to many other nanomaterials, they are extremely promising in biomedical 
applications. Numerous studies have been performed to develop novel magnetite nanoparticles 
based nanomaterials for protein purification, cell separation, heavy metal and toxic compound 
elimination, DNA sorting, biosensing, target drug delivery, gene delivery and molecular imaging. 
In this chapter, a review of several popular methods for iron oxide magnetic nanoparticle 
preparation and their subsequent surface functionalization approaches is provided. The 
stabilization strategies of iron oxide nanoparticles in aqueous solution as well as the coating 
materials including monomeric stabilizer, polymer stabilizer and inorganic materials will be 
introduced. In the last section, a discussion about how iron oxide nanoparticles benefit several 
biomedical applications including molecular imaging, drug delivery, bioseparation and cancer 
treatment is presented.  
2 
 
1.1. Wet Chemical Synthesis of Iron Oxide Nanoparticles 
The synthesis and preparation of micro-sized or nano-sized magnetite materials are usually 
realized either in physical or chemical approaches. Traditionally, physical methods such as 
high-energy ball milling techniques are used to produce nano-sized magnetite. Because the 
preparation starts with high-purity bulk magnetite, and the materials are grinded until size 
reaches desired scale, this method is usually referred to as “top-down”. Physical methods are 
easy, inexpensive and effective at reproducibly defining nanostructure dimensions.2 However, 
they are limited in control over morphology and chemical composition of the materials, and the 
cost of the preparation would increase dramatically when sizes of the materials approach 10 nm. 
Solution-based wet chemical synthesis, also known as “bottom up”, on the other hand, is very 
efficient in preparing highly crystalline, mono-dispersed magnetite nanoparticles below 10 nm. 
By adjusting variable parameters such as temperature, reaction time, pH, ion strength and 
chemical concentration, the size, shape, colloidal stability and surface composition can be tuned. 
Based on the solvents and chemical reactions that leads to the formation of nanoparticles, the 
synthesis method can be categorized into two major classes: hydrolytic routes, including 
co-precipitation, microemulsion, sol-gel, polyol, and hydrothermal/solvolthermal methods; 
non-hydrolytic routes including various thermal decomposition in polar or non-polar solvents.      
 
1.1.1. Co-precipitation Method 
Coprecipitation of iron source in aqueous solution to yield nanocrystalline ferrites is the most 
widely applied technique among hydrolytic synthesis routes for the preparation of iron oxide 
magnetic nanoparticles for bioapplications, ascribed to its facility, versatility, low cost, the use of 
environmental friendly chemicals and ease for large scale production. Although very early report 
of hydrolytic synthesis routes can be found in literature,3,4 the first controlled preparation of 
magnetite nanocrystals was described by Massart in 1980, where ferrous and ferric salts (FeCl2, 
FeCl3) were precipitated by ammonia solution to yield 12 nm magnetite nanoparticles.4 He 
suggested that the mole ratio of Fe(III)/Fe(II) should be larger than two in order to get stable sol 
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and treating the precipitate with either alkaline or acid sol can both trigger peptization to produce 
stable solution, explaining by the idea that magnetite are able to adsorb OH- to carry negative 
charge in alkaline solution and adsorb H3O+ to be positively charged in acidic solution. Later on, 
many similar methods were developed by using various iron salts and different chemicals 
including alkaline hydroxides, ammonia solutions and urea as source for hydroxide ions.5-7 With 
this simple strategy, magnetite can also be obtained by partial reduction of Fe (III) salts solely, 
and maghemite (γ-Fe2O3) can be acquired by controlled oxidation of magnetite.3,8  
Iron oxide nanoparticles synthesized by coprecipitation method are influenced by many 
factors: type of base, precursor concentration, Fe(III)/Fe(II) ratio, ion strength temperature, etc.9 
By carefully modulating these factors, the size, shape, distribution and crystal structure can be 
tailored. For example, increased pH and ion strength lead to smaller particle size and narrower 
distribution;10 higher operating temperature not only affects the size of the iron oxide 
nanoparticle, it also greatly improves the crystallinity of the particles, which implies better 
magnetic properties.11 
Although the magnetite can be prepared without any presence of surfactant in 
coprecipitation method, and the surface of particles are able to adsorb water molecules to form 
fairly stable solution, introducing capping agents into coprecipitation method during or after the 
reaction enable the possibility of a better control on the size and uniformity of the final product 
as well as rendering stronger stability in aqueous solution to iron oxide magnetic nanoparticles. 
Bee et al.12 took advantage of the strong chelating property of carboxyl group and multiple 
binding sites of citric acid to effectively inhibit the growth of the nuclei, which leaded to the 
decreased size of maghemite nanoparticles from 8 to 2 nm with increasing citric acid 
concentration. Several synthesized block polymers were tested for the stabilization of magnetite 
nanoparticles in aqueous solution and the polymers themselves are either pH sensitive or heat 
sensitive, which are valuable for cancer treatment.13  
Considering the simple preparation process of coprecipitation, its mechanism is rather 
complex. The chemical reaction leading to Fe3O4 can be generally written as: 
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Fe3+ + 2Fe2+ + 8OH-  Fe3O4 + 4H2O 
Many phase transformations between iron oxide: akaganeite (yellowish brown colored 
monoclinic iron (III) oxy-hydroxide with ideal formula: β-Fe3+O(OH)) to goethite (brownish 
black colored orthorhombic iron (III) oxy-hydroxide with formula: α-Fe3+O(OH)) and/or 
hematite (steel-grey to black colored trigonal iron (III) oxide with formula: α-Fe2O3), goethite to 
hematite, hematite to magnetite (Fe3O4, spinel group, cubic system) and lepidocrocite (deep red 
colored orthorhombic iron (III) oxy-hydroxide with formula: γ-FeO(OH)) to maghemite (γ-Fe2O3) 
were observed during the preparation of iron oxide nanoparticles in coprecipitation method. Ahn 
et al.14 presented a very detailed discussion about the underlying mechanism, which will be 
beneficial to improving the uniformity and crystallinity of the magnetite nanoparticles produced. 
The results indicated that phase transformation of iron oxyhydroxides was responsible for the 
formation of magnetite nanoparticles rather than direction reaction of Fe3+ and Fe2+ in aqueous 
solution. They also suggested that if the base was slowly and continuously added to the iron salt 
solution, the initial nucleation only resulted in akaganeite that would further dissolve and became 
goethite, followed with a topotactic transformation to magnetite as pH of reaction solution 
increased. Additional reaction route would emerge if the base was introduced immediately, 
featured in transformation from lepidocrocite to magnetite, which is probably due to the 
inhomogeneity caused by the abrupt addition of alkali solution.  
Currently, many novel synthesis methods that effectively produce high quality iron oxide 
magnetic nanoparticles have been developed, the coprecipitation method still preferred by many 
researchers because it is facile, low cost, ‘green’ and easy to scale up. However, despite the 
waters-solubility, the broad size distribution and poor magnetic properties of nanoparticles 
prepared by this method may become a significant blockage toward practical bioapplications. 
 
1.1.2. Microemulsion Method 
  Considering that iron oxide magnetic nanoparticles prepared by coprecipitation method do 
not possess ideal uniformity on size and shape, attention was paid to microemulsion, a system  
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Scheme 1.1. Microemulsion synthesis for water-soluble iron oxide magnetic nanoparticles 
used for preparing ultrafine polymeric nanoparticles, for their potential in narrowing size 
distribution of iron oxide nanoparticles.15 Many nanomaterials including metals, alloy and metal 
oxide nanoparticles have been successfully synthesized by this method.16 A typical 
microemulsion system is composed of two mutually immiscible liquids, a surfactant and 
frequently a cosurfactant, where one of the two liquids is stabilized by the surfactant molecules 
and form isotropic droplets in the second liquid.9 As shown in Scheme 1.1, these fine droplets act 
as a nanoreactor that can suppress the size distribution of the nanoparticles by confining the 
chemical reactions only within the cavities.3 The micelles loaded with chemicals that are 
necessary for the synthesis, move erratically in the solutions, leading to collide and coalesce of 
two droplets, which results in the formation of transient droplet dimers that facilitate the 
exchange of the contents within in the cores and nuclei aggregation.9,15 The size of the 
nanoparticles can be tuned by adjusting the surfactant/water ratio which determines the size of 
the droplet. The reaction behind the formation of the nanoparticles is basically the same as in the 
coprecipitation method, where stoichiometry ratio of Fe3+/Fe2+ is precipitated to form nanometer 
sized crystals upon the addition of alkali.17 Consequently, the low crystallinity of the iron oxide 
nanoparticles, which is largely affected by the reaction temperature, has not improved 
significantly in microemulsion method. Additionally, given the large amount of solvent 
consumption during the preparation, the product yield of microemulsion method is not very 
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satisfying compared to other methods. Moreover, ascribed to the presence of surfactant for the 
emulsifying process, the purification procedures can be complicated and tedious. 
  
1.1.3. Hydrothermal/ Solvothermal Method 
Given that iron oxide nanoparticles prepared by the co-precipitation method are poor in 
crystallinity, which affects their magnetic properties, hydrothermal or solvothermal methods 
were developed to obtain highly crystalline ferrites. The synthesis is performed in a sealed 
container, usually an autoclave, at a temperature close or higher than the boiling point of solvents, 
which can increase the internal pressure to more than 2000 psi.8 From literature, although many 
different compounds are used for the hydrothermal/solvothermal synthesis, the proposed 
mechanism for the formation of the iron oxide nanoparticles is mainly the same as in 
co-precipitation, where is iron salts are precipitated by hydroxide anions, usually coming from 
alkaline hydroxides, ammonia, urea or decomposition compounds, to form iron hydroxide, 
followed with dehydration to yield oxide.18,19 The high temperature and pressure assist the 
growth of well-order crystal structure, which greatly improves the magnetic properties of the iron 
oxide nanoparticles. By tuning experimental conditions, variable sized or even different 
structured particles can be prepared.20,21 Under normal circumstances, prolonged reaction time, 
higher iron source concentration and lower temperature produce large particles, because long 
reaction time favors the grain growth, and nucleation speed is slower than grain growth at lower 
working temperature, leading to larger particle size.8,20 Li and coworker reported the first 
single-crystalline ferrite particle fabrication approach by the solvothermal reduction method. 
Ethylene glycol was solvent and reducing agent, and anhydrous sodium acetate was used to 
assist the reduction process and prevent agglomeration. The particles are single crystalline, 
quasi-spherical in shape with a very narrow distribution (≈5%), and water-stable. The particle 
size can be varied from 200 nm to 800 nm through adjusting reaction time and chemical 
concentration.20 It is shown that by introducing 1,6-hexadiamine to the system and controlling 
the amount of anhydrous sodium acetate, amine-functionalized magnetic hollow nanospheres 
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were yielded.21 Xuan et al.22 claimed that, the addition of sodium acrylate instead of 
1,6-hexadiamine will produce monodispersed polycrystalline Fe3O4 nano/microspheres with 
large surface area, which can be applied for MRI and therapeutic applications. Despite the good 
crystal structure offered by the hydrothermal/solvothermal synthesis, because sealed containers 
are used, which is difficult for sufficient mixing, many reported methods using this technique do 
not yield products with satisfying shape and uniformity.18,23    
 
1.1.4. Polyol Method 
Polyol method is a versatile synthesis route to prepare various inorganic compounds, which 
use high boiling point alcohol as reaction medium. The very first reported polyol synthesis 
appeared in a patent, more than two decades ago, by which Figlarz et al. obtained metallic 
powder through the reduction of metallic cation in the presence of polyols.24,25 Feldmann 
suggested that polyol mediated synthesis can be a very efficient strategy to prepare nanoscale 
materials because of the many excellent properties offered by the polyols.26,27 For instance, 
diethylene glycol (DEG), a member of polyol, possesses relatively high boiling point (245 °C) 
which enables the reaction to be performed at high temperature so as to improve the crystallinity 
of the nanoparticles. Its high dielectric constant (ε = 32) can dissolve a wide range of polar and 
ionic substances. DEG is able to form chelate complex with metal ions, which will participate in 
the formation of nanocrystals.26 Based on polyol method, γ-Fe2O3 nanoparticles in the size range 
of 10 to 100 nm can be formed by simply dissolving FeCl3·6H2O in DEG and heating the 
mixture to near reflux temperature for different durations.26 The mechanism behind the polyol 
method can also be understood as a sol-gel method where, metal sources, e.g. metal alkoxide, 
metal chloride and metal acetate, undergo hydrolysis to form intermediate compound which will 
condensate into crystalline oxide. O’Connor and his team developed a polyol method using DEG 
as solvents to synthesize hydrocarbon-soluble transition metal ferrite nanocrystals (MFe2O4, 
M=Mn, Fe, Co, Ni, Zn). They proposed that during the synthesis, softer Cl- ligands remain intact 
and DEG molecules form complexes with metal ions. Followed with deportation upon the 
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addition of sodium hydroxide, softer alcohol ligands are converted into harder alkoxide. After 
heating is applied, the metal complexes hydrolyze, which starts the condensation of 
intermediates and leads to the precipitation of metal oxide.28 The resulting nanoparticles are 
highly crystalline and uniform, attributed to the high reaction temperature and chelating 
properties of DEG that limit the grain growth and prohibit the agglomeration of the particles.29 
Further investigation revealed that partially replacing DEG with N-Methyl diethanolamine 
(NMDEA), a DEG analog with stronger chelating ability, larger magnetite nanoparticles can be 
prepared. This result is very much like the situation in many thermal decomposition methods 
where higher ligand to iron precursor ratio usually yields larger iron oxide nanoparticles, because 
stronger or more binding ligand will lower the reactivity of monomers, leading to less nuclei and 
increased availability of precursor in solution.30  
The DEG shell on the iron oxide nanoparticles can be replaced by many small molecules or 
polymer to immobilize various functionalities to the particle surface.31 DEG itself can also render 
water solubility to nanoparticle surface by generating charges from its multiple oxygen atoms in 
the molecule.32 Moreover, the hydroxyl group of the DEG also presents reactivity toward silane 
molecules, a group of compounds that are commonly used to deliver certain functionality (e.g. 
amine) to iron oxide nanoparticles prepared by coprecipitation method.5,33  
 
1.1.5. Thermal Decomposition of Iron Precursors in Polar or Non-Polar Solvents. 
Since first introduced by Alivisatos and co-workers in 1999, the non-hydrolytic 
single-precursor approach has quickly become the most popular method for the preparation of 
surfactant capped transition-metal nanocrystals.34 In their method, metal cupferron complexes 
were chosen as precursor for transition metal oxide, and trioctylamine was adopted as solvents 
and capping agents. By using the hot injection technique that developed by Murray et al. for the 
synthesis of nearly monodispersed semiconductor nanocrytallities, transition metal precursors 
stock solution were quickly added to the hot solvents and maintain at elevated temperature for 
certain amount of time.35 The resulting nanoparticles are highly uniform with well-developed 
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crystal structure. Later, in 2002, Sun et al.36 reported a different strategy of preparing variable 
sized iron oxide nanoparticles, where the flask that contained all chemicals that are necessary for 
the synthesis, including precursors, reducing agents and capping agents, were heated to reflux 
temperature to yield nanocrystals. Inspired by this work, many similar synthesis methods using 
either slow or rapid heating instead of injection were reported to successfully synthesize high 
quality magnetite and maghemite nanocrystals with tunable size.30,37-39  
Despite the excellent product quality offered by the conventional thermal decomposition 
method, the hydrophobicity nature of the ligand shell greatly hamper employing nanoparticles in 
bio-related areas. Switching from non-polar solvents to polar solvents as synthesis medium is a 
simple but rather effective idea to improve the hydrophilicity of magnetic nanoparticles without 
sacrificing the outstanding features brought by the thermal decomposition method. Li et al.40 
chose 2-pyrrolidone, a high boiling point polar solvent (boiling point=245 °C) as reaction 
medium and iron acetylacetonate, a commonly used chemicals in many non-polar thermal 
decomposition methods as iron precursor. A 10 min heating treatment at temperature near boiling 
point would result in magnetite nanoparticles of 5 nm with 24% deviation, while larger particles 
could be synthesized by using 5 nm nanoparticles as seeds. Cai et al.41 took advantage of the 
many extraordinary properties of polyols and performed the pyrolysis in four kind of polyalcohol 
molecules with different length of repeat unit, concluding that magnetite nanoparticles prepared 
in triethylene glycol can be dispersed in water and other polar solvents and form stable solution. 
As seen from two methods above, different from thermal decomposition in non-polar solvents 
where reducing agents and capping agents are necessary during the synthesis, in polar solvents 
mediated thermal decomposition, only solvents and iron precursors are involved during the 
reaction. In fact, those polar solvents contribute to the synthesis from three aspects. First, they 
are solvents for the dissolution of the iron sources. Second, they chelate with iron atoms, 
facilitate the nucleation and subsequent particles growth. Third, they are reducing agents that 
partially reduce Fe3+ to Fe2+ so as to form Fe3O4. The as-prepared particles are highly crystalline 
and readily soluble in water, with a slight larger size deviation compared to non-polar solvents 
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synthesis method. Li and coworker further expand the versatility of their method by introducing 
homofunctional or monofunctional PEG to the 2-pyrrolidone system, which significantly 
enhance the stability of resulting magnetite nanoparticles in buffer solution, improve the 
biocompatibility and offer potential reaction site for future modifications.42,43 Besides 
pyrrolidone and polyols, polyamines are also promising candidate solvents for similar purpose. 
We have developed the first polyamine mediated synthesis of magnetite nanoparticles using 
triethylenetertramine (TETA) as solvents, reducing agents and capping ligand.44 The as-prepared 
particles have much narrower distribution compared to aforementioned methods, with stability in 
many polar solvents. Moreover, numerous reactive amine functionalities are on the surface and 
readily available for any amine related conjugation.  
 
1.2. Surface Functionalization of Iron Oxide Nanoparticles 
The bioapplications of magnetic nanoparticles require the materials to possess certain 
properties or bear specific surface functionalities, which is usually accomplished in a 
multiple-steps modification. The as-prepared iron oxide nanoparticles, however, are basically 
unable to satisfy the standards of most applications. For instance, iron oxide nanoparticles 
prepared by conventional coprecipitation method only have adsorbed water molecules on the 
surface in aqueous, which is hardly qualified for any in vivo applications. Thermal 
  
Scheme 1.2. Strategies for nanoparticles surface functionalization. 
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decomposition method produced monodispersed nanoparticles that are only stable in non-polar 
solvents, which are not readily available for bio-related purposes. Therefore, surface 
functionalization on the iron oxide nanoparticles is essential, which render water-solubility or 
desired function to nanoparticle. As shown in Scheme 1.2, there are two approaches for surface 
functionalization: ligand exchange and postsynthetic modification on the existing ligand shell.  
 
1.2.1. Ligand Exchange 
  Ligand exchange reaction which involves the replacement of original ligand shell with new 
capping agents is an extensively applied approach for surface modification among many 
researchers.45 By exposing the nanoparticles to an excess of competing ligand, followed with 
isolation, nanoparticles partially or fully covered with a new ligand layer are obtained.46 Through 
this method, a wide variety of chemical functionalities can be immobilized onto the surface of 
nanoparticles. Repeating the exchange process allow more thorough replacement even if the 
binding of new ligand with nanoparticles is less favorable than the original.46 Since the 
nanoparticles should be well dispersed to maximally expose their surface to new ligand and the 
replacement only take place at the liquid–solid (solution-nanoparticles) interface, appropriate 
solvents will assist the exchange whereas unfavorable solvents will greatly limit the ligand 
replacement, resulting in poorly covered surface with new ligand and low colloidal stability. 
Directly adding nanoparticle into nonsolvents could cause huge agglomerations that are 
extremely difficult to redisperse, which makes the exchange process difficult. A simple way to 
avoid the problem is to dissolve nanoparticles and ligand in favorable solvents respectively, 
followed with thoroughly mixing such as rapid stirring, vortexing or sonicating (Scheme 1.3). 
Driven by the mass action, nanoparticles will be extracted from their original solvents A to 
solvent B, and stabilized with new ligand. Xu et al.47,48 utilize this method to transfer 
hydrophobic iron oxide nanoparticles from hexane into water for bioseparation purpose. A 
common problem exists in this method is that if the solvents for nanoparticles and new ligand are 
not miscible, the reaction can be time consuming to allow more complete exchange because the 
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Scheme 1.3. Conventional ligand exchange reaction for nanoparticles surface modification. 
ligand replacement will only happen at the interfaces of the two solvents, which largely limit the 
exchange efficiency. An alternating route, which is more popular, is using two miscible solvents 
or a solvent in which both the new ligand and the nanoparticles possess acceptable solubility. 
Common solvents for ligand exchanges are alcohols,49,50 dimethyl sulfoxide (DMSO),51 
tetrahydrofuran (THF),52 dimethylformamide (DMF),53 dichloromethane54 and cholorform.55 
After the reaction, by simply removing the mixing force or adding non-solvent to the system, 
replaced nanoparticles will slowly precipitate. With the help of centrifuge or external magnetic 
field, functionalized magnetic nanoparticles can be collected and then redispersed in fresh 
solvent. By repeating cycle above, purified product can be obtained. Other purification methods 
such as dialysis and membrane ultracentrifugation are also suitable for water-soluble product. If 
the binding of new ligand shell is much more favorable than the original shell, a single ligand 
exchange followed with isolation and purification process can yield product with good exchange 
efficiency. However, if the binding of new ligand is weaker than the origin, multiple exchange 
reactions might be necessary to assure a more complete replacement.  
 
13 
 
Ligand exchange method offer several advantages for nanomaterials surface 
functionalization.45,56 First, numerous candidate molecules can be tested for their potential as 
coating materials using ligand exchange method. Second, only new ligand, solvents and 
nanoparticles to be functionalized are involved in the reaction, suggesting a simple and 
straightforward experimental set-up. Third, the reactions are usually performed at ambient 
condition or relatively lower temperature, which allow using heat sensitive ligand molecules. 
Fourth, before the ligand exchange reaction, the synthetic coating agents can be fully 
characterized using NMR, mass spectrometry or other techniques without the interference from 
nanomaterials.  
A major limitation for room temperature ligand exchange is their low exchange ratio, 
especially problematic when large quantities of product are needed. A possible solution is to 
perform the reaction in high boiling point solution at elevated temperature which favors the 
exchange through mass action.57 The decreased stability after ligand exchange, which either 
result from desorption of new ligand from nanoparticle surface or degradation of the ligand 
molecules themselves, is also noticed.57,58 Introduction of cross-linkage among surface ligand 
such as disulfide bonds between 2,3-dimercaptosuccinic acids molecules, are able to effectively 
improve the structural stability.59 Alternatively, multidendate ligand polymers such as polyacrylic 
acid are also resistant to desorption effect. A number of studies have shown that ligand exchange 
of quantum dots (QDs) often involves of loss of optical properties.56 In Lattuada’s studies, they 
also claimed that during the ligand exchange for iron oxide nanoparticles some surface atoms 
came off along with the replaced ligand molecules, supported by the fact that the supernatant was 
slightly red in color after the precipitation of the nanoparticles, which is an indication of the 
presence of iron atoms.50   
 
1.2.2. Postsynthetic Modification on the Existing Ligand Shell 
Different from ligand exchange method, postsynthetic modification directly take advantage 
of the ligand layer of as-prepared nanoparticles. Iron oxide nanoparticle prepared by 
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co-precipitation or polyol method usually carry plentiful hydroxyl groups, coming from the 
adsorbed water or polyalcohol itself.5,29 Utilization of these hydroxyl groups are commonly 
accomplished by reacting with silane molecules. This types of compounds such as 
(3-Aminopropyl)triethoxysilane (APTES) and (3-mercaptopropyl) trimethoxysilane (MPTMS) 
are usually bifunctional molecules which carry a silane terminal that can hydrolysis and couple 
with hydroxyl group and a functional terminal such as amine and thiol that are available for 
further reactions. Simply dispersing the nanoparticles in alcohol along with silane molecules 
containing desired functionality can yield nanoparticles coated with a thin layer of silica bearing 
selected functional groups.60 If thick silica layer which can generate more protection for the core 
materials and larger steric effect is preferred, a co-condensation process that often involves the 
addition of another silica precursor, tetraethyl orthosilicate (TEOS) and ammonia as catalyst can 
be applied.61 Other hydroxyl group activation methods either require anhydrous condition or 
very high pH to ensure an efficient coupling, where the stability of iron oxide can be a major 
issue.62  
During the preparation of iron oxide nanoparticles, certain molecules can be added to the 
synthesis medium, serving as capping ligand and providing possible site for future modification 
simultaneously. Several commercial iron oxide nanoparticles based MRI contrast agents are 
prepared by coprecipitation method with in situ coating with dextran.8,63 By refluxing polyacrylic 
acid or biscarboxyl PEG together with iron precursors, polymer stabilized nanoparticles with 
abundant surface functional groups can be easily prepared in large scale.43,64 Unfortunately, 
highly quality iron oxide nanoparticle prepared through thermal decomposition method in 
non-polar solvents are not readily available for directly surface reaction because monofunctional 
capping molecules (i.e. oleic acid, oleylamine) are general chosen for the surface passivation. 
Introduction of amphiphilic molecules to the surface, where the hydrophobic chain will insert 
into the origin ligand layer through hydrophobic interaction and leave hydrophilic head groups 
exposed to the environment, can endow aqueous stability to the nanoparticles.65 The hydrophilic 
head can be either simple charge generating groups or functions like carboxyl groups.66  
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Questions about postsynthetic modifications most lie in whether the existing coating layers 
are able to protect the core materials from degradation during the repeated reactions. For 
example, magnetite nanoparticles are sensitive to oxidative conditions and persistent exposure to 
such environment might result in attenuated magnetic properties. A thin layer of organic ligand is 
not capable to fully prevent the possible deterioration of core materials (i.e. surface atom loss) 
whereas thick polymer shell can dramatically increase the hydrodynamic radius of nanoparticles 
in aqueous solution, which may alter their metabolism and clearance pathway. Nevertheless, both 
ligand exchange and postsynthetic modification have presented their advantages as well as their 
drawbacks. Carefully choosing the appropriate method for surface functionalization will deliver 
desired functionalities to the surface while remain nanoparticles themselves intact.  
 
1.3. Stabilization of Iron Oxide Nanoparticles in Solvents 
One of the fundamental prerequisite to employ nanoparticles for clinical diagnosis and 
treatment purpose is that a stable colloidal solution can be formed without any significant 
agglomeration and precipitation over a desired time period when iron oxide nanoparticles are 
dispersed in aqueous solutions. Therefore, the stabilization of nanoparticles in solvents is a 
non-avoidable factor that must be considered during the preparation of functional nanomaterials. 
Generally, four types of forces dominate the inter-particle potential in the magnetic nanoparticles 
colloidal dispersion system.3,45 Short-range isotropic attraction induced by van der Waals forces 
and magnetic dipole interactions are responsible for the aggregation of magnetic nanoparticle 
whereas repulsive forces are mainly generated from electrostatic interaction and steric hindrance. 
From the literature, scientists also described an oscillatory force, called solvation or structural 
forces, which arises when the distance of inter-particle separation is less than about 1-2 nm. 
Within such close separation, the liquid molecules are confined between the solid surfaces and 
variation of the confinement results in the oscillatory nature of this force.67-69 Nevertheless, the 
stability of the colloidal solution is a result of the equilibrium of attractive forces and repulsive 
forces. Because the colloidal stability of the nanoparticles is closely related to their surface 
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chemistry, applying certain stabilizer that are able to generate electrostatic or steric repulsion on 
the surface of magnetic nanoparticles is considered be an effective approach to elaborate the 
dispersibility of the magnetic nanoparticles. 
 
1.3.1. Monomeric Stabilizers 
According to hard and soft acids and bases theory (HSAB), small or highly charged cations 
(hard acid), i.e. Fe3+ react faster and form more stable complexes with hard base, e.g. ROH, 
RNH2. Thus, Lewis base head groups bearing compounds that contain O or N atoms, such as 
carboxylic acids, alcohols, phenols, amines, imines, phosphates are often chose as capping ligand 
for iron oxide nanoparticles.     
 
Scheme 1.4. Possible surface complexation structures formed between surface Fe ions and 
monocarboxylate 
1.3.1.1. Carboxyl 
When referring the colloidal stability of iron oxide nanoparticles, a type of extensively 
considered candidates are molecules with carboxyl head groups. Numerous researches can be 
found using carboxyl group containing molecules that are natural occurring,50 synthetic,42 
hydrophobic,70 hydrophilic,71 amphiphilic72 and single or multidendate,64 as strong stabilizer for 
the passiviation of iron oxide nanoparticles. Generally, there are three binding schemes for a 
monocarboxylate with nanoparticles (Scheme 1.4): monodentate structure where only one 
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oxygen from carboxyl group chelating with the metal atoms; bidentate chelating structure where 
both hydroxyl oxygen and carbonyl oxygen from carboxyl group bonding with the same metal 
atoms, bidentate bridging structure where hydroxyl oxygen and carbonyl oxygen bonding with 
different metal atoms.73-75 Among these structures the bidentate chelating has the highest stability. 
If compound with two or more adjacent carboxyl group such as succinic acid, is used as capping 
ligand, besides the three aforementioned surface complexations, eight more possible chelating 
schemes emerge. For examples, oxygens from two carboxyl group can chelate with the same 
atom or two different atoms on the surface of nanoparticles leaving the other two oxygens 
unbounded or both oxygens from each carboxyl groups bind with one atom respectively or four 
different atmos.73,75 Additionally, those carboxyl oxygens are able to form hydrogen bonded 
structure with surface atoms in several different ways.73  
In many thermal decomposition methods where high quality iron oxide nanoparticles are 
synthesized, long chain fatty acids always play a vital role in obtaining desired products. In Sun’s 
method,76 where oleylamine and oleic acid were capping ligand, solely using oleylamine resulted 
in very low yield of the product. Woo et al.77 discovered that by increasing the amount of oleic 
acid with respect to iron source, larger sized maghemite nanoparticles can be prepared. Similar 
trend was observed in Yu et al.30 work where higher mole ratio of oleic to iron source leaded to 
larger magnetite nanoparticles. Interestingly, opposite results were reported by Guardia and 
co-workers.37 Not only did smaller amount of oleic acid cause larger particles size, the shape of 
nanoparticles were also more cubic like when decreasing the volume of decanoic acid. 
Among many candidates, citric acid, composed of three carboxyl group, is a popular and 
powerful capping ligand for water-soluble magnetic nanoparticles.78 Iron oxide nanoparticle 
capped by pure citric acid presents a very high and stable zeta potential of -75 mV from pH 4 to 
basic conditions, and their hydrodynamic radius is as small as 15 nm when the core size is less 
than 10 nm, indicating a excellent colloidal stability in water or water/alcohol mixture.50 The 
unattached carboxyl group are readily available for the conjugation of biocompatible polymers 
such as amine-PEG or fluorescent dyes such as Rhodamine 110.78 Although the hydroxyl group 
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are not reactive toward acylation, a combination use of citric acid and 2-bromo-2-methyl 
propionic acid (BMPA), a very efficient atom transfer radical polymerization (ATRP) initiator 
can effectively provide sufficient stability and polymerization property simultaneously.50 Until 
now, countless capping molecules with variety of functionalities, i.e. fluorescent properties, 
specific binding affinity with certain molecules, have been prepared or tested, and most of these 
compounds rely on the simple –COOH structure for forceful bonding with nanoparticles. In 
chapter II, a novel in-situ surface modification method where new ligand molecules are injected 
at the end of synthesis will be introduced. The selected capping agents are all carboxyl group 
bearing bifunctional molecules such as amino acids. Through hot injection techniques, new 
capping ligand are able to quickly replace the original layer and bound to nanoparticle via 
carboxyl group even in the presence of large excessive amount of competing capping agents, 
clearly demonstrating the strong binding affinity of carboxyl group with iron oxide nanoparticles.   
 
1.3.1.2. Amines 
Molecules containing amine functionalities are widely used for the coating of noble metal 
nanocrystals and semiconductors because of the strong binding affinity of amine with many 
transitional metal elements, which is originated from the electrons sharing between nitrogen and 
metal atoms.79-81 In iron oxide nanoparticles stabilization, amine-containing molecules also 
frequently appear. In 1999, Alivisatos and his team reported the first non-hydrolytic 
single-precursor approach to prepare dispersible nanocrystals of transition metal oxides.34 Iron 
cupferron complexes in octylamine were injected into long-chain amines at 250-300 °C to yield 
nearly mono-dispersed γ-Fe2O3 nanoparticles. After that, considerable numbers of similar 
synthesis routes have been reported and many of them adopted long chain fatty amine as capping 
ligand to passivate the surface of iron oxide nanoparticles.36,82 Instead of using hydrophobic long 
chain amine in thermal decomposition method to prepare non-polar solvents dispersible 
nanoparticles, adding them in hydrolytic method or directly applying hydrophilic amine 
containing compound will render nanoparticles with water-solubility. Aslam et al.83 prepared 
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amine-stabilized aqueous colloidal iron oxide nanoparticles by using dodecylamine as both base 
and stabilizing agents. Wang et al.21 reported a novel hydrothermal method to prepare 
amine-functionalized magnetite nanoparticles. The addition of 1,6-hexanediamine to the 
synthesis system not only deliver water-solubility to the nanoparticles, but also provide reactive 
amine groups toward the conjugation with human IgG-antigens for the separation of FITC 
labeled goat anti-human IgG antibodies.  
Interestingly, in many colloidal synthesis methods, besides the chelating properties, 
alkylamines also present reductive properties during the nanoparticles preparation. Xu et al.82 
described a facile synthesis of magnetite using oleylamine as both reducing and stabilizing 
agents. They emphasized that the presence of excess amount of oleylamine is the key to partially 
reducing Fe3+ to Fe2+ so as to form Fe3O4. In chapter IV, a novel synthesis route involving only 
iron precursor (i.e. Fe(III) acetylacetonate) and polyamine (i.e. triethylenetetramine, TETA) will 
be discussed. During the reaction, no other reducing compound or capping ligand are added, 
indicating that TETA are solvents, reducing and stabilizing agents simultaneously. Although, the 
mechanism is not fully understood, evidenced from several measurements strongly suggest that 
polyamine molecules participated in the decomposition of iron precursor and the nucleation and 
subsequent growth of the iron oxide nanoparticles.      
 
1.3.1.3. Hydroxyl 
Alcohols, glycols or any hydroxyl groups bearing compound can be considered as potential 
capping ligand for iron oxide nanoparticles coating. Until now, there are still many research 
articles using simple co-precipitation to prepare nanometer sized iron oxide magnetic 
nanoparticles, where only iron sources are added without any capping agents. The products are 
fairly stable in aqueous solution because water molecules are adsorbed on the surface of 
nanoparticles.5 Under same principle as nitrogen, oxygen atoms from –OH group of water 
molecules share electrons with iron ions and form chemical bonds. Thus, when naked iron oxide 
nanoparticles are dispersed in water, they carry many –OH groups on the surface, which is 
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available for further conjugation such as silanization.84 However, merely water adsorption can 
generate neither steric effects nor powerful electrostatic repulsion to stabilize nanoparticles, 
especially in solutions with high ion strength such as PBS buffer. In 2001, Feldmann developed a 
polyol-mediated method for the preparation of nanoscale oxide particles including iron oxide, 
using diethylene glycol as solvents and capping ligand. The multiple oxygen atoms from 
hydroxyl groups and ether groups chelate with metal ions and are charged in water, assisting 
nanoparticles to disperse in aqueous solutions well.29,85 Since then, many different polyalcohols 
varied in molecules weight and structures were used as ligand shell materials and synthesis 
medium to prepare iron oxide magnetic nanoparticles at elevated temperature, leading to good 
crystallinity, uniformity and colloidal stability.20,32,41 Comparing to carboxyl groups and amine 
groups, hydroxyl function is relatively weak in binding with metal ions not only because the less 
electronegativity than nitrogen but it only forms monodentate species without a chelating ring 
structure. However, there are a type of special hydroxyl groups bearing compounds called 
enediol such as dihydroxy cyclobutenedione, ascorbic acid and catechol, reveal outstanding 
binding ability with metal oxide particles.86 Among these compounds, dopamine a 
neurotransmitter that consists of an amine group linked to a catechol structure is an excellent 
representation of enediol in iron oxide nanoparticles surface modification. Considerable numbers 
of studies have been published using dopamine or their derivatives as a strong anchor to stabilize 
iron oxide nanoparticle in water and buffer solutions.47,53,87,88 The catechol structure bonds with 
iron ions and form a five-member metallocycle chelate while the amine side are highly reactive 
towards conjugation with numerous drug or biomolecules.58 Although there are still debates 
among researchers on the suitability of dopamine as anchors for iron oxide nanoparticle coating 
because of the possible degradation and subsequent cytotoxicity once adsorbed on particles 
surface, more efforts have being made to improve the stability of dopamine structure without 
impairing their robust anchoring properties.58,88,89   
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1.3.1.4. Others 
There are many other types of compounds can be used as monomeric stabilizers, less in 
popularity though, as long as they meet the standard of HSAB theory. Alkanephosphonic acid 
compounds are commonly seen in nanometer sized semiconductor synthesis.90 One or two 
oxygen atoms in the phosphonate groups bind with metal atoms on the surface and phosphates 
form self-assembled monolayers.91 An advantage of phosphonate or phosphate is their good 
biocompatibility which would enhance the possibility of using coated magnetic nanoparticles in 
certain in vivo application such as MRI or drug delivery. Another type of compound reported for 
iron oxide nanoparticles coating is molecules with a thiol head groups.92 The sulfur atoms in the 
thiol groups are able to bind to nanoparticle surface through a Fe-S bond. However, probably due 
to the less stability of thiol group (oxidation in air and formation of disulfide bonds), which may 
hamper their binding with nanoparticles, thiol groups are preferred as potential react site for 
further modification rather than head group for binding.  
In mid 199s, Folkers proposed a structure called hydroxamic acid that possesses stronger 
bonding ability with iron oxide nanoparticles than carboxylic acid.93 He suggested that compared 
to carboxylic acid that only chelate in monodendate style or form a four-member ring, larger bite 
size of hydroxamic acid, which forms a five-member ring indicates greater stability of the 
complex. Kim et al.55 adopted this structure, synthesis dendritic polymers bearing hydroxamic 
acid function and replace stearate-coated Fe3O4 to form super-stable colloidal solution in both 
organic and aqueous solution. However, because of the wide availability and well established 
bonding properties of carboxylic acid structure, the powerful hydroxamic acid chelating structure 
did not drag widespread attention in research area.   
 
1.3.2. Polymer Stabilizers 
Polymer stabilizers that are rich in repeat units, offer several attracting properties that are 
difficult to achieve in small molecules. They are either much more effective in generating steric 
effect or featured in a multidentate structure that provide abundant binding site with 
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nanoparticles, indicating that the common disassociation problem existing in small molecules 
stabilizer is negligible. The head groups or the binding functionalities, on the other hand, are 
basically obeying same rule as in monomeric, which are hard Lewis bases containing O or N.  
  
1.3.2.1. Polyethylene Glycol (PEG) 
PEG and their derivatives are probably the most well-known polymers and are extremely 
useful in drug molecules or proteins modification and biocompatible coating of nanomaterials. 
PEGs possess several remarkable features that make them popular in biomedical applications: 
excellent aqueous solubility, very low toxicity, long blood circulation time, low immunogenicity 
and accumulation in RES system and outstanding pharmacokinetic behavior. PEGs are often 
chosen to enhance the solubility, improve or change the biodistribution of drug molecules or 
lower the risk of severe immune response of some protein drugs.94,95 In nanomaterials, PEGs are 
broadly applied for coating purpose in order to render better aqueous stability to functional 
nanomaterials or assist them to avoid rapid clearance by RES system in liver and spleen and 
increase circulation time of several nanocarrier to realize prolong drug release.33,96-98 The 
ethylene oxide repeat units are capable to create steric effect and electrostatic charges, which are 
both important for forming stable nanoparticle dispersion. Based on the well-developed 
conjugation technique, the terminal of normal PEG molecules can be easily activated and turn 
into any function. Moreover, there are varieties of monofunctional, homofunctional, 
hetrofunctional, or even Y-shaped PEG products available commercially, which provide a lot of 
convenience for PEGylation.  
Functionalization with PEG can be achieved either during the synthesis of the nanoparticle 
or through post-synthetic modifications. Li et al. described a one-pot approach to synthesize 
biocompatible magnetite nanoparticles, where monofunctional, or homofunctional carboxyl 
terminated PEG molecules are refluxed together with iron source in a 2-pyrrolidone solvent.42,99 
Although this method able to directly preparation water-soluble and biocompatible magnetite 
nanoparticles, further functionalization is still needed to immobilize more complicated 
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functionalities to the nanoparticles. Additionally, because certain conjugation require anhydrous 
environment to eliminate rapid hydrolysis of the chemicals, solvents such as anhydrous DMSO, 
THF, DMF, are usually preferred, and the stability of nanoparticles in these solvents could be an 
issue that might affect the conjugation efficiency. Ligand exchange method is more versatile and 
can simply solve the aforementioned problems. Desired functionalities or designed structure can 
be added to PEG backbones through organic reaction. Then, high-quality iron oxide 
nanoparticles prepared by thermal decomposition are dispersed in certain solvent along with 
functional PEGs, followed with either stirring or sonication and purification to get PEG protected 
nanoparticles.53,87,96 The drawback for ligand exchange method is also obvious. The purification 
of product from each organic synthesis step is time consuming compared to direct modification 
on the surface of nanoparticles, considering the simplicity of magnetic collecting and washing 
process. Nevertheless, iron oxide nanoparticles with a PEG based ligand shell have shown 
promising future in clinic diagnosis and treatment area. 
 
1.3.2.2. Dextran  
Dextran is frequently employed in iron oxide nanoparticle coating because two 
straightforward reasons: biocompatibility and multidentate binding sites. As a matter of fact, the 
coating agents for several earliest commercialized iron oxide MRI contrast agents (i.e. 
Ferumoxide, Ferrixan and Ferucarbotran) are almost exclusively dextran and its derivatives.3,8 
Dextran, composed of α-D-glucopyranosyl units with varying degrees of chain length and 
branching is rich in hydroxyl groups, leading to the possibility of hundreds of bonding between 
nanoparticle surface and one dextran molecules. In such a circumstance, the ligand shell is very 
stable and the detaching of binding groups can be ignored under normal condition. Additionally, 
the hydroxyl groups of dextran can be easily activated and modified with other functionalities. 
For example, in anhydrous conditions, -OH groups can be coupled to amine containing 
compounds under the activation of carbonyldiimidazole (CDI) or N,N’-disuccinimidyl carbonate 
(DSC). If buffer solution is preferred, either alkyl halogens such as chloroacetic acid or 
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bis-epoxide compounds, e.g. 1,4-butanediol diglycidyl ether can be applied to transfer carboxyl 
or epoxide to dextran via hydroxyl site at high pH condition.62 Besides dextran, there are many 
other types of polysaccharide compounds that are composed of slight different repeat units, 
considered to be potential coating layer materials. Kroll et al.71 reported an approach using 
alginate, an electrolytic polysaccharide with many carboxyl groups to coat SPIONs 
(superparamagnetic iron oxide nanoparticles). Kim et al.100 embedded spherical SPIONs in 
chitosan, a linear polysaccharide with randomly distributed D-glucosamine and 
N-acetylglucosamine, by a sonochemical method and demonstrated their strong enhancement 
property in the contrast of MR image. Other common hydroxyl containing hydrophilic polymers 
in iron oxide nanoparticle coating are polyvinyl alcohol (PVA) and polyvinylpyrrolidone 
(PVP).101,102 These polymers are introduced either in-situ or through ligand exchange to 
nanoparticles surface and bonding under similar principle as dextran.103,104  
 
1.3.2.3. Polyacrylic Acid (PAA) 
Polyacrylic acid, an anionic polymer with rather simple structure, is biocompatible and 
especially rich in carboxyl groups, which make it perfect candidate for iron oxide nanoparticles 
coating for biological purposes. The abundant –COOH function is capable of steady binding, 
generating columbic repulsion and providing plentiful reaction sites for further modification. 
Lattuada et al.50 systematically studies PAA coated SPIONs and found out that nanoparticles 
with PAA layer are negatively charged with a zeta potential of -50 mV from light acidic to basic 
condition. The results from dynamic light scattering (DLS) also confirmed the good stability of 
PAA-Fe3O4 with the proof of nearly constant hydrodynamic size around 15 nm from pH 5 to pH 
10. They performed the PAA coating via direct polymerization of trimethylsilyl acrylate (TMSA) 
monomers, followed by the addition of an excess of methanol to recover the carboxyl group. Ge 
et al.64 designed a different one-pot route where PAA was reflux with iron source in DEG 
solvents and directly coated to the nanoparticles through their preferential binding with Fe3+/Fe2+. 
Preparing iron oxide nanoparticles through co-precipitation in the presence of PAA is simple, fast 
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and allowed to produce large quantity of coated nanoparticles. However, this method still suffers 
from several common problems in conventional coprecipitation method such as lower degree of 
crystallinity, irregular shaped nanocrystal and broaden size distribution.105 
There have been many other polymers used in iron oxide nanoparticles coating such as 
polyethylenimine coating for gene delivery,106 poly(lactic acid),50 cellulose107 and various 
amphiphilic block copolymers.108 The general properties of these polymers, which are also the 
fundamental requirements of coating materials, are water-solubility, biocompatibility, and strong 
binding ability. 
 
1.3.3. Inorganic Materials 
Magnetic nanoparticles can be coated with many types of inorganic materials including 
silica,109 noble metal110 and graphitic carbon.111 Not only are these materials generating repulsive 
force (Columbic force, steric repulsion) to stabilize nanoparticles in various solvents, they also 
form an inert shell to protect the inner core materials from degradation and prevent the releasing 
of toxic ion simultaneously. Additionally, these inorganic materials are also capable to react or 
interact with many bio-related molecules, and are available for further modification to design and 
fabricate functional materials for biomedical applications.   
 
1.3.3.1. Silica 
Silica is widely used as coating material for magnetic nanoparticles because it is 
biocompatible, resistant to degradation and their surface enriched silanol group are readily 
available for functionalization to covalently couple various biomolecules for different biomedical 
applications.109,112,113 As we know, both van der Waals forces and magnetic dipole forces are 
responsible for the aggregation of magnetic nanomaterials. Growing a silica layer can not only 
increase the inter-particle distance to reduce short-range van der Waals attraction, but shield the 
magnetic dipole interaction as well.8 Additionally, the negatively charged silica surface generates 
coulomb repulsion to effectively enhance the inter-particle spacing. If silica is further 
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functionalized with other functional silane such as APTES, the surface can also be positively 
charged.   
Silica coating on magnetic nanoparticles are usually realized in three different routes. The 
first is basically exploited from the well-know Stöber method.113-115 Water-soluble magnetic 
nanoparticles prepared by co-precipitation or other method are dispersed in water or a mixture of 
water and alcohol where silica precursor such as TEOS hydrolyze and condense in-situ on the 
surface of nanoparticle and form a silica layer with controllable thickness. Micelle or 
reverse-micelle based on microemulsion synthesis is another promising approach to generate 
silica coating.112,116,117 In a water-in oil system, nonionic surfactant (e.g. Ig-CO520) stabilize 
small water droplet in a continuous oil phase (e.g. cyclohexane). These reverse-micelles confine 
the hydrolysis of silica precursors and control the coating process, resulting in very uniform 
silica layer. The disadvantage of this pathway is also obvious. Because micelles are formed as 
nanoreactors, much effort is required to purify the product from the solvents and remove large 
amount of surfactant after the coating. The third one, silane exchange or silanization 
approach,118,119 which is first developed for QDs,120 is less popular than in-situ coating method 
and microemulsion method. However, it is very effective in generating ultra-thin silica layer. In a 
typical procedure, as-prepared hydrophobic Fe3O4 nanoparticles are dispersed in nonpolar 
solvents (e.g. toluene) and simply mixed with silane under heating until complete precipitation, 
producing readily water-soluble silica coated Fe3O4 nanoparticles. Because silane molecules can 
bear many types of head-group, applying different silane during the coating can easily decorate 
the surface with desired functionalities.  
In Stöber and microemulsion coating methods, surface functionalizations are usually 
performed on silica shell to improve its reactivity and availability toward the conjugation with 
biomolecules. This modification can be achieved by refluxing silica coated nanoparticles with 
functional silane molecules in alcohol or other solvents.114,117 The surface silanol groups react 
with silane and form a stable crosslinked network that imparts water-solubility and reactivity to 
the nanoparticles simultaneously. Instead of post-synthetic immobilization, desired functionality 
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can be incorporated during the growing of silica layer by a co-condensation of silica precursors 
with functional silane.121-123 Thus, multiple steps and repeated purification can be avoided. 
 
1.3.3.2. Nobel Metal  
The application of iron oxide magnetic nanoparticles (magnetite-Fe3O4, 
γ-maghemite-Fe2O3), especially Fe3O4 nanoparticles is hindered by the oxidizable surface in 
complicate physiological environment, which induce degradation and cause release of toxic 
ions.110 In order to protect their applicability, gold is widely used to coat these magnetic 
nanoparticles to enhance their stability and resistant to biodegradation. Additionally, the surface 
chemistry of gold particles is well studied and their high reactivity toward thiolated organic 
molecules will compensate for the lack of surface tunable ability of magnetic particles.124 
Furthermore, gold possess unique shape and structure depended optical properties (absorbing 
near infrared light), which are highly desired for diagnostic and therapy.125,126   
Similar as in silica coating, the deposition of Au can also be achieved in both aqueous phase 
and non-polar organic phase. By simply mixing water-soluble magnetic nanoparticles and Au 
precursors such as HAuCl4 in water, followed with addition of reducing agents (e.g. NaBH4), Au 
layer with controllable thickness can be obtained.110,127 If magnetic nanoparticles are stabilized 
with organic ligand with terminal amine or thiol groups, the coating efficiency would be 
improved because of the favorable affinity of amine of thiol with noble metals. Xie128 and 
coworker introduce another two steps method to prepare Fe3O4/Au core/shell nanoparticles, in 
which small gold nanocrystals were first attached onto polyethyleneimine stabilized 
nanoparticles as seeds. Then, more Au precursors and reducing agents are added to form a 
monolayer of gold. When hydrophobic nanoparticles are used and coating was performed in 
non-polar solvents, the same microemulsion approach for generating silica layer is applicable to 
Au. Besides reverse micelle method, Zhong129,130 et al. demonstrated a novel method for the 
formation of the gold shell at the iron oxide nanocrystal cores with high monodispersity and 
controllable thickness. The Fe3O4 nanoparticles were first synthesized via thermal decomposition 
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method. Next, without purification, the reactions solution is mixed with Au precursors, 
Au(OOCCH3)3, in which gold is deposited onto Fe3O4 via reduction of precursors.  
 
1.4. Bioapplications of Iron Oxide Magnetic Nanoparticles 
Iron oxide magnetic nanoparticles have been extensively studied for their potentials in 
various clinic areas. Their powerful magnetic properties have attracted great interests in 
developing next generation contrast agents for MRI. The very low cytotoxicity largely eliminates 
the safety concern about in vivo utilization that exists in many other nanomaterials (i.e. quantum 
dots). Small iron oxide nanoparticles (below 20 nm) that exhibit superparamagnetic behavior 
have demonstrated their ability in effective separation of many biomolecules or cells. Their large 
surface areas enable very high density of conjugation with desired drug or biomolecules, leading 
to outstanding performance on different applications. 
 
1.4.1. In Vitro Bioseparation 
Bioseparation is a separating method that used for purification and concentrating of various 
types of protein, peptide, nucleic acid, valuable pharmaceuticals and other small biomolecules or 
biomacromolecules that are important for bio-oriented research and technology, and for 
removing heavy metal ions or other toxic chemical from water or blood. During the purification, 
a mixture of components passes through an absorbent with different retention time, and eludes 
successively according to their affinity with the separating materials. Besides many powerful, 
well-developed separation methods, such as affinity chromatography, ultrafiltration and 
electrophoresis, magnetic-assist-separation-process have also presented its special value in 
biological purification for over 30 years.131-133 Although, traditional column filtration methods 
are very successful for protein and peptides separation in the laboratory scale, they often leads to 
large volume of diluted proteins and are insufficient in purifying products containing suspended 
solid and fouling components such as samples from food and fermentation industry.134 
Nanoparticles involved magnetic separation, however, has demonstrated its many advantages in 
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solving those issues, which will be introduced in more detail later. The basic principle of 
magnetic separation is quite simple: magnetic particles or beads, immobilized with peptides, 
anti-bodies, cheating structures or other functional ligand molecules that possess affinity of 
specific targets are mixed with fluid-type sample (cell lysate, mixture of proteins, blood, plasma, 
urine, contaminated water) and incubated for certain amount of time, followed by applying 
magnetic separators such as permanent magnet and electric magnet. Thus, target molecules 
would be specifically captured by magnetic carriers with binding structures collected under a 
external magnetic field, resulting in magnetically rich-retentate and non-magnetic solvents.134,135   
Using SPIONs is important, because they only response to an external magnetic field and 
do not interact themselves strongly to form aggregates when the magnetic field is removed, 
which enable the magnetic carrier and absorbents disperse separately in the solution for enough 
long time during incubation, ensuring the separation efficiency by maximizing the contact 
surface area. Ascribed to the readily oxidizable nature of magnetite nanoparticle and the 
consideration of preventing non-specific interaction with irrelevant molecules due to the surface 
charge, SPIONs are first functionalized with polymers or other materials rather than directly link 
capturing structure to the surface of nanoparticles. Examples are sub-micron magnetic particles 
functionalized with carboxyl group to facilitate the attachment of affinity ligand for enzyme 
purification,136 silica coated nanoparticles functionalized with nitrilotriacetic acid as affinity 
probes for enrichment of histidine-tagged proteins and phosphorylated peptides,84 gold 
nanocrystals attached magnetite nanoparticles for the separation of arginine kinase from cell 
lysate,137 silica-coated magnetite nanoparticles prepared by microemulsion method as magnetic 
separable nano-vehicle for bovine serum albumin (BSA),138 multivalent cationic agent, 
polyethylenimine (PEI) modified Fe3O4 nanoparticles for purification of ultrapure supercoiled 
plasmid DNA with high yields from bacterial cultures.139 . 
Because conventional liquid column chromatography remain gold standard for the 
purification process, magnetic separations often adopt some valuable techniques from column 
chromatography to improve its performance. For example, Ni2+ affinity chromatography are 
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widely used in the purification of polyhistidine-tagged recombinant proteins expressed in 
Escherichia coli.140 Xu et al. developed a novel capping ligand that has dopamine on one side for 
nanoparticles attachment and nitrilotriacetic acid on the other side for the chelating of Ni2+ ions 
that bind the polyhistidine tag in the target proteins.47 Lee et al. improved this method by directly 
decorate the surface of polymer coated SPIONs with Ni2+ ions, and demonstrated the 
applicability of this approach by successfully separating histidine-tagged green fluorescence 
protein (GFP) from a multicomponent solution.141 Furthermore, the elution of captured protein 
from the magnetic separator is also very similar to the method in Ni2+ affinity chromatography, 
which involves the addition of concentrate imidazole solution, resulting in the disassociation of 
target protein from the separating materials with a 92% recovery efficiency.141  
During the separation, especially for protein purification, two strategies can be considered. 
First, affinity ligand are directly conjugated to the polymer or silica protected SPIONs surface, 
and the separating materials are added to the sample solution for binding, followed by applying 
external magnetic field to collect target molecules. Alternatively, appropriate antibodies are 
mixed with sample containing target proteins that will be captured and collected by magnetic 
nanoparticles immobilized with secondary proteins. Then direct method is more controllable 
whereas the indirect method may be preferred when target molecules have poor affinity with the 
ligand.134 
Besides the purification of proteins, peptides, nucleic acid and heavy metal ions,48 
magnetic-nanoparticles-assist separation has also been a time-honored approach to cell isolation. 
As early as 1977, Kronick et al.142 described a facile method to prepare magnetic microspheres, 
and separated neuroblastoma cells in only 6 min with a efficiency higher than 99%. The principle 
is almost the same as in protein or DNA separation, where the magnetic nanoparticles are 
coupled with affinity ligand and then added to the sample for target binding. Xu et al.143 
modified the surface of polymer coated iron oxide nanoparticle (30nm) with anti-body against 
human epithelial growth factor receptor 2 (anti-HER2), a cell membrane protein that is 
overexpressed in several types of human cancer cells, and separate human breast cancer cell 
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from normal cell with an enrichment factor of 1:10,000,000. Pimpha et al.144 prepared anti-CD4 
monoclonal antibody coupled poly(glycidyl methacrylate) coated iron oxide nanoparticles for the 
specific separation of CD4+ lymphocytes from whole blood. When fluorescent components such 
as QDs or dyes are coupled to the nanoparticles, dual-functional agents for luminescence 
detection and magnetic separation can be obtained.80 Different from common approach that 
target cell is separated directly through the interaction between affinity ligand and their receptors 
on the cell surface, Horák et al. 101 adopted of idea from phagocytic capacity measurement by 
separating the macrophages after polymer coated iron oxide nanoparticles were engulfed into the 
cell. Apart from cancer cell, lymphocytes or other interested human cell, magnetic separation are 
also popular in pathogenic bacteria. Gao et al.145 took advantage of the molecular recognition 
between vancomycin and the terminal peptide, D-Ala-D-Ala, on the surface of Gram-positive 
bacteria and use vancomycin modified magnetic nanoparticles for the capture of E. coli. Guven 
et al.146 reported a different method for the E. coli. enumeration, in which biotin-labeled anti-E. 
coli antibodies were immobilized onto avidin coupled, gold coated iron oxide magnetic 
nanoparticles.  
 
1.4.2. Target and Controlled Drug Delivery in Cancer Treatment. 
Cancer is a group of diseases characterized by the uncontrolled growth of abnormal cells in 
the body.147,148 In 2011, less than two millions new cancer cases are expected to be diagnosed and 
more than half million Americans are expected to die of cancer, about 1500 people a day. Cancer 
has become the second most cause of death in US.148 Traditionally, cancer can be treated with 
surgery, radiotherapy and chemotherapy.149 Chemotherapy is drug therapy that uses 
antineoplastic agents to kill uncontrolled abnormal cancer cell. Generally, anti-cancer drug act by 
un-specifically attacking cells that have rapid division, a very common but also main character of 
cancer cells. Therefore, any cells in normal human organs or tissues that divide rapidly such as 
skin, bone marrow, hair follicle and gastrointestinal tract can also be killed by anti-cancer drugs. 
Maximizing the therapeutic effect of anti-cancer drug to tumor tissues and eliminating their 
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damages to normal cells are the two main goals for chemotherapy, and can be accomplished by 
applying target specific delivery and controlled release strategy. Iron oxide magnetic 
nanoparticles, as a promising material in clinic area have shown their great potential in cancer 
treatment. The basic idea of magnetic target delivery, which dates back to 1970s,150 is that when 
anti-cancer drugs are coupled to the magnetic carrier and injected into to human body, instead of 
systematic distribution, the majority of drug is accumulated at preferential location under the 
guide of high-gradient external magnetic field generated by rare earth permanent magnets or 
electromagnets.151,152 Like every other therapies, magnetic drug delivery method also 
encountered several difficulties during the studies such as the requirement of strong gradient of 
magnetic field to retain the carrier/drug complex at tumor site or the lack of spatial geometry of 
the magnetic field with respect to the target site, which limit the targeting at near-surface site and 
hardly to deep tumor tissue within the human body.152 A lot of efforts have been made to 
overcome the insufficient targeting ability brought by the weak magnetic field. A simple route to 
enhance the retention time at particular locations is to control the size of magnetic carrier, either 
by varying the size of core or through appropriate surface coating. Nanomaterials in different 
size ranges usually experience different uptake and elimination pathways, which offer us a 
solution to determine which organs or tissue the nanoparticles will reside in. Additionally, they 
tend to concentrate in tumor tissue rather than normal tissue due to the enhanced permeability 
and retention effect (EPR effect), which increase the chance and residence time of the 
drug/carrier complex at target site. A more straightforward and effective approach is to conjugate 
targeting-molecules (folic acid, transferrin, etc.) which specifically bind to receptors on cancer 
cell. Thus, the magnetic cargos that carrying anti-cancer drugs will persist at cancer tissues 
instead of releasing drugs broadly to normal and abnormal site simultaneously. There are many 
ways to incorporate drugs molecules into a magnetic carrier. First, they can be linked to the 
carrier surface through stable chemical bonds. Young et al. reported a method using 
trichloro-s-triazine to prepare methotrexate conjugated magnetite nanoparticles that maintain the 
anticancer activity of drug molecules and present colloidal stability under physiological 
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conditions for over 72 hours.53 Similarly, Hua et al. conjugated doxorubicin to nano-carriers, 
consisting of a superhigh-magnetization core and aqueous stable polymer coating, and delivery 
the agents to MGH-U1 bladder cancer cells through magnetic targeting therapy.153 
Based on the fact of lower pH condition in tumor tissues and deep penetration depth of 
near-infrared light into soft tissue, drugs molecules can be coupled to the magnetic nanoparticles 
through a pH or light sensitive bond to further improve the response of magnetic carrier to cancer 
environment.154 Wang et al. use dopamine as anchor for the nanoparticles immobilization and 
amine as terminal group for the conjugation of chromones, a group of benzopyranone derivatives 
showing antifungal, antiviral and anticancer activities, through pH sensitive Schiff-base bonds.87 
Another alternative pathway to design magnetic carrier for drug delivery is using iron oxide 
nanoparticles as core or component and coating materials as matrix for drug loading.33,92,155 The 
matrix can be a mesoporous silica coating or hollow silica structure that are able to effectively 
load hydrophobic anti-cancer drug,33,155,156 smart polymer coating that are sensitive to 
temperature and able to quickly release the drug above critical temperature,92 polyelectrolyte that 
can be ruptured under magnetic field and release drug,157 or a similar lipid bilayers that also 
undergo phase transition under a external magnetic field.158  
In cancer treatment, besides surgical operation, radiotherapy and chemotherapy, gene 
therapy a method that use nucleic acid to either encode a normal functional gene to replace 
mutated gene or directly encode therapeutic protein drugs is also promising for cancer 
treatment.159 The delivery of gene, also known as transfection, is usually realized in two major 
designs, viral vectors that using recombinant viruses or non-viral vectors assembled with DNA 
and transfection agents. Although the transfection efficiency of non-viral vectors is relatively 
lower, they certainly are safer than virus and can be produced at very large scale.160 The 
association of transfection agents with iron oxide magnetic nanoparticles may open a new route 
to improve the gene delivery performance with the help of external magnetic field and 
targeting-molecules that are conjugated to the nanoparticles. González et al. and Pan et al. 
reported their studies of using dendrimer modified iron oxide nanoparticles as vector to transport 
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plasmid DNA or oligodeoxynucleotide into cancer cell.160,161 Polyethylenimine (PEI), a highly 
positively charged molecule is known for stabilizing SPIONs in very high salt concentration over 
wide pH conditions and excellent transfection efficiency, ascribed to the proton sponge 
effect.8,162,163 They can interact with DNA, form stable complexes and effectively send 
therapeutic gene to target cell when conjugated to functional magnetic nanoparticles. Although 
some issues such as toxicity of cationic transfection agents still exist in non-viral vector gene 
therapy, the participation of biocompatible iron oxide nanoparticles will definitely shine light on 
this treatment method. 
 
1.4.3. Magnetic Resonance Imaging (MRI) 
  Since first introduced in 1970s,164 MRI, a real-time, non-invasive imaging method with 
excellent spatial resolution, has become one of the most powerful diagnostics tool in clinical area. 
The basic principle of MRI is based on the mechanism of nuclear magnetic resonance (NMR) 
and hydrogen proton spin relaxation in an applied field.165 In a strong external magnetic field, the 
proton spins of water molecules will align with the direction of the field. If an electromagnetic 
pulse that match the Larmor frequency is applied, the proton spins will be excited by this energy 
and tipped away from z-axis (main magnetic field direction, B0) toward the transverse plane. 
Immediately after the excitation, the transverse magnetization fades and the proton spins return 
to equilibrium state via two independent process: longitudinal relaxation (T1 relaxation) and 
transverse relaxation (T2 relaxation), which give rise to the signal in receiver coil and generate 
MR image.166 However, MRI is suffering from several drawbacks such as low contrast between 
lesions and surrounding healthy tissue in acquired images.165 Until now, many contrast agents 
have been developed to enhance the sensitivity of MRI so as to improve image quality. Generally, 
they are working under a principle of shortening the T1 or T2 relaxation time by altering local 
magnetic field or the resonance properties in tissue. Substances with unpaired electrons such as 
Gd3+, Mn3+ and Fe3+ are able to withdraw the excess energy the nearby proton have absorbed 
from the electromagnetic pulse and are referred to as T1 contrast agents. Differently, SPIONs 
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Table 1.1. Iron oxide contrast agents which are commercialized or at different clinical stages3,8 
 
such as magnetite (Fe3O4) or maghemite (Fe2O3) that can induce local magnetic field 
inhomogeneities and accelerate dephasing due to spin-spin relaxation effect are T2 contrast 
agents. Traditional gadolinium-based small molecular complexes that are applied for T1 contrast 
enhancement usually have short circulation time and high toxicity. In contrast, SPIONs are easier 
to modify and more biocompatible in order to satisfy various imaging conditions. Table 1.1 
presents the SPIONs agents that are commercial available or under clinical investigation.   
Because contrast agents are administered either orally or via intravenous injection, several 
fundamental requirements should be applied to develop SPIONs contrast agents. First, 
nanoparticles should have low toxicity so as to be biocompatible. According to many studies, 
iron oxide nanoparticles usually exhibit acceptable safety for human use.167 Second, the 
nanoparticles should possess well stability in physiological environment, which means they 
should be able to sustain the internal ion strength and tolerate numerous biomolecules such as 
Coupound Size (nm) Coating agent Target Development Tradename Company
Ferumoxides,
(AMI-25) 120-180 Dextran Liver Phase 1 Feridex
Guerbet,
Advanced
Magnetics
Ferumoxtran-
10, AMI-227 15-30 Dextran
Lymph node,
liver, blood pool Phase 3
Sinerem/
Combidex
Guerbet,
Advanced
Magnetics
Ferristene 3500
Sulfonated
styrene-
divinylbenzene
copolymer
GI Commercial Abdoscan GE-Healthcare
Ferumoxsil,
AMI-121 300 Silicon GI Commercial
Lumirem/
Gastromark
Guerbet,
Advanced
Magnetics
Ferucarbotra
n 60 Dextran Liver Commercial Resovist Schering
SHU-555C 21 Carboxydextran Blood pool Phase 1 Supravist Schering
VSOP-C184 7 citrate Blood pool Preclinical Ferropharm
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antibodies and enzymes. Nanoparticles with poor colloidal stability would easily aggregate in 
biofluid and significantly increase their size, which will be eliminated rapidly. Third, specific 
MRI condition such as blood pool imaging or lymphatic imaging requires prolonged circulation 
time for data acquisition. Because as-prepared SPIONs are either insoluble in aqueous solution 
or only bear simple functionality that cannot be directly employed for imaging, appropriate 
surface modification is necessary for the applications. For example, Tong98 and co-workers 
demonstrate that, by fine-tuning the core size and PEG coating of SPIONs, the T2 relaxivity per 
particle can be increased by >200-fold.   
Another very important factor for SPIONs as MRI contrast agents is their hydrodynamic 
size rather than their actual size in dry state because human body is a water-rich system, and 
magnetic nanoparticles are working normally only when they are fully dispersed.3 Iron oxide 
nanoparticles with hydrodynamic size smaller than 40 nm are often classified as USPIO 
(ultra-small particles of iron oxide), whereas SPIO (small particles of iron oxide) is refer to as 
those with hydrodynamic size larger than 40 nm. According to their hydrodynamic size, different 
sized SPIONs have different biodistribution and elimination pathway that distinguished their 
types as contrast agents. Generally, larger particles are recognized as foreign particles and 
quickly taken up by reticuloendothelial system (RES) and eventually accumulated in liver or 
spleen after the administered into body. Therefore, SPIOs are widely designated as RES contrast 
agents to detect liver lesion or cancer. UPIOS, on the other hand, are able to pass through RES 
due to their small size and remain in the blood for 24-36 h.166 These particles will accumulate in 
lymph nodes or lymph vessels and reach a high concentration, producing pronounced T2 
shortening effect. UPIOS can also be used as intravascular or blood pool contrast agents if they 
are coated with suitable materials such as PEG, so as to evade phagocytosis of RES cell and 
show long residence time in blood vessels.  
Up to date, most SPIONs based contrast agents can be categorized into passive imaging 
mode. For example, in lymphatic imaging, SPIONs based contrast agents present their properties 
replying on the natural biodistribution of nanoparticles, where particles are predominantly 
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phagocytosed by macrophages in normal tissue while metastatic lymph node are lack of 
macrophages and do not take up contrast agents, resulting in different signal intensity.168 In other 
cancer detections or blood pool imaging, the distribution of contrast agents is mainly determined 
by the EPR effect.169,170 As we know, the tumor tissues are filled with abnormal, unsmooth 
vessels that are formed with poorly aligned cell with many leakages, which tend to accumulate 
more macromolecular drugs or nanoparticles than normal tissues. Thus, leakage of contrast 
medium into the extravascular space provides information on the permeability of a lesion or 
damage to capillary membranes.166 Conjugation of target specific molecules such as folic acid, 
vascular endothelial growth factor (VEGF) or transferrin whose receptors are over-expressed on 
cancer cell to the surface SPIONs can guide the contrast agents to favorite tissue and efficiently 
increase their residence time at target site.171,172 Thus, actively enhance the signal intensity and 
improve the image quality.  
Iron oxide nanoparticles are mainly developed for T2 weighted image enhancement because 
when high T1 relaxivity (r1) and low r1/r2 is preferred to maximize the T1 effect, the high 
magnetic moment of iron oxide nanoparticles present much stronger effect on r2 than the 5 
unpaired electron from ferric ions on r1. Hyeon173 et al. solved this problem by simply adjusting 
the synthesis condition and decreasing the size of as-prepared nanoparticle to around 1.5 nm, 
which maintains a large surface area of Fe3+ with unpaired electrons and effectively suppress the 
magnetic moment due to spin-canting effect and reduction of volume magnetic anisotropy.  
 
1.4.4. Hyperthermia 
From general clinical aspect, hyperthermia is a medical emergency where body temperature 
is elevated due to failed thermoregulation.174 However, interests in using hyperthermia as a 
treatment method in cancer therapy have been existed for decades. It is known that the abnormal 
tumor vessels are not able to provide sufficient oxygen to the cancer tissues, which would lower 
the tissues pH because of the anerobic metabolism under hypoxia condition.175,176 Tumor cells in 
such living environment are usually resistance to radiotherapy and chemotherapy but more 
38 
 
sensitive to heat. Some studies claimed that the death rate of cancer cell increases gradually with 
the temperature up to 42.5 °C, followed with a sharp drop in the survival rate with further 
heating above 42.5 °C.177 Therefore, applying local, regional or even whole body hyperthermia is 
clearly rational for cancer treatment. Applying electromagnetic or ultrasound energy to treatment 
volume or perfusing organ or body cavity with heated fluid can realize local or regional 
hyperthermia. If energy loss is minimized when introducing the energy, whole body 
hyperthermia can be achieved.178 Certain heat mediators can be applied for efficiently generating 
heat, and iron oxide magnetic nanoparticles are promising candidate because they are able to 
generate heat through Brownian relaxation, hysteresis loss (ferro- or ferrimagnetic materials) and 
Néel relaxation (superparamagnetic materials) under alternate magnetic field.179 Additionally, 
SPIONs are very biocompatible and considered to be low toxic or non-toxic compared to other 
materials.177 The pioneering work of Gilchrist et al.180, which involved the injection of Fe2O3 
particle into lymph nodes and heating under radio frequency field is dated back to 1950s, and 
many attempts have been made to improve this method since then. However, until now, the 
evaluation of SPIONs for hyperthermia is still localized in parametric studies181-184 or by directly 
interacting the agents with tumor cell.185 The situation arise from the fact that early studies on 
hyperthermia treatment did not bring widespread attentions due to insufficient and randomized 
clinic investigation and the use of inadequate heating techniques as well as lack of public 
awareness and investment on hyperthermia equipments.178 Meanwhile, iron oxide magnetic 
nanoparticles suffer from relatively low specific power loss (SPL) value which causes their 
inherently poor heat generating properties. Although, some other transition metal ferrite 
nanoparticles such as cobalt or manganese ferrite offer better SPL, their toxicity strongly hinder 
in vivo applications. Nowadays, increasing evidences have shown that hyperthermia is effective 
when combining with conventional treatment such as chemotherapy and radiotherapy. Scientists 
also dedicate to develop next-generation iron oxide nanoparticles based heat mediators that are 
able to work at low frequency oscillating magnetic field, present improved heat releasing 
property and possess targeting ability to tumor site.177,186 Iron oxide magnetic nanoparticles 
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based multifunctional nanomaterials will be powerful tools for clinic diagnosis and cancer 
treatment in the near further.    
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Chapter II: Polyalcohol as Solvents in Preparing Water-Dispersible Magnetite 
Nanoparticles with Surface Reactivity. 
 
Part 1: Diethylene Glycol as Reaction Medium for the Preparation of 
Water-Soluble Magnetite Nanoparticles with Versatile Surface 
Functionalities.* 
 
2.1.1. Introduction 
In recent years, bioapplications of superparamagnetic iron oxide nanoparticles (SPIONs) 
including targeted drug delivery, bioseparation, magnetic resonance imaging (MRI) and cancer 
diagnostics have been extensively investigated because of the biocompatibility and stability of 
SPIONs in a physiological environment.1-5 The thermal decomposition of different iron 
precursors such as FeCup3,6 Fe(acac)3,7 Fe(CO)58 and iron oleates9 in nonpolar organic solvents 
at elevated temperature has been demonstrated to be an effective way to produce highly 
crystalline monodispersed iron oxide nanoparticles. Other techniques such as coprecipitation and 
microemulsion methods10,11 can directly produce nanoparticles that are dispersible in water. 
However, these two methods usually have a lower degree of control over the size distribution and 
crystallinity. For biological applications, the magnetic nanoparticles should possess good 
uniformity and dispersibility in aqueous solution. Since iron oxide magnetic nanoparticles 
present size dependent magnetic properties, non-uniform nanoparticles response differently to 
external magnetic field which could cause misleading contrast in MRI and undesired distribution 
of agents in drug delivery. Poorly stable nanoparticles would aggregate and form large 
agglomeration which only has very short life because of the rapid clearance by liver and spleen 
and they could also trigger sever immune response. 
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Postsynthetic modifications are usually employed to introduce desired functionalities onto 
the surfaces of the nanoparticles. The modification strategies can be categorized in two major 
classes: ligand exchange12-14 and postsynthetic functionalization on the existing ligand shell.12 
Magnetic nanocrystals prepared by thermal decomposition methods are usually stabilized by 
monofunctional fatty acid molecules that are unable to sustain a secondary reaction to bring new 
functionalities to the surface of the nanoparticles.12 Therefore, ligand exchange is a more 
strategic approach to modifying the surface composition. Xu and co-workers demonstrated that 
dopamine is a robust anchor for immobilizing functional molecules on the iron oxide shell of 
magnetic nanoparticles.15-17 Peng and his team produced Fe3O4 nanocrystals that are dispersible 
in both organic and aqueous solutions by using dendritic ligands.18 Hatton and Lattuada 
successfully modified monodispersed magnetic nanoparticles with several candidate molecules 
by simple ligand-exchange reactions.19   
Though a wide variety of ligand shells can be produced by room-temperature ligand 
exchange, this approach suffers from several disadvantages, including incomplete replacement 
and reduced stability in aqueous solution after the reaction. Consequently, the direct synthesis of 
high-quality magnetic nanoparticles that are stable in water is the solution to this problem. Much 
effort has been made to develop such methods. Caruntu and co-workers20 reported a synthesis 
route to produce variably sized nanocrystalline metal oxides with hydrophilic surfaces in a 
diethylene glycol (DEG) system. Gao’s research group described several one-pot procedures to 
synthesize water-soluble magnetite nanocrystals.21-25 Li and colleagues26 prepared 
amine-functionalized magnetite nanoparticles and hollow nanospheres in 1,6-hexadiamine. 
However, there is still a challenge to produce nanoparticles with diverse surface functionalities in 
these direct synthesis approaches. Because the synthesis conditions are particularly optimized for 
single type of capping ligand, changing it can greatly impact the synthesis route and result in 
different sizes or morphologies. Therefore, the development of new general fabrication 
techniques that can produce water-dispersible magnetic nanoparticles with variable surface 
functionalities is necessary.   
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In this chapter, we discuss a one-pot procedure to synthesize magnetic nanoparticles and 
introduce different functionalities to SPIONs by merely switching the capping ligand. A ligand 
exchange reaction is performed at the end of the synthesis in the same pot, where a specific 
ligand shell replaces the original coating layer without disturbing the formation step of the 
nanocrystals. Thus, iron oxide nanoparticles with a variety of surface compositions on the same 
nanocrystal core can be prepared. In this study, five small organic molecules, including 
acetylcysteine (ACYS), aminobenzoic acid (ABA), dopamine, mercaptoundecanoic acid (MUA) 
and citric acid each of which having different molecular structures or functional groups are 
chosen as capping ligands. We successfully tested the compatibility of this system and 
demonstrated that it can be developed into a general procedure for the preparation of SPIONs 
with versatile surface functionalities. 
 
2.1.2. Experimental  
2.1.2.1. Materials and chemicals. Absolute ethanol was used as received. Diethylene glycol 
(DEG, 99%), Iron (II) chloride hydrate (99%), Threonine (99%) 
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, 98%), Serine (99%) and 
N-hydroxysuccinimide (NHS, 98%) were purchased from Alfa Aesar. Iron (III) chloride 
hexahydrate (97%), sodium hydroxide (97%), 4-aminobenzoic acid (99%), N-acetyl-L-cysteine 
(99%), citric acid (99.5%), dopamine hydrochloride, 11-mercaptoundecanoic acid (95%), lysine 
(98%), alanine (99%), glycine (99%) and arginine (99%) were purchase from 
SIGMA-ALDRICH. 
 
2.1.2.2. Preparation of functionalized magnetic nanoparticles. In a typical synthesis, 0.5 mmol 
(99.4 mg) of FeCl2·4H2O, 1 mmol (270.3 mg) of FeCl3·6H2O, and 20 g of DEG were 
subsequently added to an argon-protected three-necked flask. Separately, 4 mmol (160 mg) of 
NaOH was dissolved in 10 g of diethylene glycol and added to the flask. The mixture was then 
heated to 220 °C and kept constant at 220 °C for 2h. During this time, 1 mmol of capping ligand 
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molecules was dissolved in 400 μL of H2O and mixed with 5 g of DEG. At the end of heating, 
this mixture was injected into the flask and then the system was cooled to room temperature. The 
solid product was isolated by applying a magnetic field and washed five times with absolute 
ethanol to remove the excess DEG and other chemicals. Finally, these particles were redispersed 
in deionized water (10 mL) to give a clear solution. For FT-IR and SQUID measurements, after 
extensively washing with ethanol, the solid part was dried under vacuum. 
 
2.1.2.3. Graft fluorescence molecules to Fe3O4 nanoparticles via amine side. A amount of 100 
mg of EDC (0.5 mmol) and 100 mg of NHS (20 mmol) were dissolved in 8 mL of deionized 
water and added to 1 mL of fluorescein or rhodamine B solution (0.5 mmol). After being stirred 
for 15 min, 1 mL of aqueous dispersion of as-synthesized dopamine or ABA-capped magnetic 
nanoparticles was added to the solution and stirred for 3h at room temperature (Scheme 2.1.1). 
The solid products were precipitated by applying a magnetic field, washed five times with 
absolute ethanol, and finally redispersed in water.  
 
Scheme 2.1.1. EDC involved reaction with fluorescein and amine-terminated nanoparticles 
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2.1.2.4. Graft fluorescence molecules to Fe3O4 nanoparticles via carboxyl side. An aliquot of 1 
mL aqueous dispersion of as-synthesized citric acid-capped magnetic nanoparticles was diluted 
by 7 mL water. Then, 100 mg of EDC (0.5 mmol) and 100 mg of NHS (20 mmol) were 
dissolved in 2 mL deionized water and added to the solution. After being stirred for 15 min, 60 
μL of ethylenediamine (EDA) was added to the solution and the mixture was allowed to react for 
3h. The resulting solid product was collected and washed with absolute ethanol three times and 
redispersed in 1 mL of deionized water. Separately, 1 mmol of fluorescein was dissolved in 7 mL 
of water and mixed with a 2 mL solution containing 100 mg of EDC and 100 mg of NHS. After 
being stirred for 15 min, 1 mL of EDA-grafted Fe3O4 nanoparticle dispersion was added and the 
mixture was reacted for 3h. The resulted solid product was collected and washed with absolute 
ethanol five times and redispersed in water.  
 
2.1.2.5. Dialysis. The water dispersion of fluorescence molecules-grafted Fe3O4 nanoparticles 
was transferred to a SnakeSkin dialysis bag (Thermo Scientific, MWCO 7000) and then dialyzed 
in 1000 mL deionized water for at least 5 days. The 1000 mL deionized water in the beaker was 
completely changed every 12 h. UV-vis spectroscopy was used to monitor the absorption of 
dialyzate outside the dialysis bag. 
 
2.1.2.6. Characterization. The structure and phase purity of the product were examined by X-ray 
diffractometry using a Philips X’pert system equipped with a graphite monochromator (Cu Kα 
radiation, λ=1.54056 Å). A JEOL 2010 transmission electron microscope (TEM) was used to 
investigate the particle morphology. The sizes statistics of nanoparticles were required by using 
Gatan Digital Micrograph software to measure the diameters of about 200 individual 
nanoparticles and the data were processed in Excel software. This procedure was repeated for 
three times on every batch of sample. Nanocrystals’ structure was studied in high-resolution 
transmission electron microscopy (HRTEM) and selected-area electron diffraction (SAED). The 
surface composition was examined with Thermo Nicolet Nexus 670 FT-IR machine over 
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650-2000 cm-1 and 2000-4000 cm-1 regions and Kratos AXIS 165 X-ray Photoelectron 
Spectroscope. Energy-dispersive X-ray analysis (EDS) was performed on a JEOL model 5410 
scanning electron microscope. The magnetic properties were measured with a Quantum Design 
SQUID magnetometer (MPMS XL-7) in the temperature range 5-300K. The colloidal stability 
was investigated by dynamic light scattering (DLS) and zeta potential measurements (DelsaNano 
C) when the functionalized nanoparticles were dispersed in physiological saline solution 
followed with pH adjustment using either sodium hydroxide or hydrochloric acid solution. 
Inductively coupled plasma atomic emission spectroscopy (ICP-AES, Varian Vista-MPX) and 
thermogravimetric Analysis (TGA, TA Q600) were used to calculate the net weight of iron oxide. 
The absorbance of dye-conjugated nanoparticles was acquired by dissolving the nanoparticles in 
concentrated hydrochloric acid and measuring with a Varian Cary 500 UV-vis spectrophotometer. 
Photoluminescence spectra were recorded on a PerkinElmer LS 55 fluorescence spectrometer. 
Fluorescence life time was studied on PTI's diverse LaserStrobe systems. 
 
2.1.3. Results and Discussion 
2.1.3.1. Preparation of magnetite nanoparticles functionalized with different capping ligand 
molecules and the studies of their morphology, size and size distribution. As shown in Scheme 
2.1.2, the Fe3O4 nanocrystals were synthesized at elevated temperature in DEG. In our previous 
study, the chemical and physical properties of DEG make it an ideal reaction medium for 
nanocrystal synthesis. The high boiling point (245 °C) of this solvent allows us to perform the 
hydrolysis at higher temperature to improve the crystallinity. Its large dielectric constant enables 
a wide range of organic compounds and highly polar inorganic precursors to dissolve while the 
chelating property of DEG can serve to mediate the nanocrystals growth during the synthesis. 
This reaction can be easily controlled by adjusting the heating rate and changing the 
concentration of NaOH and/or H2O.20,27 A ligand exchange reaction is performed in the same 
flask where the original labile ligand shell is replaced by the new ligand that bears the desired 
functional groups.  
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Scheme 2.1.2. Illustration of the synthesis route for SPIONs with different coating 
Instead of sophisticated postsynthetic treatment, numerous functionalities can be delivered 
to the surface of the nanoparticles with minimal consumption of solvent and chemical resources. 
As mentioned above, five molecules with different structures and functionalities are selected as 
capping agents. For example, ABA and dopamine have the same pendant (free functional groups 
that are exposed to the surroundings and available for secondary reaction) amine groups but 
differ in head groups (functional groups that are used to bind to the surfaces of the nanoparticles) 
where ABA uses carboxyl as a coordinating group and dopamine utilizes its enediol structure for 
binding. MUA however, bears the same thiol and carboxyl groups as ACYS but has limited 
solubility in water. Therefore, it is necessary to investigate whether these differences will have a 
major impact on the final products.  
Aliquots of reaction solutions are taken and studied by TEM right before adding the capping 
ligand and after the system was cooled to room temperature, where the ligand exchange was 
finished. As seen in Figure 2.1.1, the well-separated ACYS-coated nanoparticles are 
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quasi-spherical and possess a narrow size distribution. Compared to the nanocrystals before the 
ligand exchange reaction, there are no obvious changes in morphology and size deviation. 
Similarly, nanoparticles coated with the other four molecules are also well dispersed and 
narrowly distributed (Figure 2.1.1). Therefore, regardless of the molecular structure (i.e., pendant 
functional group, length of the carbon chain) and the solubility in solvents or other properties, all 
the chosen candidate molecules are demonstrated to be good capping ligand by preserving the 
shape of the nanocrystals well. By counting more than 200 nanoparticles, we calculated the 
average diameters of the functionalized nanoparticles to be 6.1±1.8 (SD=0.9, α=0.05) nm for 
ACYS, 5.9±1.6 (SD=0.8, α=0.05) nm for ABA, 5.9±1.8 (SD=0.9, α=0.05) nm for dopamine, 
5.8±1.8 (SD=0.9, α=0.05) nm for MUA and 6.0±1.8 (SD=0.9, α=0.05) nm for citric acid as the 
capping ligand, illustrating a very small effect of changing the capping ligand on the size of the 
nanocrystals (Figure 2.1.2b-2f). It is worth noting that besides the five molecules reported in this 
paper, we also tested many other capping ligands such as different amino acids and their 
derivatives and TEM studies showed no significant differences on the size and shape of the 
nanocrystals. By comparing to the nanoparticles before the ligand injection, we noticed a slight 
increase in the average size among all of the products despite the differences in their surface 
chemical composition.  
As shown in Figure 2.1.2a, the average size of the nanoparticles is 5.2±1.0 (SD=0.5, α=0.05) 
nm, corresponding to the sample taken right before adding the new ligand. Clearly, there is an 
increase in the size of the nanocrystals after the ligand injection. A possible explanation for this 
phenomenon is that during the formation and subsequent crystallization of the nanocrystals the 
surface of the isolated nanoparticles is coated with a labile layer of the solvent, which remains 
chemically active and available for further derivatization.20 After the injection of capping 
molecules at high temperature, a new ligand shell rapidly replaces the original DEG layer and 
stabilizes the nanocrystals. During this process, the equilibrium of the system is destroyed and 
the surface energy of relatively smaller particles is dramatically increased because of this 
replacement. Thus, following the well-known Ostwald ripening process,28 small nanocrystals 
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Figure 2.1.1. TEM images of Fe3O4 nanocrystals (a) before adding the capping ligand and after 
the injection of (b) ACYS (c) citric acid. (d) ABA (e) dopamine (f) MUA. (Inset: HRTEM image 
of a single ACYS coated Fe3O4 nanocrystal. SAED pattern of the ACYS coated Fe3O4 
nanoparticles.) 
with higher surface energy dissolve and the resulting material is redeposited on the larger 
nanocrystals, leading to an increased average size. High-resolution TEM reveals that each 
particle is a well-ordered single crystal with a fringe distance of 3.01 Å, corresponding to the 
(220) lattice plane of magnetite. Powder X-ray diffraction is THE used to determine the 
crystalline structure and phase purity. As shown in Figure 2.1.3, the patterns were found to match 
well with those of the standard bulk Fe3O4 (JCPDS no. 19-0629) with no other secondary iron 
oxide phases, and the pattern superposes with the corresponding selected-area electron 
diffraction pattern (Figure 2.1.1 inset). 
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Figure 2.1.2. Size statistics of Fe3O4 nanoparticles with different coating (a) before injecting the 
new ligand (b) acetylcysteine (c) citric acid (d) aminobenzoic acid (e) dopamine (f) 
mercaptoundecanoic acid. (Note: Gauss fitting curves were generated in software Origin®8.0 
automatically, using non-linear fitting mode and Gauss as function) 
 
Figure 2.1.3. XRD pattern of the ACYS coated Fe3O4 nanoparticles (black) with standard 
reference pattern of magnetite (red) JCPDS No. 19-0629.21 
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2.1.3.2. Surface composition of the functionalized magnetite nanoparticles and their magnetic 
properties. After the synthesis, a careful investigation on the surface chemistry is required so that 
detailed information of ligand shell can be acquired. First, an EDS analysis is performed on 
MUA- and ACYS-coated Fe3O4 nanoparticles. As shown in Figure 2.1.4, besides oxygen and 
iron elements from Fe3O4, both MUA- and ACYS-coated nanoparticles give a clear sulfur peak, 
which can be ascribed to the thiol group, indicating the existence of these ligand molecules on 
the surfaces of the magnetic nanoparticles. A detailed surface composition of the as-synthesized 
Fe3O4 nanoparticles is characterized by FT-IR spectroscopy. The results reveal a significant 
change of the surface composition of magnetic nanoparticles before and after injecting the 
capping ligand molecules into the system (Figure 2.1.5). The IR spectrum of magnetic 
nanoparticle before adding the capping ligand (Figure 2.1.5a) shows a broad band at 3421 cm-1 
and a strong band at 1063 cm-1 corresponding to the O-H and C-OH stretching modes, 
respectively. The peak at 1594 cm-1 is assigned to the δOH vibrations originating from the 
 
Figure 2.1.4. EDS spectrum of MUA coated Fe3O4 nanoparticles. 
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Figure 2.1.5. FT-IR spectra of Fe3O4 nanoparticles with different capping ligand (a) before 
adding new ligand (b) MUA (c) ACYS (d) citric acid (e) dopamine (f) ABA. 
hydration changes on the surfaces of nanoparticles and intensity changes due to hydrogen 
bonding on the charged surface.29 The weak peaks at 2921 cm-1 and 2853 cm-1 can be attributed 
to the asymmetric and symmetric stretches of the CH2 group. A weak peak located at 1454 cm-1 
is assigned to the scissoring vibration of CH2 from diethylene glycol.  
After injecting the ligand molecules, MUA for example (Figure 2.1.5b), the spectrum of the 
sample exhibits a strong band at 1519 cm-1 corresponding to the asymmetric COO- stretching 
mode and at 1413 cm-1 assigned to the symmetric COO- stretching vibration.30,31 The intense 
asymmetric and symmetric stretches of the CH2 group (2916 cm-1, 2844 cm-1) are probably due 
to the longer carbon chain of MUA. Similarly, both ACYS- and citric acid-coated magnetic 
nanoparticles (Figure 2.1.5c&5d) exhibit characteristic COO- stretching peaks which are absent 
in the DEG-stabilized nanoparticles, indicating a successful ligand exchange process. 
Additionally, ACYS-coated nanoparticles give a N-H bending peak at 1603 cm-1 and a weak 
band at 2971 cm-1 which is in good agreement with the position of the CH3 stretching. 
When ABA is used as a capping ligand (Figure 2.1.5f), the sample shows strong symmetric 
COO- stretching at 1383 cm-1, asymmetric COO- stretching at 1509 cm-1 and a overlapped N-H 
bending vibration of primary amine and ring C=C stretching at 1605 cm-1. The band at 3367 cm-1 
is due to N-H stretching and the band at 1302 cm-1 is assigned to aromatic C-N stretching.  
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Figure 2.1.6. FT-IR spectra of a) pure MUA and b) MUA functionalized Fe3O4 nanoparticles  
However, dopamine-coated Fe3O4 nanoparticles show a characteristic catechol pattern in 
FT-IR measurements (Figure 2.1.5e).32 The absorption band at 1607 cm-1 is attributed to N-H 
stretching and 1583 cm-1, 1479 cm-1 are assigned to ring C=C stretching, overlapped by CH2 
scissoring around 1465 cm-1. The intense C-O stretching of phenolic OH is located at 1255 cm-1. 
Since ligand molecules are chemically adsorbed on the surface of nanoparticles rather than 
physically adsorbed, the IR spectra of functionalized nanoparticles are not identical to the spectra 
of pure ligand molecules. In IR spectroscopy, absorption corresponding to the vibration of alkane 
groups are relatively stable than other function groups, and do not exhibit notable shift. For 
example, the spectra of MUA and MUA functionalized nanoparticles were compared (Figure 
2.1.6) and it was observed that both pure MUA and MUA coated nanoparticles showed intense 
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peak from 2800 cm-1 to 3000 cm-1 with nearly the same peak location, which is assigned to the 
symmetric and asymmetric stretching of methylene groups. Unfortunately, due to the limited 
number of ligand molecules on the nanoparticle surface and interference from other functional 
groups, absorptions of alkane in the finger print region were difficult to clearly indentify. 
Different from C-H bond vibration, characteristic absorption attributed to the vibration in 
carboxyl group presented significant change and shift. Because of the direct coordination of 
carboxyl group with surface atoms on nanoparticles, the intense C=O stretching vibration 
disappeared and it was replaced by the intense symmetric and asymmetric of COO- stretching. 
The number of ligand molecules on the surface of the magnetic nanoparticles is calculated. 
Assuming that each nanocrystal has spherical shape and all the nanocrystals are identical, the 
mass of a single nanocrystal is calculated by using bulk magnetite density 5.2 g cm-3 and the 
radius of each functionalized nanoparticles (i.e. 3 nm for citric acid coated nanoparticles). The 
mass of the same nanocrystals without the surface atomic layer is derived by using radius of 3 
nm minus the surface atomic layer with Fe-O distance of 2.045Å. The fraction of the number of 
the surface metal atoms over the number of the total metal atoms per particle is equal to the ratio 
between the mass of the surface atomic layer and total mass of a single nanocrystal. The mole 
ratio of magnetite to each type of capping ligand is calculated based on the results from ICP-AES 
and TGA measurements. If one gram of sample is considered, the quantity of inorganic Fe3O4 
and organic ligand layer can be acquired by using the weight percentage of each component in 
the functionalized nanoparticles. Since the mass of a single naked Fe3O4 nanocrystal can be 
calculated, the mole amount of nanoparticles in one gram of sample is determined. In a similar 
way, the mole amount of ligand molecules can also be easily gained, which subsequently lead to 
the mole ratio of magnetite to ligand molecules. With this value, the fraction of iron ions covered 
by capping ligand can be calculated. From the calculation (Table 2.1.1), for ACYS, ABA, 
dopamine and citric acid coated nanoparticles, most of the carboxylate anion acts as a bidentate 
chelating ligand where two oxygen atoms coordinate with one iron atom. For MUA coated 
nanoparticles, only 40% of the iron atoms are covered by the capping molecules. In this case 
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every carboxylate anion of MUA acts as a bidentate bridging ligand where the oxygen atoms are 
bound to adjacent iron metals/sites. Due to the steric hindrance from long carbon chain, the iron 
atoms on the surface are not fully covered by MUA. From IR studies, all five samples show clear 
symmetric and asymmetric COO stretches which support the above calculation. 
The zero-field-cooled (ZFC) and field-cooled (FC) curves were measured in a magnetic 
field of 100 Oe in the temperature range of 5 – 300 K. As shown in Figure 2.1.7a, the ZFC curve 
of MUA coated nanoparticles shows a maximum at 100 K, which is the blocking temperature 
(TB). Such behavior is characteristic of superparamagnetism typically observed in small 
ferromagnetic or ferrimagnetic nanoparticles. At very low temperature, the magnetic moment 
aligns along the energetically favorable axis and cannot be changed due to the anisotropy energy 
barrier. The net magnetization is closed to zero because of the random axis orientation of 
nanoparticles. As the temperature increasing, thermal fluctuation switch the magnetic moment of 
nanoparticles to the direction of applied field leading to a growing magnetization. When the 
temperature is above TB, the thermal energy overcomes the anisotropy barrier and randomizes 
the magnetic moment. Thus, the nanoparticles appear a superparamagnetic behavior. Figure 
2.1.7b shows the hysteresis loops of MUA coated nanoparticles at 5 K and 300 K. Consistent 
with the ZFC-FC measurements, the nanocrystals are superparamagnetic at 300 K and the 
hysteresis loop shows no remanence and coercivity. At 5 K, the hysteresis loop indicates a 
typical ferrimagnetic behavior with coercivity of 301 Oe and remanence of 16 emu g-1. The 
saturation magnetization of MUA coated nanoparticles at 5 K and 300 K are 64 emu g-1 and 53 
emu g-1, respectively.  
Table 2.1.1. Surface coverage and the number of surface capping ligand molecules with respect 
to each functionalized nanoparticle. 
 ACYS ABA Dopamine MUA Citric Acid 
Surface coverage (%) 58.1 78.3 74.5 40.6 70.2 
Capping ligand per 
particle 502 677 644 351 606 
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Table 2.1.2. Saturation magnetization of functionalized Fe3O4 nanoparticles. 
Temperature 
Saturation Magnetization of Functionalized Fe3O4 Nanoparticles with 
Different Ligand Shell (emu g-1) 
ACYS  MUA  ABA  Dopamine  Citric acid  
5K 66.2 (80.7)a 64.3 (79.4) 69.9 (84.2) 71.7 (84.4) 62.7 (83.6) 
300K 54.4 (66.4) 53.1 (69.5) 57.9 (69.8) 57.7 (67.8) 51.3 (68.4) 
aSaturation magnetization of Fe3O4 nanoparticles normalized to the weight of magnetic core. 
 
Figure 2.1.7. (a) Temperature dependence of magnetization of MUA coated Fe3O4 under 
ZFC-FC condition (b) Hysteresis loops of MUA coated Fe3O4 at 5K and 300K. Hysteresis loops 
of citric acid coated Fe3O4 and fluorescein grafted citric acid coated Fe3O4 at (c) 5K (d) 300K 
Nanoparticles coated with other capping ligands also exhibit superparamagnetic behavior 
and relatively high saturation magnetization (Table 2.1.2). It should be noted that besides the iron 
oxide core, the coating layer also contributes to the mass of the samples. Consequently, the 
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saturation magnetization might vary in response to the change on the number of capping ligand 
molecules on the surface of the nanoparticles. After normalizing to the weight of magnetic core, 
all five samples have similar saturation magnetization values, which imply that the 
functionalized nanoparticles prepared by our method differ only in surface composition.  
 
2.1.3.3. Colloidal stability of the functionalized magnetite nanoparticles. The dispersibility and 
stability of the nanoparticles are strongly dependent on their surface chemistry.33,34 As a result of 
the strong binding ability of the carboxyl group35-37 and catechol structure38 with Fe atom, these 
solutions are very stable in aqueous or buffer solution under ambient conditions without showing 
any precipitates even after several months. The thoroughly washed magnetic nanoparticles can  
 
Figure 2.1.8. (a) Photo of Fe3O4 nanocrystals aqueous solutions in response to external magnetic 
fields. Fe3O4 nanocrystals dispersed in (b) physiological saline solution and (c) PBS buffer 
solution. 
also be dried under flowing nitrogen and stored in an inert environment for future use. The 
samples aged for 8 months can still be easily redispersed in a small amount of water within 
seconds to form a concentrated solution that exhibits ferrofluidic behavior when an external 
magnetic field is applied to it (Figure 2.1.8). 
The stability of nanoparticle dispersions that strongly depends on the net surface charge is 
also affected by the pH. At a pH below 6, the stability of colloidal solutions of citric acid coated 
nanoparticles is dramatically changed. Well separated nanoparticles tend to aggregate and form a 
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turbid dispersion that is completely precipitated over one night or can be quickly collected by an 
external magnetic field. However, this turbid dispersion will immediately turn into a clear, stable 
solution if a small drop of NaOH solution is added because the functional group of the capping 
ligand molecules will get deprotonated and switch to their ionic forms under basic conditions. 
Not only are these ionic groups more hydrophilic than their protonated forms, but also the 
Coulombic interaction between these charged groups will prevent aggregation. ABA or 
dopamine coated nanoparticles can be dispersed in acidic conditions and form stable solutions 
because a net positive charge will be induced on the amine groups and generate electrostatic 
repulsions.  
Zeta potential is widely used as an indication of the stability of the colloidal system. In 
nanoparticle dispersion, the surface of particle is usually stabilized by capping ligand molecules 
that are able to generate charge or steric hindrance. If the capping agents are carboxyl bearing 
molecules, for example, nanoparticles carry many negative charges on their surface, which will 
attract positive ions to particles surface. This strongly bound ion layer is referred as stern layer. 
Outside the stern layer, positive ions are less firmly associated and form a diffuse layer. The ions 
within the diffuse layer form a stable entity with the particles, in which ions move together with 
particle while ions beyond the diffuse layer stay in the bulk dispersant. The potential at this plane 
is defined as the zeta potential. The magnitude of zeta potential indicates the stability of the 
particles dispersion. Large value of zeta potential (absolute value) suggests that particles are 
strongly positive or negative charged at the boundary of diffuse plane and the electrostatic 
repulsion are able separate particles and prevent aggregation. Conversely, low zeta potential 
implies that there are not enough repulsive forces among particles, and they tend to aggregate 
easily to produce an unstable colloidal dispersion. 
In Figure 2.1.9, Zeta potentials of functionalized nanoparticles were plotted as a function of 
pH value in physiological saline solution. Their values coincide with the colloidal stabilities of 
the functionalized nanoparticles. From the figure, we notice that ACYS and MUA coated 
nanoparticles can only be well dispersed in basic condition and show negative Zeta potential. 
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Since thiol group is electrical neutral in aqueous and cannot be deprotonated, we speculate that 
some of the thiol groups of MUA and ACYS or carbonyl groups from the amide bond of ACYS 
coordinate with the iron cations on the surface of magnetite which leaves uncoordinated 
carboxylate groups exposed to the aqueous solution and get deprotonated under basic condition. 
Table 2.1.3 presents detailed information of functionalized nanoparticles from colloidal stability 
studies. ABA and dopamine coated nanoparticles have large positive zeta potential under acidic 
condition whereas ACYS, MUA and citric acid coated nanoparticles have negative value in basic 
pH solution. When they are highly charged, they all give similar hydrodynamic diameters with 
small polydispersity. It is worth mentioning that other than adding ethyl acetate or ethanol for 
precipitation the instability of these functionalized nanoparticles at different pH offer another 
effective route to separate them from the solution quickly. 
 
 
Figure 2.1.9. Zeta potentials of functionalized nanoparticles as a function of pH value in 
physiological saline solution. 
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Table 2.1.3. Hydrodynamic radius and Zeta potential of well dispersed functionalized iron oxide 
nanoparticles in aqueous solution. 
 
ACYS ABA Dopamine MUA Citric Acid 
Hydrodynamic 
Radius (nm) 
11.2 11.7 11.3 15.7 10.9 
Polydispersity(%) 20.2 23.2 17.8 25.9 22.7 
ζ(mV) pH=3a - 53.7 48.6 - - 
ζ(mV) pH=9a -25.7 - - -16.8 -65.7 
aZeta potentials as a function of pH are measured by initially dispersed functionalized 
nanoparticles in physiological saline solution (0.15 M NaCl aqueous solution pH=7) followed 
with pH adjustment using hydrochloric acid or sodium hydroxide solution. 
2.1.3.4. Surface reactivity of the functionalized magnetite nanoparticles. The most 
significant aspect of our synthesis method is that almost any functionality can be introduced to 
the surface of nanoparticles by choosing appropriate molecules as capping ligands. Although 
only thiol, amine, and carboxylic groups are chosen here to demonstrate the idea, molecules with 
other functional groups such as aldehyde, epoxide, amide, and hydrazide can also be used as the 
capping agents to build a specific ligand shell. Under conditions of well established 
bioconjugation techniques,39 each type of functional group can be activated by several 
commercially available reagents.   
Usually, for a particular application, multiple surface modifications steps on the 
nanoparticles are required to reach the final products.40,41 Therefore, to be functional in different 
biomedical applications, these nanoparticles need to sustain a secondary reaction to introduce 
new functionalities onto the surface without consuming the magnetic properties of the 
nanoparticles. The availability of the surface functional groups can be studied by conventional 
spectroscopy, using fluorescent molecules as probes.25 Here, the reactivity of the amine and 
carboxyl groups is examined by covalently grafting different fluorescent molecules onto the 
Fe3O4 nanoparticles via a zero-length cross-linker EDC. Fluorescein and rhodamine B, two 
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commonly used dyes in biological applications, which have different excited fluorescent colors 
were selected to study the activity of those functional groups. 
For the ABA and dopamine coated Fe3O4 nanoparticles, a one step protocol involving EDC 
and NHS was applied to activate the carboxyl groups of fluorescent molecules and directly 
conjugate them to the surfaces of nanoparticles through the amine side. For citric acid coated 
nanoparticles, EDA was chosen as a linker between fluorescent molecules and nanoparticles. The 
carboxyl groups from citric acid were first activated by EDC and NHS, followed by the coupling 
of EDA to the surfaces of the nanoparticles through one amine group, leaving another amine 
group available for the conjugation of fluorescent molecules. Before we studied the fluorescent 
properties, all of the samples were treated with extensive dialysis to remove any residual free 
fluorescence molecules. As shown in Figure 2.1.10 and the insets, after conjugation, fluorescein 
and rhodamine B grafted Fe3O4 nanoparticles successfully give clear emission spectra and strong 
green or orange fluorescence under a 5 W UV lamp, which is consistent with neat fluorescein 
and rhodamine B water solution. 
In order to study the quenching effect of the nanoparticles, the quantum yields of the 
obtained samples are calculated by applying a second standard phosphor solution, using formula:  
s
ssu
uus
u nFA
nFA
φφ 2
2
=  （1） 
where Φu is quantum efficiency of an unknown phosphor, Φs is quantum efficiency of a 
secondary standard, Au is absorbance of unknown phosphor at the excitation wavelength, As is 
the absorbance of a secondary standard at the excitation wavelength; Fu is the integrated photon 
flux of an unknown phosphor, Fs is the integrated photon flux of the secondary standard, nu is the 
refractive index of solvent used for an unknown phosphor solution; and ns is the refractive 
index.42  
After the conjugation of fluorescence molecules to the magnetic nanoparticles, the quantum 
efficiency drops to 52% and 41%, compared to the 79% and 70% in neat fluorescein43 and 
rhodamine B44 ethanol solution respectively. The products were reexamined by FT-IR and as 
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Figure 2.1.10. (a) Emission spectra of fluorescein coupled citric acid coated Fe3O4 nanoparticles. 
(b) Emission spectra of rhodamine B coupled ABA coated Fe3O4 nanoparticles. (Insets: the 
corresponding fluorescent images of sample dispersion under UV light.) 
shown in Figure 2.1.11, an additional peak appeared at 1640 cm-1, corresponding to the 
overlapped C=O stretch and N-H bending of amide bond,45 which implies a successful 
conjugation. The spectra of nanoparticles after the dye molecules coupling also presented 
obvious differences compared to the ones before the conjugation. 
However, it is necessary to reach full understanding of how the luminescence properties are 
changed before and after linking dyes to the surface modified Fe3O4 nanoparticles. 
Time-resolved fluorescence measurements, an important tool in applied luminescence 
spectroscopy,46-48 is performed to study these properties and obtain other direct evidence to prove 
fluorescence molecules are covalently linked to the magnetic nanoparticles rather than physically 
adsorbing on the surface. Here, fluorescein on citric acid modified Fe3O4 nanoparticles is taken 
as an example in our discussion. Figure 2.1.12 shows the decay curves of (a) fluorescein in 
ethanol (b) fluorescein on citric acid modified Fe3O4 nanoparticles by monitoring 530 nm 
emission under 337 nm N2 pulse laser excitation. Both of the curves can be fitted to single 
exponential: I= I0exp(-t/τ), and the lifetimes are determined to be 3.8 ns and 2.3 ns (Table 2.1.4) 
for neat fluorescein in ethanol and fluorescein on citric acid modified Fe3O4 nanoparticles, 
respectively. From these data, it is clear that the lifetime of fluorescein decreases after the 
reaction with citric acid modified Fe3O4 nanoparticles. This quenching effect can be ascribed to 
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Figure 2.1.11. FT-IR spectra of functionalized magnetic nanoparticles after the conjugation with 
fluorescence molecules (a) fluorescein-citric acid (b) rhodamine B -ABA. 
 
 
Figure 2.1.12. Decay curves of (a) fluorescein in ethanol (b) fluorescein on citric acid modified 
Fe3O4 nanoparticles by monitoring 530 nm emission under 337 nm N2 pulse laser excitation. 
Both of the curves can be fitted to single exponential: I= I0exp(-t/τ). 
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the multiphonon relaxation from the surrounding and bonding between fluorescein and citric acid 
modified Fe3O4 nanoparticles.42 To study further how the nanoparticles affect the non-radiative 
process, the radiative rate constant and non-radiative rate constant are investigated. Usually, the 
quantum efficiency can be expressed by 
  
nrr
r
kk
k
+
=ϕ  (2) 
  
nrr kk +
=
1
τ  (3) 
where τ is the fluorescence decay time, kr is the radiative rate constant and knr is the non-radiative 
rate constant.42,49  
The quantum efficiency of (a) fluorescein in ethanol (b) fluorescein on citric acid modified 
Fe3O4 nanoparticles were listed in Table 2.1.4. From the table, it is clear that molecular 
fluorescence is quenched by non-radiative processes that augment knr but do not change kr  
resulting in a proportional change in the observed decay time and changes in the fluorescence 
quantum yield,50 implying the existence of chemical bonds between fluorescent molecules and 
functionalized magnetic nanoparticles, which gives direct evidence of our successful 
functionalization. 
Table 2.1.4. Variation of the fluorescence lifetimes and relative quantum yields upon 
coupling to magnetic core. 
 Quantum efficiency Lifetime kr (s
-1
) knr (s-1) 
Fluorescein in ethanol 79% 3.8ns 2.1e+8 5.3e+7 
Fluorescein on citric 
acid modified Fe3O4 
nanoparticles 
52% 2.3ns 2.3e+8 2.2e+8 
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Figure 2.1.13. TEM images of Fe3O4 nanoparticles after coupling fluorescence molecules. (a) 
fluorescein-citric acid-Fe3O4 (b) rhodamine B-ABA- Fe3O4 
 
Table 2.1.5. Saturation magnetization of fluorescence molecules conjugated Fe3O4 nanoparticles. 
Temperature 
Saturation Magnetization of Fluorescence Molecule Conjugated 
Fe3O4 Nanoparticles (emu g-1) 
Rhodamine conjugated ABA 
coated Fe3O4 
Fluorescein 
conjugated-EDA-citric acid 
coated Fe3O4 
5K 61.54 52 
300K 47.16 41.53 
The stabilities of fluorescence molecule grafted nanoparticles are tested. After dialysis, the 
nanoparticles were precipitated by excess diluted hydrochloric acid. The solid products are still 
readily dispersible in water, forming a clear solution even after 1h of sonication treatment, which 
proves that the capping ligand is tightly bound to the surface and stabilizes the nanoparticles. A 
TEM study (Figure 2.1.13) also reveals that there is no obvious morphology change before and 
after grafting the fluorescent molecules to the particle, which suggests that the organic reaction 
between the capping ligand and fluorescent molecules does not dramatically affect the properties 
of the nanoparticles. 
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The magnetic properties of the fluorescence molecule conjugated SPIONs were also 
investigated and compared with the nanoparticles before conjugation. The hysteresis loops of 
fluorescein coupled citric acid coated SPIONs at 5 and 300 K are presented in Figure 2.1.6c and 
2.1.6d. While the coercivity and remanence remain almost unchanged, the saturation 
magnetization drops about 19.1% and 17% for 300 K and 5 K respectively (Table 2.1.5), which 
is attributed to the large molecular weight of fluorescein (MW=332.32) counted to the total mass 
of nanoparticles. 
 
2.1.4. Conclusions 
In this chapter, we describe a one-pot procedure that successfully hybridizes the synthesis of 
SPIONs with their surface functionalization. With this method, a variety of functionalities can be 
brought to the surface of the nanoparticles by using appropriate capping ligand molecules. Thus, 
sophisticated postsynthetic modification can be avoided, and the consumption of solvents or 
chemical resources is minimized. The pendant functional groups were tested to be very active, 
which can afford a secondary reaction for further modification. Through simple bioconjugation 
chemistry, biomolecules such as antibody, drug, fluorophore, or cancer cell receptor molecules 
can be easily linked to the magnetic nanoparticles. The new coating shell not only effectively 
retains the morphology of the nanoparticles, it also brings desire functionalities to the 
nanoparticles without altering the magnetic properties. It should be addressed here that in this 
chapter, we are focusing on testing the compatibility of this system. Therefore, the five capping 
ligand molecules selected in our experiment are chosen to demonstrate the advantages of our 
system, and the ligand molecule itself is not necessarily suitable for some biological applications. 
So far, a variety of small molecules have been successfully tested in this system and gave good 
results, indicating that desired surface functionalities can always be achieved by choosing 
appropriate capping molecules. As for polymers, dextran for example, molecule with multiple 
binding sites is even more efficient in synthesizing stable magnetic nanoparticle with water 
solubility. In addition, the biocompatibility of these polymers will greatly enhance the possibility 
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of applying SPIONs in biomedical area such as MRI and target drug delivery. The method we 
developed uses inexpensive, low toxic and commercial available chemicals, which meets the 
principle of green chemistry by offering an economical and environmental friendly approach. 
 
* Part of this work was adapted with permission from DOI: 10.1021/la104471r. Copyright (2011) 
American Chemical Society. 
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Chapter II, Part 2: Hydrophilic Natural Amino Acids as Capping Ligand for 
the Functionalization of Iron Oxide Nanoparticles: The Effect of Variation 
from Amino Acids on the Final Products.* 
 
2.2.1. Introduction: 
The most common surface functionalization approach for nanoparticles is ligand exchange 
reaction, where the original ligand shell is exposed to excessive amounts of competing capping 
ligand1,2 followed by precipitation and isolation. Although a wide variety of functionalities can 
be immobilized onto the surface of nanoparticles, and repeating the cycle above allows more 
thorough replacement, relatively low product yield and decreased stability after the exchange 
remain issues with this method. Many types of nanostructured materials such as gold 
nanocrystals, quantum dots and magnetic nanoparticles have been successfully modified by this 
method. Lin3 and coworker adopted a ligand exchange method to transfer fluorescent gold 
nanoclusters with reduced photobleaching from toluene to water by using dihydrolipoic acid as 
stabilizer. Wang4 and his group developed waters-soluble multicolor quantum dots probes with 
compact size, good stability and high quantum yield by performing ligand exchange reaction 
under two-stage heating at 50 ℃ and 90 ℃, using poly(maleic anhydride) homopolymer as 
capping agents, followed by a reaction with heterobifunctional polyethylene glycol (PEG). 
Although, ligand exchange has demonstrated their advantage in nanomaterilas surface 
functionalization, they also have several significant shortages. As introduced above, ligand 
exchange is relying on the fact that new capping agent is more favorable in binding with 
nanomaterials or in larger excess in amount than existing ligand. Therefore, this reaction is 
progressing under the competing between two different molecules and ends up with equilibrium 
exchange. Completed ligand replacement is impossible to achieve and irreversible desorption of 
the new ligand may also affect the surface chemistry of the nanoparticles. Thus, information 
regarding the completeness of the exchange or the percentage of the new ligand after the reaction 
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and the availability of the new ligand molecules is important for further modification. 
Additionally, ligand exchange reaction may also affect some properties of the core materials and 
careful characterizations are necessary to monitor their properties.   
Despite efforts to develop more efficient modification methods, the stabilization of iron 
oxide nanoparticles in different solvents is another major concern during functionalization. 
Choosing an appropriate capping ligand molecule is crucial to obtain nanoparticles with good 
stability since these stabilizers are responsible for generating inter-particles repulsive force in 
order to prevent aggregations. Many small organic molecules and polymers such as citric acid,2 
dopamine5 and polyethylene glycol6 have been tested as stabilizing agents for magnetic 
nanoparticles in aqueous solution. Among the candidates, natural amino acids (AA’s) represent a 
unique class of small organic molecules with attractive properties for magnetic nanoparticle 
functionalization. Their low cost, good biocompatibility and available functional groups for 
binding make them an ideal choice as capping ligand to stabilize magnetic nanoparticles in 
physiological conditions. In addition, besides amine and carboxylic groups at α position, many 
AA’s possess additional functional groups such as guanidine, thiol and phenolic hydroxyl groups 
which are potential reaction sites for further modification. Moreover, some AA’s such as 
arginine and leucine would cause tumor shrinkage when reaching certain concentration levels.7 
So far, attempts have been made to prepare the iron oxide nanoparticles with AA 
functionalities;8-10 Zhang11 reported a novel approach to fabricate diverse noble metal-Fe2O3 
hybrid nanomaterials by reducing noble metal precursor on the surface of lysine coating iron 
oxide nanoparticles. With this method, various noble metal nanocrystals can be decorated 
through their strong affinity with amine groups of lysine. In the present of lysine molecules, 
Durmus and co-workers used a co-precipitation method to synthesize amino acid functionalized 
nanoparticles. Many other teams also reported similar results. However, most of these reported 
methods only result in products with very poor solubility and dispersibility in aqueous solution 
after the functionalization which strongly limits their practical applications such as drug delivery 
and cell imaging.   
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In this study, we demonstrate a novel one-pot method that successfully integrates the 
synthesis of nanocrystals with a high temperature ligand exchange reaction. Six different 
hydrophilic AA’s, glycine (Gly), alanine (Ala), serine (Ser), arginine (Arg), threonine (Thr) and 
lysine (Lys) were selected as capping ligand molecules. The effect on the morphology and 
properties of the nanoparticles from different AA’s were evaluated by transmission electron 
microscopy (TEM), X-ray diffractometry (XRD), Fourier transform infrared spectroscopy 
(FT-IR), X-ray photoelectron spectroscopy (XPS) and superconducting quantum interference 
device (SQUID). The reactivity of uncoordinated functional groups was investigated through 
gold nanocrystal attachment and biocompatible polymer conjugation. 
 
2.2.2. Experimental Section: 
2.2.2.1. Preparation of amino acids functionalized magnetic nanoparticles. All chemicals were 
used as received without any further purification. In a typical synthesis,12 0.5 mmol (99.4 mg) of 
FeCl2·4H2O, 1 mmol (270.3 mg) of FeCl3·6H2O, and 20 g of DEG were subsequently added to 
an argon protected three neck flask. Separately, 4 mmol (160 mg) of NaOH was dissolved in 10 
g diethylene glycol and added to the flask above. The mixture was then heated up to 220 ℃ and 
maintained at 220 ℃ for two hours. Meanwhile, 1mmol of AA molecules was dissolved in 400 
μl H2O and mixed with 5 g DEG. At the end of heating, this mixture was injected into the flask 
and then the system was cooled to room temperature. The solid product was magnetically 
isolated and washed five times with absolute ethanol to remove the excess of DEG and other 
chemicals. Finally, the particles were redispersed in deionized water (10 ml) to give a clear 
solution. For FT-IR and SQUID measurements, after extensively washing with ethanol, the solid 
part was dried under vacuum. 
 
2.2.2.2. Preparation of Au-Fe3O4 nanocomposite. The synthesis of 2-3 nm gold nanoparticles 
was based on Duff et al method.13 In a typical experiment, 0.5 ml 1 M NaOH was diluted by 45 
ml deionized water, then mixed with 1 ml tetrakis(hydroxymethyl)phosphonium chloride (THPC 
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80%) solution for 5 min. Then, 1.5 ml 1% HAuCl4 solution was quickly added and the solution 
was further stirred for 5 min.  
For gold attachment, 5 ml of colloidal gold nanoparticles solution was introduced into 2 ml 
water dispersion of Fe3O4 nanoparticles, and the mixture was stirred for 6 h. The solid product 
was magnetically separated and washed with deionized water for five times to remove excessive 
amount of gold particles. The final product was redispersed in ethanol or water by sonication. 
 
2.2.2.3. Conjugation of biocompatible polymer to the surface of amino acids coated 
nanoparticles. In a 10 ml flask, 10 mg AA coated nanoparticles was dispersed in 2 ml nanopure 
water. Separately, 50 mg 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 20 mg 
carboxyl polyethylene glycol (PEG, Mw~2000) were dissolved in 3 ml water. The solution was 
activated for 15 min under thorough mixing. Then, the activated PEG solution was transfer to the 
2 ml nanoparticles dispersion and stirred for 6 h. The solid product was magnetically separated, 
washed with ethanol for five times to remove excess PEG and dried under vacuum.  
 
2.2.2.4. Characterization. The structure and phase purity of the product were xamined by X-ray 
diffractometry using a Philips X`pert system equipped with a graphite monochromator (CuKα 
radiation, λ=1.54056 Å). Size distribution, particles morphology and crystallinity were studied 
on a JEOL 2010 transmission electron microscope (TEM). Surface composition was examined 
by Thermo Nicolet Nexus 670 FT-IR machine in 650-4000 cm-1 region and Kratos AXIS 165 
X-ray Photoelectron Spectroscope. Energy-dispersive X-ray analysis (EDS) was performed on a 
JEOL 2010 transmission electron microscope. The magnetic properties were measured by 
Quantum Design SQUID magnetometer (MPMS XL-7) in the temperature range 5-300K. 
Inductively coupled plasma atomic emission spectroscopy (ICP-AES) were used to calculate the 
net weight of iron oxide. The colloidal stability was investigated by dynamic light scattering 
(DLS) and zeta potential measurement (DelsaNano C). The absorbance spectra were measured 
with a Varian Cary 500 UV-Vis Spectrophotometer. 
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Scheme 2.2.1. Preparation of amino acids functionalized magnetite nanoparticles. 
2.2.3. Results and Discussion: 
2.2.3.1. The effect of variation from amino acids on the morphology, size and size distribution 
of nanoparticles. We adopted the same method as described in last chapter. As shown in Scheme 
2.2.1, the synthesis and surface functionalization of iron oxide nanoparticles with AA’s were 
performed in the same pot instead of conducting a separate ligand exchange reaction after 
purifying and isolating the nanoparticles from the synthesis medium. By carefully adjusting the 
chemical concentration and heating rate during the synthesis, we can control the nucleation and 
growth of the nanocrystals, which effectively yields narrowly size distributed iron oxide 
nanocrystals. At the end of the synthesis, AA molecules were introduced by rapid injection at 
elevated temperatures, which induced a fast ligand exchange reaction. Owing to the increased 
thermal energy at high temperatures and strong coordinating ability of carboxylic groups,14 AA 
molecules would quickly replace the labile solvent shell and stabilize the nanocrystals. Figure 
2.2.1 presents the TEM studies of as-prepared, AA coated iron oxide nanoparticles. Different 
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from last chapter where we use five ligand molecules which differ not only in molecular 
structure but also in their properties such as solubility, and electric neutrality, the six amino acids 
discussed here are only slight varied in structure. Therefore, it is an ideal system to study what 
effect would bring to the final product by changing the capping ligand within this high 
temperature ligand exchange method. From the images, nanoparticles with different AA coatings 
are all well dispersed and narrowly distributed without obvious variation on the morphology. 
Although nanoparticles stabilized by Ala and Gly appeared limited inter-particle spacing because 
of the short length of the ligand molecules, no massive aggregation was found in any AA 
functionalized nanoparticles. However, it was noticed that positively charged Lys and Arg 
protected iron oxide nanoparticles presented improved dispersibility comparing to polar and 
nonpolar AA’s. It can be explained by the strongly protonated amine groups of Lys and Arg in 
aqueous solution, which largely increases the electrostatic repulsion. Furthermore, relatively 
longer carbon chains are able to generate more steric hindrance to enhance the separation among 
nanoparticles.15 On the basis of measuring more than 200 nanoparticles, the average diameters 
are 7.2 nm (SD=17.6) for Ala, 7.0 nm (SD=20.9) for Gly, 7.1 nm (SD=18.6) for Ser, 6.9 nm 
(SD=18.1) for Thr, 7.1 nm (SD=20.7) for Arg and to 7.0 nm (SD=17.2) for Lys functionalized 
iron oxide nanoparticles. Owing to the similar structure and properties of selected AAs, 
functionalized nanoparticles stabilized by different ligand shell only present slight variation on 
the size and distribution of the nanoparticles (Figure 2.2.2). Because the ligand exchange was 
performed at elevated temperature, the reaction system is far more complicated than commonly 
used room temperature method. The competition between two types of ligand could be 
completed different at high temperature. Thus, the small difference in the size and distribution 
could be a consequence from combined contribution of thermal energy, surface energy, reaction 
time and thermal stability of ligand molecules. 
  The high resolution TEM images shown in Figure 2.2.1 demonstrate that each AA 
functionalized nanoparticle is a well-developed nanocrystal. Detailed crystal structure and phase 
purity were examined by powder XRD (Figure 2.2.3), and magnetic nanoparticles with different  
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Figure 2.2.1. TEM images of amino acid coated Fe3O4 nanoparticles. (Insets: High resolution 
TEM images of single magnetite nanoparticles). a) Ala, b) Gly, c) Ser, d) Thr, e) Lys, f) Arg 
surface composition gave similar patterns which matched standard bulk magnetite (JCPDS 
No.19-0629) with no other secondary iron oxide phases. The calculated lattice constants are 
8.390 Å, 8.371 Å, 8.390 Å, 8.378 Å, 8.379 Å, 8.379 Å for Ala, Gly, Thr, Ser, Arg and Lys 
coated nanoparticles, respectively, which are very close to the lattice parameter of standard bulk 
magnetite (8.396 Å) and relatively far from the constant of maghemite (8.346 Å), indicating that 
AA functionalized iron oxide nanoparticles are magnetite. 
 
2.2.3.2. Surface Chemistry. Natural AA’s share many similarities in their molecular structure 
such as carboxylic groups and amine groups at α position. Consequently, AA’s coated 
nanoparticles showed similar spectra during FT-IR measurement (Figure 2.2.4). More 
specifically, the characteristic vibrations of the carboxylic groups are located at 1410 cm-1 and 
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Figure 2.2.2. Size statistics of amino acid functionalized magnetite nanoparticles. 
 
Figure 2.2.3. XRD patterns of the amino acid coated Fe3O4 nanoparticles with the standard 
reference pattern of magnetite JCPDS No. 19-0629. 
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Figure 2.2.4. FT-IR spectra of Fe3O4 nanoparticles with different capping ligands. 
 
Figure 2.2.5. FT-IR spectra of (a) pure glycine, (b) Gly coated Fe3O4 nanoparticles, (c) pure 
lysine, (d) Lys coated Fe3O4 nanoparticles. 
1580 cm-1 which are assigned to the symmetric and asymmetric COO- stretching. The difference 
between these two peaks is about 170 cm-1, implying a bridging structure between the surface 
iron ions and carboxylic groups.16 The absorption peaks at 1610 cm-1 which are overlapped with 
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asymmetric COO- stretching corresponded to the N-H bending of amine groups. The weak peaks 
in 2800 cm-1 to 3000 cm-1 region can be attributed the C-H stretching of methyl or methylene 
groups. In addition, AA functionalized nanoparticles exhibit strong peaks near 1070 cm-1 
ascribed to the C-OH stretching from DEG, which implies an incomplete replacement of original 
DEG with AA’s during the ligand exchange. Functionalized iron oxide nanoparticles also exhibit 
a strong peak at 630 cm-1 and 585 cm-1 which are assigned to the Fe-O vibration,17 indicating a 
covalent bond between capping ligand molecules and the surface of the nanoparticles rather than 
physical absorption.18 
  The spectra of AA coated nanoparticles were compared with their corresponding pure 
amino acid molecules. Gly coated nanoparticles, for example, exhibited with similar pattern as 
pure glycine, especially in the fingerprint region (Figure 2.2.5a&b). If the structure of ligand 
molecules is complicate such as lysine, the differences between spectra of pure amino acid and 
AA stabilized nanoparticles would become obvious. Figure 2.2.6c&d shows the spectra of pure 
lysine and Lys coated nanoparticles. Due to the coordination of lysine with nanoparticles and 
interference of iron oxide, many adjacent absorption peaks in pure lysine only appear as weak or 
shoulder peak in functionalized nanoparticles, and many of them are even unable to distinguish. 
However, it should be noted that most of the important characteristic absorption such as stretch 
vibration of CH2 and COO- and bending vibration of N-H are still easily indentified.  
The surface capping molecules not only stabilize the nanoparticle in solvents, they also 
provide potential reaction sites for further modification. As indicated from FT-IR studies, the 
ligand exchange is incomplete and the surface of the nanoparticles is covered with both AA’s 
and DEG (solvent) molecules. Therefore, the availability of the reaction site is a crucial factor 
that regulates the chemical concentration in the secondary reaction. Here, ICP-AES was 
employed to determine the weight percent of iron oxide core and the organic layer, and XPS was 
applied to provide quantitatively elemental information of surface composition. Since DEG 
contains only oxygen and carbon atoms, nitrogen merely comes from amine groups in amino 
acids, and inorganic magnetite does not have carbon, the atomic ratio of carbon and nitrogen is a 
86 
 
reflection of the ration between amino acid molecules and DEG molecules. One the basis of this 
ratio and the weight percentage of the ligand layer, the numbers of surface capping ligands were 
obtained. As shown in Table 2.2.1, except Thr coated nanoparticles, all other five AA 
functionalized nanoparticles present a similar amount of ligand molecules on the surface with 
ligand exchange efficiency varied from 27% to 67% for different AA’s. We believe that the 
major cause to this variation is the solubility of the AA’s in DEG solvent. As mentioned above, 
during the ligand exchange process, a new capping ligand will rapidly replace the labile DEG 
layer and stabilize the nanoparticles in the solvent. Ascribed to the solubility differences, 
nanoparticles coated by relatively poorly soluble ligand such as Ala and Thr lose their stability in 
DEG and form precipitates, which prevents further contact with DEG. On the contrary, DEG 
soluble ligands including Gly, Lys, Arg and Ser stabilize the nanoparticles in the solvents, which 
prolongs the contact of nanoparticles with DEG. The favorable binding of AA’s with Fe ions on 
the surface is unable to fully overcome the competition from excessive amounts of DEG at  
Table 2.2.1. Colloidal properties and surface capping ligand information on amino acid coated 
Fe3O4 nanoparticles. 
Capping 
Ligand 
Zeta 
Potential 
(mV) 
Hydrodynamic 
Radius (nm) 
PD 
(%) 
Total No. 
of Surface 
Capping 
Ligand 
No. of 
Amino 
Acids 
No. of 
DEG 
Ala 25.6 13.7 0.195 1370 685 685 
Gly 32 13.4 0.205 1390 428 962 
Ser 27 13.1 0.214 1300 347 953 
Thr 25 13.2 0.202 1010 673 337 
Arg 52 12.9 0.223 1280 427 853 
Lys 41 12.4 0.218 1440 480 960 
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elevated temperatures. Therefore, the percentages of AA’s on the surface of nanoparticles for 
Ala or Thr are higher than others resulting from the short exchange time and limited contact with 
competing ligands. 
The colloidal stability of the nanoparticles are closely related to their surface chemistry.19,20 
Although the AA’s involved in this study are varied in polarity and charge, they all have very 
good water solubility. Consequently, the functionalized magnetic nanoparticles are able to form 
clear solutions either in water or buffer solutions such as saline or PBS buffer without any 
observable turbidity or precipitate after several months at ambient conditions.  
Nanoparticle dispersions with good stability usually have narrow size distribution of 
hydrodynamic radius (HD) whereas poorly stable dispersions give a broad distribution because 
of aggregation. Furthermore, HD is an important evaluating factor for employing nanoparticles 
in clinical diagnostic or therapeutic agents. Highly polydispersed nanoparticles with large HD 
only have limited clinical usage. From the DLS measurement (Table 2.2.1), nanoparticles with 
different functionalization show similar values of polydispersity (~0.2) and HD (~13 nm), which 
were about 6 nm larger than the size observed in TEM. The small HD and good uniformity 
greatly enhance the possibility of using this kind of functionalized nanoparticles in the 
development of in vivo biomedical applications. 
The surface charge can largely affect the stability of the nanoparticle dispersion. AA 
functionalized nanoparticles appear positive zeta potential from acidic to lightly basic condition 
(Figure 2.2.6) which is ascribed to the positive charge from protonated amine groups in aqueous 
solution. It is worth mentioning that the observed zeta potentials of Lys and Arg coated 
nanoparticles are larger than the one from other AA’s under the same pH conditions, and the 
zero value of zeta potentials are also higher than the others. It is because that besides the α-amine 
group, both Arg and Lys hold additional amine groups which necessarily provide more positively 
charged group for Colombo repulsion. Furthermore, they are both strong basic natural AA’s with 
much higher isoelectric points than other AA’s (pILys=9.59, pIArg=11.15). Therefore, it requires 
stronger basic conditions to neutralize the positive charge and give zero zeta potential. As the pH 
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continuously increases, deprotonation minimizes the electrostatic interaction, causes aggregation 
of the nanoparticles and induces turbidity in the colloidal solutions. Interestingly however, zeta 
potentials of the AA functionalized nanoparticles are extended into negative value range and 
clear solution can be recovered by the addition of base (Figure 2.2.7). As indicated from XPS 
studies, the surface of the nanoparticles are also partially protected by DEG molecules rather 
than fully covered by AA’s. Therefore, the hydroxyl group of DEG will be deportonated and 
carry a negative charge in strong basic conditions. Thus, the zeta potential of the nanoparticles is 
also largely depended on the amount of DEG on the surface, which is reflected clearly in the 
results. Compared to other AA’s, Ser and Thr carry additional hydroxyl group that can also be 
deportonated in basic conditions. Consequently, their zeta potentials are able to extend to more 
basic ranges. The attempt to correlate the isoelectric point and Pka of amino acid with the pH 
value of zero zeta potential is not successful. Although, lysine and arginine possess higher  
 
Figure 2.2.6. Zeta potentials of amino acid functionalized nanoparticles as a function of pH 
value in buffer solutions. 
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Figure 2.2.7. Examples of AA functionalized nanoparticles dispersion under different pH 
conditions. Ser functionalized nanoparticles are stable from pH 2 to 6. As pH increasing, the 
dispersion started losing their stability and reach to a complete precipitation when pH=8. 
Addition of more NaOH solution, clear and stable dispersion can be recovered by shaking or 
sonication. Other AA functionalized nanoparticles also present similar behavior that coincides 
with the results from zeta potential measurement. 
isoelectric point and nanoparticles functionalized with lysine and arginine also showed zero zeta 
potential at more basic condition, there is no direct correlation between isoelectric point with pH 
of zero zeta potential among other amino acid. This is probably because the surface of 
nanoparticles is not merely stabilized with AA, and DEG also contributed to generation of 
charge in aqueous solution. Therefore, the variation of zeta potential of AA coated nanoparticles 
is a combination effect of both AA and DEG. 
  The magnetic properties of the nanoparticles mainly depend on the intrinsic nature of the 
core materials. Therefore, AA functionalized magnetite nanoparticles are expected to present  
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Figure 2.2.8. (a) Temperature dependence of magnetization of Lys-coated Fe3O4 under ZFC-FC 
conditions. (b) Hysteresis loops of Lys-coated Fe3O4 at 5 and 300 K. 
Table 2.2.2. Size, size distribution and magnetic properties of magnetite nanocrystals capped 
with different amino acids. 
Capping 
Ligand 
Size 
(nm) 
Deviation 
(%) 
TB (K) Hc(Oe) 
MR 
(emu/g) 
Ms(emu/g) 
Normalized 
Ms(emu/g) 
Ala 7.2 17.6 77 288 12 60.6 75.2 
Gly 7.0 20.9 77 290 16.5 63.2 77.2 
Ser 7.1 18.6 69 300 16.9 60.5 75.6 
Thr 6.9 18.1 74 292 14 65 78.7 
Arg 7.1 20.7 80 294 13 57 76 
Lys 7.0 17.2 74 272 13.7 62 78.3 
similar magnetic properties after removing the protective organic layer as long as the chemical 
composition of the core materials was not largely affected during the ligand exchange reaction. 
The as-prepared materials were examined by a SQUID magnetometer. Figure 2.2.8 shows the 
field-cooled (FC) and zero-field-cooled (ZFC) curves of lysine coated nanoparticles. As 
expected, the product exhibits superparamagnetism with a blocking temperature (TB) of 74 K 
which is very close to TB of other AA functionalized nanoparticles (Table 2.2.2). The hysteresis 
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loops also indicate superparamagnetic behavior at room temperature (RT) with no coercivity and 
remanence, and the saturation magnetization (Ms) is 62 emu g-1. At 5 K, ferromagnetic or 
ferrimagnetic behavior are observed in Lys functionalized nanoparticles with a coercivity of 272 
Oe and a remanence of 13.7 emu g-1. Nanoparticles coated with other AA’s show similar values 
of coercivity, remanence and Ms (Table 2.2.1), implying AA functionalized nanoparticles 
prepared by this method differ only in surface composition. After removing the organic ligand 
layer, the normalized Ms are 75.2-78.7 emu g-1, which are very close to the previously reported 
value of magnetite in similar size.12,21,22 
 
2.2.3.3. The surface reactivity of the amino acid functionalized magnetite nanoparticles and 
their bioconjugation. In bioapplications, nanomaterials usually experience several steps of  
 
Figure 2.2.9. FT-IR spectra of Lys coated nanoparticles before and after the conjugation with 
carboxylic terminated PEG. 
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Figure 2.2.10. TEM images of a) gold nanocrystals (3.0 nm) attached Lys coated Fe3O4 
nanoparticles (7.0 nm). b) Fe3O4 nanoparticles without functionalization with amino acids mixed 
with residual gold nanocrystals. c) EDS spectra of Au/Fe3O4 nanocomposite. 
functionalization to get desired products, and these modifications are performed on the surface 
layer, i.e. organic ligand shell. The reactivity of the organic layer not only reply on the activity of 
the functional group because they are the real part that participates in the modification process, 
the actual number of ligand molecules containing desired functional groups which are available 
for secondary reaction also determine the easiness of the following reaction. Therefore, it is 
important to study whether AA coated nanoparticles are useful for further functionalization. The 
surface reactivity of surface functional groups was first tested in polymer conjugation. Under the 
activation of EDC,23 carboxylic terminated PEG was introduced to react with AA functionalized 
nanoparticles. Comparing with the FT-IR spectra of AA coated nanoparticles (Figure 2.2.9), an 
additional peak located at 1730 cm-1 appeared after the conjugation with PEG, which is ascribed 
to the C=O stretching of free carboxylic group, suggesting a successful coupling of PEG with the 
AA’s on the surface of nanoparticles. Additionally, dramatic weight percent increases in the 
organic layer among all AA functionalized nanoparticles are observed in ICP-AES measurement, 
which is also attributed to the coupling of large molecular weight PEG. 
In light of the affinity of noble metals to amine or thiol groups, the surface reactivity of AA 
coated nanoparticles were also investigated in a gold nanocrystals attachment test. Solutions 
containing negative charge stabilized gold nanocrystals were mixed with functionalized iron 
oxide nanoparticles. After removing excess gold, UV spectroscopy was first used to study the 
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nanocomposite aqueous solution. However, because of the very low concentration of gold and 
strong absorption background of iron oxide, no characteristic plasma band of gold nanoparticles 
at 520 nm was observed. Alternatively, electron microscopy was applied to verify the present of 
gold nanocrystals on magnetite. As shown in Figure 2.2.10 small gold nanocrystals (small dark 
black particles, average size of 3 nm) are uniformly attached on to the surface of iron oxide 
nanoparticles (large grey color particle) whereas non-functionalized nanoparticles with only 
DEG coating exhibit a mixture of magnetite and residual amount of gold nanocrystals (dark 
black particle, the size of gold nanocrystals is dramatically increased because of the attaching 
process) after washing. High resolution TEM demonstrated that gold nanocrystals are actually 
docked onto the surface of magnetite nanoparticles rather than simply surrounding them. In 
contrast, magnetic nanoparticles without surface functionalized were found unable to capture 
gold nanocrystals to their surface, suggesting that amine groups from the AA’s are responsible 
for the gold attachment. EDS scan was also performed on the nanocomposite. Besides the iron 
from the nanoparticles and copper from the background, a clear gold peak emerged after the 
attachment, confirming the elemental composition of the attached nanocrystals. The 
gold-magnetite nanocomposite was treated with one hour sonication, and no observable changed 
was found, illustrating the affinity of amine groups with gold. It is noticed that adding gold 
nanocrystals affects the dispersibility of all functionalized nanoparticles and induces slight 
aggregation. Since the solubility of AA’s protected nanoparticles are majorly contributed from 
the charged functional groups of ligand molecules, consuming the amine groups by attaching 
gold nanocrystals will reduce electrostatic repulsion and lead to decreased inter-particles 
separation. 
The magnetic properties of PEG functionalized nanoparticles and magnetite-Au 
nanocomposites were investigated. The saturation magnetization is around 72 emu g-1 after 
normalization to iron oxide, which is very close to the values of AA functionalized nanoparticles 
before the attachment or reaction, indicating further modification does not have a significant 
effect on the properties of AA protected nanoparticles. 
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2.2.4. Conclusions 
Using a simple in situ method, we have successfully prepared six different AA 
functionalized magnetic nanoparticles. By using injection techniques at elevated temperature, 
surface modification was accomplished in a one-pot process, and time consuming post-synthetic 
ligand exchange reaction can be avoided. The as-prepared products present good crystallinity, 
uniformity and superior stability in aqueous solution. Although each capping molecule is only 
slight varied in molecular structure, the differences brought to the final product including size 
deviation, colloidal properties and surface compostions are still observed. However, because 
functionalized nanoparticles share the same core materials and differ only in the composition of 
organic layer, they possess similar magnetic properties, implying all of them have potentials in 
certain applciation. Attachment of noble metal nanocrystals and biocompatible molecules 
confirm the availability and reactivity of the organic layer, which is crucial for the design and 
synthesis of complicated multi-functional platforms for clinical applications. 
 
* Part of this work was adapted with permission from DOI: 10.1016/j.ica.2012.01.058. 
Copyright (2012) Elsevier. 
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Chapter III: High Efficiency In-Situ Decoration of Silica Nanospheres with 
Water-Soluble Magnetite Nanoparticles in Polyalcohol. 
 
3.1. Introduction 
In the past few years, scientists have paid increasing attention to many types of 
nanomaterials because of their potential in designing and fabricating next-generation agents for 
clinical purposes such as imaging, diagnosis and therapy.1-3 Magnetic nanoparticles especially 
iron oxide nanoparticles represent a unique class of nanomaterials that have a strong potential in 
biomedical applications. Owing to their good biocompatibility, stability in physiological 
environment and size dependent magnetic properties, magnetic nanoparticles play an important 
role in the research and development of magnetic field controlled target delivery, image contrast 
agents in magnetic resonance imaging (MRI), and cancer diagnostics.4-7 Silica nanoparticles 
belong to another type of important nanomaterial that shows great potential in biomedical areas. 
The Stöber silica has been used as a support for assembling various kinds of nanoparticles onto 
their surface.8,9 Mesoporous silica materials with large pore size, on the other hand, are widely 
investigated as a carrier for drug delivery.10-12  
Integrating several nanostructured materials into a single agent based on physical adsorption 
or chemical bonding through layer-by-layer assembly can effectively combine the special 
properties of different materials and build multifunctional platforms that satisfy diagnostic and 
therapeutic purpose simultaneously.9,13 Generally, either Stöber silica or mesoporous silica are 
commonly used as the starting support for the integration process and the silica nanoparticle 
itself can be doped with organic dye molecules to be fluorescent.14,15 The surface of silica 
nanoparticles are usually functionalized with silane in order to bear reactive functional groups 
(e.g. amine, thiol). Then, various types of small nanomaterials that have values in biological or 
clinical studies such as noble metal nanocrystals, quantum dots or magnetic nanoparticles can be 
loaded on to the surface of silica through their affinity with amine or thiol groups. Until now, a 
number of research groups have reported several examples of silica based dual-functional or 
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multifunctional nanomaterials. Their preparation methods, however, usually involve multiple 
steps of preparation and surface functionalization of both silica and magnetic nanoparticles, 
which is time consuming and difficult to scale up. Therefore, the development of a synthesis 
procedure that is able to directly decorate magnetic nanoparticles onto the surface of silica sphere 
is extremely desirable. 
In this chapter, we introduce a novel in-situ synthesis method to efficiently decorate silica 
nanospheres with magnetite nanoparticles in polyalcohol. With this method, magnetite 
nanoparticles can be attached onto any silica-based nanomaterials, varied in size, shape and 
structure. By carefully controlling the experimental condition such as chemical concentration, 
ratio of iron precursor with silica and refluxing duration, the size of the magnetite and their 
attaching efficiency can be well tuned. 
 
3.2. Experimental 
3.2.1. General information. Iron (III) acetylacetonate (Fe(acac)3, 99.9%), Tetraethyl 
orthosilicate (TEOS, 98%), Tetraethylene glycol (TEG, 99%), Hexadecyltrimethylammonium 
bromide (CTAB, 99%) (3-Aminopropyl) triethoxysilane (APTES, 98%), L-arginine (98%) 
Fluorescein isothiocyanate (FITC, 90%), Rhodamine B isothiocyanate were purchase from 
Sigma-Aldrich, Methoxy PEG succinimidyl carboxymethyl ester (MPEG-SCM, MW~2000) was 
purchased from JenKem Technology. Other general chemicals and solvents such as ethanol, 
acetone were used as received.  
Product structure and phase purity were determined by X-ray diffraction with a Philips 
X`pert system equipped with a graphite monochromator (CuKα radiation, λ=1.54056 Å). Size 
distribution, particles morphology, crystallinity and elemental composition were studied on JEOL 
2010 transmission electron microscope (TEM) with energy dispersive X-ray spectrometer (EDS) 
and LEO 1530VP Field Emission Scanning Electron Microscope (FESEM). Surface composition 
was examined by Thermo Nicolet Nexus 670 FT-IR machine in 650-4000 cm-1 region. 
Inductively coupled plasma atomic emission spectroscopy (ICP-AES, Varian Vista-MPX) were 
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used to calculate the net weight of iron oxide. The magnetic properties were measured by 
Quantum Design SQUID magnetometer (MPMS XL-7) in the temperature range 5-300K. The 
colloidal stability was investigated by dynamic light scattering (DLS) and zeta potential 
measurements (DelsaNano C). Fluorescence images of the fluorescent particles were taken using 
a digital fluorescence imaging microscopy system that consisted of an inverted fluorescence 
microscope (Olympus IX70) equipped with a 100-W mercury lamp as a light source. 
 
3.2.2. Synthesis of silica nanostructures. Non-mesoporous silica nanoparticles above 100 nm 
were prepared through classic Stöber method.16 For 130 nm silica spheres, for example, in a 250 
ml flask cleaned with aqua regia, 100 ml of absolute ethanol, 18 ml of nanopure water and 2.1 ml 
of concentrated ammonia hydroxide (25~28 %) were subsequently added. Then, 5.5 ml of TEOS 
was rapidly injected into the flask and the solution was let stir at 800 rpm for 6h. The resulting 
particles were precipitated in centrifuge (3500 rpm), washed with ethanol for 3 times and dried in 
air.  
Highly monodispersed small silica spheres (<100 nm) were prepared according the reported 
method with some modifications.17 In a typical synthesis, 9.1 mg of L-arginine was first dissolved 
in 6.9 ml of nanopure water. Then 0.55 ml of cyclohexane was added and the vial was heated to 
60 °C in a sand bath under magnetic stirring using TEFLON coated stir with a length of 1 cm. 
The stirring was adjusted to 300 rpm. Once the temperature of solution reached 60 °C, 0.55 ml of 
TEOS was carefully added to the cyclohexane layer. The solution was allowed to react for 20 h. 
Then 2 ml of reaction solution in aqueous phase was transferred to a vial containing 7.2 ml of 
water, 4.4 ml of cyclohexane at 60 °C. An aliquot of 4.27 ml of TEOS was added to cyclohexane 
layer and the solution was stirred at 60 °C under constant rate of 300 rpm for 50 h. The particles 
were precipitated by the addition of acetone and centrifuge at 14000 rpm for 10 min. After 
washing with ethanol and acetone for 3 times, the products were air dried.  
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Mesoporous Hollow Silica Nanotubes were fabricated based on the published method.18 
Typically, an amount of 3 g of CaCO3 nanoneedles was dispersed in 80 ml of ethanol by 
ultrasonic treatment. Then, 1 g of CTAB was added and the mixture was further sonicated for 20 
min. After that, under a mechanic stir with rate of 500 rpm, appropriate amount of concentrated 
ammonia hydroxide and 3.2 ml TEOS were subsequently injected into flask. The reaction 
solution was mixed for 2 h at room temperature and aged for 4 h. The washed and dried products 
were calcined at 300 °C for 3 h and 550 °C for another 5h. Then, the immersion of calcined 
products in diluted acetic acid solution for 4 h resulted in template removed hollow silica 
nanotube. 
Mesoporous Silica Nanosphere were prepared using a reported procedure.19 Briefly, 3.43 g 
of KH2PO4 and 0.58 g of NaOH were dissolved in 500 ml water to prepare reaction buffer. Then, 
0.182g CTAB was mixed well in 50 ml reaction buffer and 0.9 ml of TEOS was slowly added. 
The reaction was performed at 80 °C for 8 h. After washing with ethanol for three times, the 
as-prepared particles were refluxed in 50 ml of ethanol containing 2 ml of 38% hydrochloric acid 
for 8 h, centrifuged, washed with ethanol and dried under vacuum.   
 
3.2.3. Synthesis of Fe3O4 attached silica nanostructures. Iron precursors, silica nanomaterials 
were refluxed in polyalcohol for different amount of time to yield Fe3O4 attached Silica. For 
Fe3O4 attached 400 nm silica sphere, for example, 400 mg of silica nanoparticles was dispersed 
in 2 ml of water by placing in a sonication bath for 30 min. Then 10 g of TEG and 0.177 g (0.5 
mmol) of Fe(acac)3 were added. The mixture was first heated to 110 °C for 30 min to remove 
water, and then to 210 °C for 2h. The system was finally refluxed at 300 °C for 1-3 h and then 
cooled to room temperature. The nanocomposite was precipitated and washed with acetone for 
five times and dried under vacuum. By varying the silica materials and chemical concentration, 
Fe3O4 attached silica nanostructure with different attaching efficiency can be prepared, and the 
size of magnetite can also be tuned. 
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3.2.3. Surface functionalization of Fe3O4 attached silica nanosphere with biocompatible PEG. 
In a 20 ml vial, 6 mg of 110 nm Fe3O4 attached silica sphere was fully dispersed in absolute 
ethanol by sonication. Then 100 μl of APTES was added and the solution was stirred overnight. 
After washing with ethanol for five times, APTES functionalized nanoparticles were redispersed 
in 4 ml of ethanol with 40 mg of MPEG-SCM, followed with 12 h of thorough stirring. The 
resulting products were washed with ethanol and dried in vacuum.  
 
3.2.4. Fluorescent silica coating. The silica coating was achieved by the co-condensation of 
TEOS and APTES. FITC-APTES was prepared according to literature.10 In a glove box, 4 mg of 
FITC or 5 mg of Rhodamine B isothiocyanate and 44 μl of APTES were mixed in 1 ml of 
anhydrous ethanol in dark for 12 h. In a typical reaction, 5 mg of 400 nm Fe3O4 attached silica 
sphere was dispersed in 9 ml ethanol and 1 ml of water containing 100 μl of ammonia hydroxide 
(~28%). Then 50 μl FITC-APTES and 20 μl of TEOS were added and the solution was stirred 
for 24 h. The products were washed with ethanol for 3 times and dried in vacuum.   
 
3.3. Results and Discussion 
3.3.1. Attaching efficiency and size evolution of the iron oxide nanoparticles on silica 
nanosphere. Scheme 3.1 describes the synthesis procedure to prepared magnetite nanoparticles 
attached silica nanosphere. Well dispersed silica nanoparticles aqueous solution was mixed with 
TEG solvents and iron source. This mixture was first heated to 110 °C for certain amount of time 
to remove the water from the reaction medium. Then, the system was heated to reflux  
 
Scheme 3.1. Preparation procedure of magnetite nanoparticle attached silica nanosphere. 
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Figure 3.1. Bright field TEM images of (a) 100 nm SiO2 nanospheres, (b)&(c) Fe3O4@SiO2 
under different magnification. (Inset: HRTEM image of a single magnetite nanocrystal) 
 
Figure 3.2. Bright field TEM images of Fe3O4@SiO2 in different sizes. (a) 55nm, (b) 115nm, (c) 
180 nm, (d) 300 nm, (e) 650 nm, (f) 930 nm. 
temperature to yield Fe3O4@SiO2. Figure 3.1a is the TEM image of silica nanoparticles with 
average size of 109 nm prepared by Stöber method. After the reaction, magnetite nanoparticles 
with average diameter of 7.7 (SD=1.2 nm) are individually attached onto silica nanosphere and 
form a thin layer of magnetite with uniform distribution on silica surface. And no disassociated 
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magnetite nanoparticles were observed near the silica or in any sample area. Low magnification 
TEM suggests that all silica spheres are decorated with magnetite nanoparticle and there is no 
observable variation on the attaching efficiency, imply the attachment is not a random incident. 
Considering the increased diameter contributed from the magnetite nanoparticles, the diameter of 
Fe3O4@SiO2 should be around 127 nm. However, from TEM studies, the size of Fe3O4@SiO2 is 
115 nm, only 6 nm larger than the pure silica particles. This could be ascribed to the shrink of 
silica nanoparticles caused by the high reaction temperature during the preparation. 
 
 
Figure 3.3. TEM images of (a) as-prepared mesoporous silica nanoparticles, (b) magnetite 
attached mesoporous silica, (c) hollow silica nanotube, (d) magnetite attached silica hollow 
nanotube. 
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The size of Fe3O4@SiO2 can be tuned according to the purpose and requirement of the 
application by simply changing the size of silica. From Figure 3.2, silica nanoparticles with sizes 
from 50 nm to less than 1 micron are all covered with a uniform magnetite layer, and no affinity 
difference of silica surface with magnetite was observed in any sized product. Besides Stöber 
silica, the in-situ decoration method can be extended to immobilize any non-crystal silica 
nanostructure such as mesoporous silica, silica nanowire and nanotube. Figure 3.3 presents the 
TEM and SEM images of magnetite nanoparticles attached to mesoporous silica nanoparticles 
and hollow silica nanotubes. No obvious difference was found when changing Stöber silica to 
mesoporous silica. The hollow silica nanotubes are also covered with a smooth layer of 
magnetite nanoparticles. The mesoporous and hollow structure are of great value in target 
delivery because a large amount of drug molecules can be stored within the porous structure and 
hollow cavities. The attachment of numerous magnetite nanoparticles render powerful magnetic 
properties of these silica structures, which make them promising nanomaterials for target drug 
delivery for cancer treatment. 
  The formation course of magnetite nanoparticles on the silica surface was investigated by 
taking aliquots solution at different temperature and checking with TEM. A possible mechanism 
is proposed as follows. During the heating, iron precursors decompose and form monomers in 
the reaction solution, and nucleation is initiated when the monomer concentration is raised above 
nucleation threshold. Nuclei are formed not only on the surface of silica but also in reaction 
solution. However, ascribed to the very high surface energy, small nuclei tend to adsorb on the 
surface of silica nearby. As reaction progressing, more and more nuclei adhere to silica sphere 
and result in nearly fully covered silica surface and these nuclei start to grow upon the 
consumption of monomers decomposed from precursors as long as their concentration is above 
saturation level. Followed with Ostwald ripening, relatively smaller nanocrystals dissolved and 
redeposit the material on adjacent bigger nanoparticles, leading to partially covered silica sphere 
with increased magnetite size. Previous studies have suggested that polyols act as both 
stabilizing agents and reducing agent during the synthesis of magnetite nanoparticles.20 Similar 
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Figure 3.4. TEM images of samples taken at different intermediates. (a) 140 °C, (b) 180 °C, (c) 
210 °C, (d) after 45 min at 210 °C. 
results were observed in our synthesis. The decomposition temperature of neat Fe(acac)3 is 
around 175 °C. However, small nuclei with size about 1.3 nm appeared in reaction solution as 
early as 140 °C, indicating the reductive condition generated by the TEG. From the image 
(Figure 3.4), it is clear that nucleation was developed both on silica surface and in synthesis 
medium. At higher temperature, the surface coverage of silica was enhanced and reached to a 
saturation whereas nuclei concentration in reaction solution was dramatically decreased, 
implying the adsorption of nuclei onto silica sphere. 
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Experimental conditions including concentration of the iron precursors and silica, the ratio 
between iron source and silica, and refluxing duration were varied to understand the formation of 
magnetite nanoparticles on surface. 
  Since magnetite nanoparticles are directly decorated onto silica surface during the synthesis, 
the amount silica that determines the total surface area is expected to have influence on the final 
product. By maintain the iron precursor concentration and other parameter constant, the quantity 
of silica nanoparticles added at the beginning was gradually increased in each synthesis. From 
TEM studies (Figure 3.5b-d), double the silica quantity would induce such a notable decrease in 
the attaching efficiency that much less of surface area of silica is covered with magnetite 
nanoparticles compared to origin concentration. Triple or quadruple the amount of silica would 
lead to sparser decoration of magnetite nanoparticles. Additionally, when large amount of silica 
were used, some silica spheres were observed having much less magnetite nanoparticles attached  
 
Figure 3.5. TEM images of 100 nm Fe3O4@SiO2 prepared under different iron precursor to 
silica weight ratio. (a) 1.77:1 (original ratio and concentration), (b) 1.77:2, (c) 1.77:3, (d) 1.77:4, 
(e) 1.77:0.5, (f) 3.54:1, (g) 0.88:1 (h) original ratio and concentration (1.77:1) and refluxing time 
was decreased from 3h to 1h. (Insets: higher magnification). Note: the volume of TEG solvent 
was 10 ml in all preparations. 
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than other Fe3O4@SiO2 prepared from the same batch. This is probably because before the 
addition of TEG solvent and iron precursor, the dry powder form of silica was needed to be 
dispersed in small amount of water, and triple or quadruple the silica quantity would increase the 
difficulty of fully dispersing large amount of particles in such small volume of water. 
Consequently, aggregated silica would hinder the uniform attachment of magnetite onto 
individual SiO2. A feasible solution to this problem is using as-prepared ethanolic or water 
dispersion of silica nanoparticles dispersed without drying them into powder form. The results 
showed a dramatically decrease in the number of poorly decorated SiO2. However, experimental 
conditions during Stöber silica synthesis including the volume of TEOS, ammonia, water and 
ethanol, temperature and reaction time should be carefully monitored to have consistent yield so 
that the concentration of silica dispersion of every batch is constant.     
When the quantity of silica was decreased, silica spheres with more compact decoration 
would appear ascribed to the less available total surface area. Figure 3.5e presents the 
Fe3O4@SiO2 after halving the amount of silica. The surface coverage is significantly higher than 
the one prepared in original silica quantity. Although there is still uncovered surface, because of 
the possible high steric resistance raised by fully covering the silica sphere, many magnetite 
nanoparticles start to grow on the top of other magnetite nanoparticles. Further reducing the 
silica quantity would cause insufficient surface area for docking, which lead to many detached 
magnetite particles mixed with Fe3O4@SiO2. 
The magnetite attaching situation can also be tuned by varying the concentration of iron 
precursor. As shown in Figure 3.5f, when the concentration of iron precursor was increased to 
twice as much as the origin, the attaching efficiency did not exhibited very significant 
improvement. However, the average size of magnetite nanoparticle was grown from 7 nm to 10 
nm, which can be attributed to the more available iron source for particles growth. On the 
contrary, diluted iron source concentration affect attaching efficiency and size of the magnetite 
simultaneously (Figure 3.5g). When Fe(acac)3 quantity was halved (silica amount and other 
parameters were remained unchanged), although the attaching efficiency of magnetite is very 
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similar to the one prepared in triple amount of silica condition, the average size of magnetite 
shrank to a much smaller value of 5.8 nm (SD=1.0 nm).  
In many iron oxide nanoparticles synthesis, longer refluxing time would lead to larger 
particles due to the Ostwald ripening process where smaller particles dissolve and the resulting 
materials are redeposited on larger ones. In our synthesis, refluxing at 300 °C for 3 h produces 
7.6 nm magnetite nanoparticles whereas 1 h refluxing produces particles of 7.0 nm, which is 
consistent with reports in the literature. 
The influence of iron precursor to silica ratio and the chemical concentration was observed 
on silica nanosphere of all sizes. Figure 3.6 presents the SEM images of 400 nm Fe3O4@SiO2 
synthesized under different conditions. It is clear that lower silica amount would produce 
compact surface coating with magnetite nanoparticle whereas increasing silica feeding would 
decrease the silica surface coverage. 
   
Figure 3.6. SEM images of 400 nm Fe3O4@SiO2 prepared under different iron precursor to silica 
weight ratio. (a) 1.7:1, (b) 1.7:2, (c) 1.7:4, (d) 1.7:6. 
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Figure 3.7. TEM and SEM images of Fe3O4@SiO2 prepared using iron precursor to silica weight 
ratio 3.54:1 (a)&(c), and 0.88:0.5 (b)&(c). 
In summary of above results, the silica quantity which determine the total surface area 
mainly affect the attaching efficiency in such a way that more total surface area leads to less 
surface coverage of each silica sphere. The iron precursor concentration, however, strongly 
influence both attachment and the size of magnetite nanoparticles. In order to support our 
speculation we performed two more synthesis where the amount of iron precursor and silica are 
both either doubled or diluted twice. TEM studies (Figure 3.7) shown that even though the ratio 
between iron source and silica were the same, higher concentration of iron source lead to larger 
size of magnetite nanoparticles and slight enhanced surface coverage compared to the original 
concentration, whereas diluted one resulted in smaller magnetite nanoparticles and lower 
attaching efficiency, suggesting that the average size of attached magnetite nanoparticles and 
attaching efficiency are both determined by iron precursor concentration and silica quantity 
dominantly affects the attachment.  
109 
 
 
Figure 3.8. TEM images of 200 nm Fe3O4@SiO2 (a) as-prepared, (b) sonication for 1h, (c) 
sonication for 5h (Insets: higher magnification) 
 
Figure 3.9. X-ray diffraction patterns of Fe3O4@SiO2 with standard reference magnetite 
It is not clear that which force or how many forces are responsible for the interaction between 
magnetite nanoparticles and silica sphere. In order to test ability of this interaction, a small vial 
containing ethanolic dispersion of as-prepared Fe3O4@SiO2 were immersed in a 40 kHz 
ultrasonic bath (Branson 1510) for different duration. Surprisingly, no observable change was 
found on the samples after 2 h and even 5 h continuous ultrasonic treatment (Figure 3.8), 
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implying the possible existence of chemical bonding between magnetite and silica rather than 
simple physical adsorption. 
 
3.3.2. Characterizations of Fe3O4@SiO2 Nanocomposites. The crystallinity and phase purity of 
magnetite nanoparticles on the silica were routinely examined with HRTEM and XRD. Clear 
crystal lattice can be seem from HRTEM image of a single magnetite nanoparticle on silica 
(Figure 3.1c), suggesting the good crystallinity of the nanoparticles. In XRD (Figure 3.9), 
magnetite attached silica of all sizes gave the same pattern which matches the standard bulk 
magnetite (JCPDS No. 19-0629)     
The surface composition of Fe3O4@SiO2 was studies in FT-IR. From Figure 3.10a, the 
spectra of silica before and after attached with magnetite nanoparticles are very much alike in 
most regions, which can explained by strong background intensity generating by the large 
amount of silica. The intense peak at 1056 cm-1 can be signed to the Si-O stretching vibration, 
and band in 1620 cm-1 is the result of δOH vibrations originating from the hydration changes on 
the surfaces of nanoparticles and intensity changes due to hydrogen bonding on the charged 
surface.21 However, it is notice that in Fe3O4@SiO2, the Si-O band was shifted to lower 
wavenumbers. A close examination in the regions corresponding to alkane groups revels the 
differences between two samples. The emerging peaks in 2800 cm-1 to 3000 cm-1 section and few 
more bands around 1460 cm-1 in Fe3O4@SiO2, which are absent in pure silica nanospheres, are 
contributed from the C-H bond stretching from methylene groups, indicating the present of TEG 
molecules. To further confirm this idea, we exam the spectrum of magnetite nanoparticles 
prepared in TEG (no silica nanoparticles were added). As clearly showing in the figure, the 
spectrum of TEG coated magnetite nanoparticles shares many similar bands with Fe3O4@SiO2. It 
is worth mentioning that, TEG coated magnetite nanoparticles also exhibit a fairly strong 
absorption at 1068 cm-1, which is ascribed to stretching of C-O that is falls in the same region as 
Si-O bond. Therefore, the absorption at 1044 cm-1 of Fe3O4@SiO2 can be a combination effect of 
both Si-O and C-O bond vibration. 
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Figure 3.10. (a) FT-IR spectra of neat silica, TEG coated iron oxide nanoparticles and 
magnetite attached silica nanocomposite. (b) EDS spectrum of Fe3O4@SiO2 
 
Figure 3.11. Hysteresis loops of Fe3O4@SiO2 at 300 K and 5 K. 
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Elemental composition of the nanocomposite was investigated in EDS. From Figure 3.10b, 
very clear peaks from both silica and iron can be seen after the scan and the atomic ratio between 
Si and Fe is constant through whole sample area, suggesting magnetite nanoparticles are 
uniformly attached onto each silica particles with similar efficiency. 
The magnetic properties of Fe3O4@SiO2 were studied with a Quantum Design SQUID 
magnetometer and the results indicate that the all the samples are superparamagnetic at room 
temperature with no coercivity and remanence (Figure 3.11). At temperature of 5 K, 400 nm 
Fe3O4@SiO2 presented ferrimagnetic behavior with a coercivity of 353 Oe and remanence of 6.9 
emu g-1. The saturation magnetization at room temperature is 18.8 emu g-1 for Fe3O4@SiO2 
nanocomposites. After normalizing the Fe3O4 core, the saturation magnetization is about 80 emu 
g-1, which is very close to the value of magnetite nanoparticles prepared in TEG. Other 
Fe3O4@SiO2 in different sizes all exhibited similar magnetic properties. 
 
3.3.3. Surface functionalization on Fe3O4 attached silica nanosphere. The stability of 
nanomaterials in aqueous is crucial for their application in clinical area. Since larger aggregates 
will captured by the RES system in liver or spleen and have very short life inside the body, 
appropriate surface functionalization is an efficient strategy to improve the stability of 
nanomaterials and enhance their lifetime so as to increase the possibility of nanomaterials to 
arrive target site. Unfortunately, the as-prepared Fe3O4 attached silica nanospheres do not possess 
ideal colloidal stability in water or PBS buffer. Although the surface of magnetite nanoparticles 
are capped with TEG, the charge and steric effect producing by these molecules is insufficient to 
overcome the van de Waals attraction which would become stronger as the size of the 
nanoparticles increasing. The cross-linkages among these nanocomposites, which are generated 
during the preparation of silica nanosphere also contribute to the instability of our materials. 
Biocompatible PEG was chosen as coating materials to promote aqueous stability and 
biocompatibility of the magnetite silica nanocomposites. First, a silane compound-APTES was 
reacted with hydroxyl, from either surface of silica or TEG molecules, to immobilize amine  
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Figure 3.12. Hydrodynamic size distribution of PEG functionalized 100 nm Fe3O4@SiO2. 
functionality to the materials. Then, PEG with a succinimidyl carboxymethyl ester terminal was 
reacted with amine to yield a stable amide bond. We performed a colloidal stability test of 
Fe3O4@SiO2 before and after functionalized with PEG. Within several hours, most of the 
as-prepared Fe3O4@SiO2 aggregate and precipitate gradually at the bottom while no observable 
aggregation was found in PEG coated Fe3O4@SiO2 even after 4h, suggesting that PEG coating 
effectively enhances the stability of Fe3O4@SiO2 in aqueous solution. DLS and zeta potential 
measurement were used to further quantify the colloidal stability of Fe3O4@SiO2. However, due 
to the limited stability of as prepared Fe3O4@SiO2 in aqueous solution, the nanocomposite 
precipitated and formed larger aggregation in PBS buffer solution during the measurement, and 
we are unable to get reliable values of their HD and zeta potential. PEG functionalized 
Fe3O4@SiO2 on the other hand presented a HD of only 165 nm with very narrow distribution. 
The zeta potential of Fe3O4@SiO2 was measured to be -35 mV, suggesting nanoparticles are 
negatively charged in buffer solution at neutral pH.   
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Figure 3.13. (a) TEM images of Fe3O4@SiO2 coated with fluorescent silica layer. (b) 
Fluorescent microscope image of fluorescent Fe3O4@SiO2 water dispersion under excitation of 
530 nm (“a” an area containing dispersed Fe3O4@SiO2 coated with fluorescent silica layer. 
“b”&”c” areas containing aggregations of Fe3O4@SiO2 coated with fluorescent silica layer) 
To incorporate fluorescent properties into Fe3O4@SiO2 nanoparticles, a co-condensation 
process was employed. By adding dye labeled silane compound which was prepared by reacting 
FITC or Rhodamine B isothiocyanate with APTES, TEOS and ammonia into ethanolic 
dispersion of Fe3O4@SiO2, fluorescent magnetic silica nanosphere can be fabricated. From TEM 
studies (Figure 3.13), the co-condensation process on a 400 nm Fe3O4@SiO2 resulted in an 
amorphous silica layer, about 24 nm thick, which increased the diameter of the Fe3O4@SiO2 to 
about 450 nm. Due to the slight cross-linkage between as-prepared Fe3O4@SiO2, the coating 
process caused certain degree of coalesce on the edge of coated particles, which might induce 
light aggregations. From fluorescence microscope, numerous bright green spots can be observed 
with a black background, indicating that the fluorescent color are coming from the coating layer 
rather than liberated dye molecules that desorbed from the particles. However, because of the 
limited resolution of fluorescence microscope, we are unable to identify whether these spots are 
composed of single Fe3O4@SiO2 particles or a result of agglomeration. It is possible that the 
very tiny green dots in circle “a” are single Fe3O4@SiO2 particles whereas bigger spots in circle 
“b” and “c” are convinced to be aggregation of several nanoparticles.  
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The coating procedure can be applied to any sized Fe3O4@SiO2, and adjustment of the 
amount of silica precursor and fed nanoparticles as well as the reaction pH, time, temperature 
and other factors, the thickness of the layer, the fluorescent color and the dye molecules content 
quantity can be controlled. The silica layer not only renders fluorescent properties to the 
Fe3O4@SiO2 nanocomposites, the water-stability and resistance to chemical degradation of 
nanoparticles are also greatly improved. 
 
3.4. Conclusion 
In this chapter we described a novel high efficiency in-situ method to decorate silica-based 
nanomaterials with magnetite nanoparticles. The resulting products have an evenly distributed 
magnetite nanoparticles on silica layer with adjustable surface coverage under variable synthesis 
conditions. The attached iron oxide is pure phase magnetite with a well-developed crystal lattice, 
which delivery strong magnetic properties to silica. It is suggested that the size of magnetite 
nanoparticles are strongly determined by the concentration of iron precursor and the surface 
coverage is affected by the amount of iron precursor and silica added during the preparation 
phase. Ascribed to the cross-linkage from silica nanoparticle themselves, the resulting product 
also presented a small portion of aggregated particles, which could harm the water-solubility. 
Functionalization of the Fe3O4@SiO2 with biocompatible PEG could dramatically improve their 
stability in aqueous solution, indicated by the high zeta-potential value and small hydrodynamic 
radius. Coating with a thin silica layer is able to increase the colloidal stability of Fe3O4@SiO2 in 
water as well and prevent possible oxidation and other degradation to magnetite so as to maintain 
the magnetic properties. During the coating process, fluorescence dyes can be incorporated into 
the silica layer, immobilizing fluorescent properties to nanoparticles, which modify the 
Fe3O4@SiO2 into a dual-functional probe for both MRI and fluorescent imaging.  
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Chapter IV: Polyamines as Solvents, Reducing and Stabilizing Agents in 
Preparing Water-Soluble Magnetite Nanoparticles with Reactive Amine 
Surface Functionalities.* 
 
4.1. Introduction 
Water-solubility and surface reactivity are two crucial factors that determine whether certain 
nanomaterial is suitable for clinical purposes. Bioapplications such as drug delivery, magnetic 
resonance imaging (MRI) and hyperthermia rely on the human circulation system to deliver 
nanosized agents to the target.1-4 Nanomaterials that are naked or hydrophobic on the surface are 
not stable in physiological fluids. They precipitate instantly and form large agglomeration that 
will be cleared by liver or spleen rapidly. Severe immune response could also be triggered by 
these aggregations. Therefore, appropriate coating that can tolerate the ion strength and 
numerous biomolecules such as antibodies, and stabilize nanomaterials in physiological 
environment is fundamental for in vivo applications. As we mentioned several times in pervious 
chapters, the majority of the studies adopted thermal decomposition of several iron precursors in 
non-polar solvent as the method to prepare hydrophobic SPIONs that are unable to sustain a 
secondary reaction for further modification.5-9 Consequently, these NPs are treated with ligand 
exchange reaction to modify the surface moiety with desired functionalities.10-13 Other 
preparation approaches such as co-precipitation and microemulsion methods cannot offer the 
same degrees of uniformity, crystallinity and magnetic properties NPs as achieved in the thermal 
decomposition route.14,15  
Several high-temperature synthetic approaches have been developed to prepare 
water-soluble SPIONs by performing the synthesis in polar solvent at elevated temperature.16-18 
Li17 and coworkers selected 2-pyrrolidone as the synthesis medium to directly prepare 
water-soluble magnetite nanoparticles. By simply refluxing iron precursors such as Fe(acac)3 or 
more economical source like FeCl3·6H2O in 2-Pyrrolidone, uniform and water-stable magnetite 
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nanoparticles can be obtained. Furthermore, they also demonstrate that biocompatible magnetite 
nanoparticles with surface reactivity can also be synthesize in a similar way by adding 
bi-functional carboxyl terminated PEG to the 2-pyrrolidone system. The strong binding between 
carboxyl groups with iron assures the presence of this PEG ligand on the surface of nanoparticles. 
Their results indicate that there are free carboxyl group available for further reactions. In chapter 
II, we also introduced a one-pot synthesis pathway to produce water-soluble magnetite 
nanoparticles using diethylene glycol as solvent. Not only can these high boiling point polar 
solvents provide a wide operating-temperature range, they also act as reducing agent and 
coordinating ligands that can effectively stabilize the NPs during the reaction and prevent 
aggregation.19,20 Despite interest in direct preparation of uniform water-soluble NPs, the 
reactivity and availability of the surface functional groups of ligand shell remain an issue, which 
hinders the subsequent functionalization step for designing complicate multifunctional agents for 
clinical diagnostic and treatment. 
Besides carboxylates,21,22 phosphates,23,24 and sulfates,5 primary amines are also known to 
bind to the surface of NPs due to their coordinating ability with many transition metals.7,25 While 
ligand exchange reactions and hydrothermal synthesis of iron oxide NPs using hydrophilic 
molecules containing amine functionalities as ligand have been reported,5,26 the colloidal 
chemistry using polyamines as solvent and stabilizing agents is unexplored, and little attention 
has been paid to their interesting properties such as high boiling point, water-solubility and 
reduction abilities. Additionally, amine groups are also well-known for their reactivity in 
bioconjugation chemistry. A variety of organic molecules are able to couple with a 
amine-containing molecules and give a stable amide or secondary amine bond in a rapid and 
high yield reaction.27  
In this chapter, a one-pot synthesis method, using polyamine as both solvent and stabilizing 
agents to prepare water-soluble amine functionalized magnetite NPs is described. Under a 
reductive environment provided by polyamine, Fe(III) precursors are partially reduced to yield 
Fe3O4. The as-prepared materials were routinely characterized with TEM, XRD, SQUID and 
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FT-IR. Their surface chemistry and colloidal properties were examined by TGA, ICP-AES, XPS, 
DLS and zeta potential measurement. The reactivity and availability of the amine groups were 
studied in gold and quantum dots attachment tests, and in conjugation with biocompatible 
polymers. 
 
4.2. Experimental 
4.2.1. General information. Synthesis medium triethylenetetramine and Fe(acac)3 were 
purchased from SIGMA and used as received. Other chemicals and solvent were purchased from 
SIGMA and Alfa Aesar and used without further purification. Sample structure and phase purity 
were determined by X-ray diffraction with a Philips X`pert system equipped with a graphite 
monochromator (CuKα radiation, λ=1.54056 Å). Size distribution, particles morphology and 
crystallinity were studied on a JEOL 2010 transmission electron microscope (TEM). Surface 
composition was examined by Thermo Nicolet Nexus 670 FT-IR machine in 650-4000 cm-1 
region and Kratos AXIS 165 X-ray Photoelectron Spectroscope. Thermogravimetric analysis 
(TGA, TA SDT Q600) and inductively coupled plasma atomic emission spectroscopy (ICP-AES, 
Varian Vista-MPX) were used to calculate the net weight of iron oxide. The magnetic properties 
were measured by Quantum Design SQUID magnetometer (MPMS XL-7) in the temperature 
range 5-300K.  
 
4.2.2. Preparation of 7 nm Fe3O4 nanoparticles. Under a flow of argon, 0.353g (1 mmol) of 
Fe(acac)3 was mixed with 20 ml of TETA. This mixture was first heated to 110 °C for 20 min to 
complete dissolved the solid. The resulting solution was gradually heated to 210 °C for two 
hours and then, heated to reflux for another 1 hour. After cooled to room temperature, the solid 
product was magnetically collected and washed with acetone for five times. The nanoparticles 
were dispersed in polar solvents such as water or alcohol. 
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4.2.3. Preparation of 10 nm Fe3O4 nanoparticles using 7 nm nanoparticles as seeds. Under a 
flow of argon, 0.353 g (1 mmol) of and 5 ml of ethanolic dispersion of 7 nm Fe3O4 nanoparticles 
(10 mg/ml) were added to 20 ml of TETA. The mixture was first heated to 110 °C for 20 min to 
remove ethanol. The mixture was heated to 210 °C for 2 h, then further to reflux for another 1h. 
After cooled to room temperature, the solid product was collected and washed following same 
procedures described in the synthesis of 7 nm nanoparticles. By repeating this cycle, larger Fe3O4 
nanoparticles can be made. 
 
4.2.4. Preparation of TETA coated Fe3O4 nanoparticles under variable conditions. Under a 
flow of argon, 0.353g (1 mmol) of Fe(acac)3 was mixed with 20 ml of TETA. This mixture was 
first heated to 110 °C for 20 min to complete dissolved the solid. The solution was either 
gradually heated to 210 °C (200 °C, 190 °C or 180 °C were also applied instead of 210 °C) under 
a heating rate of 1 °C/min, 2 °C/min, 5 °C/min, 10 °C/min or 20 °C/min for two hours and 
then, heated to reflux for another 1 hour or directly heated to reflux by using same heating rate. 
After cooled to room temperature, the solid product was magnetically collected and washed with 
acetone for five times. The nanoparticles were dispersed in polar solvents such as water or 
alcohol. Other experimental factors such as precursor concentration and nitrogen flowing rate 
were also varied to understand the formation of the nanoparticles. 
 
4.2.5. Preparation of TETA coated Fe3O4 nanoparticles via a hot injection technique. A 
amount of 0.177 g (0.5 mmol) of Fe(acac)3 was dissolved in 1, 2 or 5 ml of TETA. Separately, 9, 
8 or 5 ml of neat TETA was heated to 260 °C in a three-necked flask under a flow of argon. Then, 
the pre-dissolved precursor solution was rapidly injected into the flask, inducing an immediate 
color change from light yellow to black. The flask was heated at 260 °C for another 2 h, and then 
the heating mantle was removed. After cooled to room temperature, the solid product was 
magnetically collected and washed with acetone for five times. The nanoparticles were dispersed 
in polar solvents such as water or alcohol. 
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4.2.6. Preparation of Au-Fe3O4 nanocomposite. The synthesis of 2-3 nm gold nanoparticles was 
based on Duff et al method. In a typical experiment, 0.5 ml of 1 M NaOH was diluted by 45 of 
ml deionized water, then mixed with 1 ml of tetrakis(hydroxymethyl)phosphonium chloride 
(THPC 80%) solution for 5 min. Then, 1.5 ml of 1% HAuCl4 solution was quickly added and the 
solution was further stirred for 5 min.  
5 ml of colloidal gold solution was introduced into 2 ml of water dispersion of Fe3O4 
nanoparticles, and the mixture was stirred for 6 h. The solid product was collected by a magnetic 
field and washed with deionized water for five times to remove excess amount of gold particles. 
The final product was redispersed in ethanol or water by sonication.  
 
4.2.7. Preparation of QDs- Fe3O4 nanocomposite. Different sized CdSe-ZnS core-shell quantum 
dots were synthesized according to the literature and dried under vacuum.28 Briefly, 12 mg of 
CdO, 200 mg of lauric acid, 1.5 g of 1-hexdecylamine and 1.5 g of trioctylphosphine (TOP) were 
added to a 50 ml three-neck flask and the temperature was raised above 200 °C to completely 
dissolve the chemicals. Then, the system was heated to 280 °C for 2 min and 2 ml of TOP with 
80 mg of dissolved selenium was quickly injected into the flask at certain temperature for desired 
QDs size. The flask was cooled to 200 °C, and a premixed solution containing 250 μl of 
hexamethyldisllathiane, 1 ml of diethylzinc and 2 ml of TOP was gradually added to the flask 
over a minute. The mixture was kept at 180 °C for 1 h. The nanocrystals were precipitated by 
adding excess ethanol and centrifuge. The solid product was dried under vacuum. 5 mg of 
CdSe/ZnS was dispersed in 2 ml of chloroform and mixed with ethanol and magnetic 
nanoparticles water dispersion in a 2:2:1 ratio. The solution was stirred for 6 h. The solid product 
was isolated by a permanent magnet, washed with chloroform for 5 times to remove excess 
amount of quantum dots and redispersed in ethanol. In order to enhance the solubility of 
QDs/Fe3O4 nanocomposites, 30 mg of 5-aminopentanol-1 was added and the solution was stirred 
for another 3 h. The solid part was collected, washed and redispersed in ethanol.  
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4.3. Results and Discussion  
4.3.1. Preparation of variable sized magnetite nanoparticles with amine surface functionalities. 
As shown in Scheme 4.1, iron source (Fe(acac)3 in this method) was first mixed with TETA in a 
flask and heated to 110 °C for about 20 min. Then, the flask was further heated to reflux 
temperature. Figure 4.1a is a typical transmission electron microscopy (TEM) image of 
as-prepared Fe3O4 NPs. The narrowly distributed NPs with an average size of 7.4 nm (SD=9.5%) 
can be easily achieved by refluxing iron source in polyamine without any size selection process. 
Uniform Fe3O4 NPs with larger diameter can be accomplished via a seed-mediated growth 
method. By mixing the seeds, 7.4 nm NPs, with more iron precursors, the average diameter is 
increased to 9.8 nm (SD=12.2%). Following the same procedure, 12 nm or larger NPs can be 
prepared. The histogram of each size group of the Fe3O4 NPs is given in Figure 4.1, and 
examination of this figure shows that different sized Fe3O4 NPs are all quasi-spherical with small 
size deviations. Based on the data from ICP measurements the yield of the synthesis is between 
87% and 92%. 
Synthesis conditions such as concentration of the precursors, heating rate were varied to 
understand the formation of the NPs. It is suggested that mild heating ramp is important to 
achieve narrow size distribution while rapidly heating the system from room temperature to 
reflux (20 °C/min) would result in NPs with broad size distribution. 
 
Scheme 4.1. Preparation of polyamine coated Fe3O4 coated nanoparticle through pyrolysis of 
iron precursor in TETA. 
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Figure 4.1. TEM images and size statistics for Fe3O4 NPs: (a,d,g) low magnification, (b,e,h) high 
resolution, (c,f,i) size distribution of different sized Fe3O4 NPs. 
We have performed a series of controlled synthesis under different reaction condition, and 
monitor their effect on the final products. Detailed results and discussions are as follows. First, it 
is noticed that maintaining the reaction medium at relatively low temperature (i.e. 110 °C) for 
certain amount of time is important. The purpose of this step is to fully dissolve the precursor 
before reaching the decomposition temperature, and to deplete the oxygen and moisture in the 
solution. Nanoparticles prepared by directly heating the system to 210 °C without degassing 
treatment at lower temperature are less uniform and spherical shaped than the ones with the  
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Figure. 4.2 TEM images of Fe3O4 nanoparticles prepared under varied condition a) 1 °C/min, b) 
normal condition, heating rate = 2 °C/min, c) 5 °C/min, d) 10 °C/min, e) 20 °C/min, f) prepared 
through a injection technique, f) doubled concentration of iron source. 
treatment. From our observation, both water and oxygen molecules can participate in the 
decomposition process and disturb the formation of the nanocrystals. Therefore, air and moisture 
depletion is necessary to get high quality product. 
The investigations regarding the effect of heating rate on the uniformity of the nanoparticles 
were performed. Five sets of rate (1 °C/min, 2 °C/min, 5 °C/min, 10 °C/min, 20 °C/min) were 
used to increase the temperature to 210 °C/min while other parameters are identical. As mention 
above, the results indicate that slow heating is helpful to produce narrowly size distributed 
nanoparticles. From Figure 4.2, under normal condition, nanoparticles prepared under a heating 
rate of 2 °C/min are round-shape and uniform. However, if the ramp was raised to 5 °C/min, the 
shape of the nanoparticles was still quasi-spherical whereas larger size particles start to appear 
and size deviation was increased. Further elevating the rate to 10 °C/min or higher value would 
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enlarge the distribution, and produce irregular shaped nanoparticles. In previous studies,29 
researcher speculate that if the decomposition of metal precursor is slow, the heating ramp should 
not be very steep so as to prepare uniform particles. It is probably because if the decomposition 
and nucleation are not a fast process, the system would enter growth phase before the formation 
of the nuclei is finished when applying a steep heating ramp. Surprisingly, synthesis with heating 
rate decreasing down to 1 °C/min produced less monodispersed nanoparticles instead of  
 
Figure 4.3. TEM images of Fe3O4 nanoparticles prepared under varied condition. a) remaining at 
200 °C instead of 210 °C for 2h. Directly heat the solution to reflux under rate of b) 1 °C/min, c) 
2 °C/min, d) 5 °C/min. 
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improving the quality, indicating the existence of minimum decomposition rate of iron precursor, 
which affect the duration of nucleation and growth of the nanoparticle under specific heating 
rate. 
During the studies, we have found that heating the solution to 210 °C and maintaining at 
this temperature for 2 h can produce highly uniform nanoparticles. However, from TEM studies 
(Figure 4.3 a) decreasing this temperature to lower value would reduce the homogeneity of the 
materials. After the initial nucleation burst, the compound from the decomposition of iron 
precursor only server as the growth materials for the nuclei and does not induce further 
nucleation because of the depletion from the burst. We speculate that lower the temperature 
would decrease the decomposition rate and affect the duration of nucleation and growth of the 
nanocrystals, which subsequently affect the size distribution of the product.  
The study of keeping a constant temperature for 2 h above 210 °C was not performed. 
Instead, we carried out series of synthesis by directly heating the solution to reflux temperature 
under different heating rate. As expected, when the heating rate is 1°C/min or 2 °C/min, 
nanoparticles with same size and distribution was synthesized, supporting the speculation as 
proposed above. (Figure 4.3) Further inclining the ramp would lead to the similar results as we 
observed in indirect heating method.  
The system was finally heated to near reflux temperature (260 °C, boiling point of TETA: 
265 °C). We maintain the solution at this temperature for different amount of time to observe 
their effect on the product. Ascribed to Ostwald ripening phenomenon, small sized particles with 
high surface energy would dissolve in the solution, whereas the materials is recondense on the 
surface of larger particles. Therefore, extended refluxing usually leads to larger and more 
uniform nanocrystals. Negligible change was observed when reflux time was extended from 30 
min to 1 h. Further lengthen this period to 2 or 3 h brought no difference on the final product. We 
did not perform any synthesis with refluxing time more than 3 h. Because of the strong 
reducibility of TETA, prolong refluxing would cause compound with even lower valence state to 
appear (i.e. Fe0), and lead to final product with mixed materials phase.   
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Figure 4.4. TEM images of Fe3O4 nanoparticles prepared under a) slow nitrogen feeding, b) fast 
nitrogen feeding. TEM images of Fe3O4 nanoparticles prepared via hot injection technique, c) 0.5 
mmol Fe(acac)3 in 1ml TETA was injected in to 9 ml TETA at 260 °C, d) 0.5 mmol Fe(acac)3 in 
5ml TETA was injected in to 5 ml TETA at 260 °C. 
During the studies (Figure 4.4), we have found out that the flowing rate of nitrogen plays a 
vital role in the preparation of uniform spherical shaped magnetite nanoparticles. Synthesis with 
slow nitrogen feeding always result in nanoparticles with broad size distribution, and the stability 
of the as-synthesized nanoparticles in alcohol is also largely decreased compared to the one with 
fast nitrogen flowing. From the literature,30 the decomposition of neat Fe(acac)3 would produce 
acetone and carbon dioxide, and these red crystal compound does not present any change before 
175 °C. However, we have observed the nucleation as early as 150 °C, indicating that TETA 
interacts with Fe(acac)3 and participates in the decomposition of iron source. Although more 
studies are required to fully characterize the gaseous decomposition product, we believe that the 
byproduct of the decomposition would have an impact on the formation of the nanoparticles.  
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Figure 4.5. Powder X-ray diffraction patterns for (a) 7.4, (b) 9.8, (c) 11.9 nm and standard 
reference pattern of magnetite (JCPDS No. 19-0629) 
Therefore, when fast inert gas flowing is applied, the byproduct will be rapidly cleared out of the 
reaction system, leading to uniform product. 
To further confirm the speculation that the decomposition of iron precursor in polyamine is 
not a fast process, instead of heating the mixture gradually to reflux, we conduct the synthesis 
through an injection technique. The iron precursors are pre-dissolved in TETA under protection 
of argon and neat polyamine solvents were heated to reflux temperature. Then, the iron source 
was introduced to the hot solvents by an instant injection which induced an immediately color 
change from light yellow to black, indicating the formation of iron oxide nanoparticles. Under 
similar situation, nanoparticles prepared with an injection technique usually yield nanoparticles 
with very narrow distribution. This is because rapid addition of iron precursor above 
decomposition temperature would raise the concentration of iron source above nucleation 
threshold immediately and cause a short nucleation burst. Further nucleation does not occur 
because of the depletion from the burst, which minimize the percentage of growth during 
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nucleation period. Assuming that the reaction system is uniform, the size distribution of the 
particles is largely determined by the time over which the nuclei are formed and begin to grow.31 
Therefore, slow growth of nuclei from a short nucleation produces nanoparticles with very high 
uniformity.32 However, in our method, synthesis with an injection technique only produce 
nanoparticles with broaden size distribution compared to controlled heating method, implying 
that a controlled slow decomposition and nucleation process is crucial in receiving uniform 
product.  
  Under the same heating rate, double the concentration of iron precursor would not only 
result larger nanoparticles but also decrease the uniformity (Figure 4.4f). In a concentrated 
system, nuclei saturate at early stage and start to grow while a large fraction of the reactant is 
under decomposition and forming new nuclei, resulting a mixed phase of nucleation and growth, 
which lead to larger size-deviation. 
 
4.3.2. Phase purity, magnetic properties and surface chemistry. High resolution TEM (Figure. 
4.1 b,e,h) and XRD studies (Figure 4.5) confirm good crystallinity and phase purity of the as 
prepared NPs, and the XRD pattern matches well with the standard bulk magnetite (JCPDS no 
19-0629). Due to the similar diffraction pattern of magnetite and maghemite, lattice parameters 
are calculated and compared with standard bulk materials. The calculated lattice parameters for 
7.4 nm, 9.8 nm and 11.9 nm nanocrystals are 8.381, 8.392 and 8.394 Å, which are very close to 
the lattice parameter of standard bulk magnetite (8.396Å) and far from the one of maghemite 
(8.346Å). XPS was also used to precisely indentify the composition of as-prepared NPs. From 
the scan, the two photoelectron peaks at 711.4 eV and 725.2 eV are very close to the previously 
reported binding energy value of core-level Fe 2p lines in magnetite.33 Additionally, based on the 
fact that iron and oxygen element can only come from iron oxide (TETA contains only nitrogen 
and carbon), the calculated atomic ratio of iron and oxygen (Fe:O=1.33 for magnetite) also 
confirm the present of single phase magnetite of as-prepared NPs. Previous studies have shown 
that, metal precursors can be reduced and yield nucleation in the present of primary amines.25,34 
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Figure 4.6. TEM images of sample solution taken at a) 150 °C, b) 160 °C, c) 180 °C, d) 200 °C e) 
210 °C, f) after 1h at 210°C  
Similar results are observed in the present study, indicating a vital role of hydrophilic TETA in 
the synthesis of iron oxide NPs. Although, a clear mechanism is not yet fully understood, 
polyamines are believed to provide a reductive environment to partially reduce the iron 
precursors and facilitate the nucleation and subsequent growth period. From the literature, neat 
iron (III) acetylacetonate decompose at around 184 °C, which coincide with its melting point.30 
Thus, no cluster or small nanocrystals should be formed before reaching the decomposition 
temperature of Fe (III) acetylacetonate if TETA does not participate in the nucleation period and 
acts as only solvent during the synthesis. However, by taking aliquots of reaction solution from 
the system at different temperature, we observed small nucleus with size around 1.1 nm as early 
as 150 °C. As temperature rising, small nucleus started to grow and reach to about 4 nm after 1h 
at 210 °C (Figure 4.6). We also applied FT-IR to monitor the progress of the reaction (Figure 4.7) 
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Figure 4.7. FT-IR spectra of reaction solution sampled at 110 °C and 140 °C. 
The spectra of the synthesis solution sampled at 110 to 130 °C are nearly identical to neat TETA 
whereas the absorption peaks from iron acetylacetonate were unable to identify, probably 
because of the relatively small amount compared to the amount of solvents. When the 
temperature was raised to 140 °C, a weak absorption band at 1660 cm-1 that exists neither in 
TETA nor in iron acetylacetonate appeared, which could be explained by an assumption that 
some intermediate compounds were formed through the reaction between solvents and iron 
precursors. Further instrumentations including XPS, TGA coupled-GS-MS or other techniques 
that are able to identify what compounds are produced during the synthesis are needed to fully 
understand the mechanism.  
The magnetic properties were studied in a Quantum Design SQUID magnetometer (MPMS 
XL-7) and Fe3O4 NPs of all sizes exhibit superparamagnetism at 300K (Figure 4.8.). The weight 
percentages of Fe3O4 in different size NPs were acquired by TGA and confirmed by ICP-AES. 
After normalizing to the magnetic core, the saturation magnetizations of pure Fe3O4 are 
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Figure 4.8. Hysteresis loops of different sized TETA functionalized magnetite nanoparticles at 
300K.  
75.8 emu g-1, 79.5 emu g-1 and 82.0 emu g-1 respectively, which are very close to the value of 
magnetite NPs in similar size reported in the literature.7,34,35 
The surface composition of as-synthesized NPs was studied by FT-IR and XPS. As shown 
in Figure. 4.9, as-prepared NPs give similar spectrum as neat TETA. The peak at 1600 cm-1 is 
assigned to N-H bending, and the peaks in 2800 cm-1 to 3000 cm-1 region are corresponded to the 
symmetric and asymmetric CH2 stretches, which indicate that as-prepared Fe3O4 NPs are coated 
with polyamine molecules (Table 4.1). From XPS measurement, the atomic ratio between Fe and 
N for 7.4 nm particles is 1.9. This suggests that there are roughly 1120 TETA molecules on the 
surface of nanoparticles. This result was also confirmed by the data from TGA and ICP-AES 
studies. As reported in the literature, the binding energy of N 1s will shift to lower value if a 
chemical bond is formed between the nitrogen and metal elements.17 We observed that the 
binding energy of N 1s was shifted from 340.0 eV to 369.9 eV (Figure. 4.10), indicating a direct  
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Figure 4.9. FT-IR spectra of a) Polyamine coated Fe3O4. b) Neat TETA. 
Table 4.1. The number of capping ligand molecules on a single nanoparticle in different sizes. 
 7.4 nm 9.8 nm 11.9 nm 
Capping ligand per 
particle 1120 1840 2310 
coordination of nitrogen with iron, which directly prove the presence of TETA as capping ligand 
on the surface of NPs. The TETA protected NPs can be easily dispersed in polar solvents such as 
alcohols, DMSO and water or buffer solutions for several months without any precipitates 
(Figure 4.11). The small polydispersity from DLS measurement (Table 4.2) also confirm the 
good colloidal stability of polyamine coated NPs. Additionally, ascribed to the protonation of 
multiple amine groups from polyamine molecules, TETA coated NPs are highly positively 
charged in aqueous solution.  
The surface moiety of NPs should not only tolerate different reaction conditions to protect 
the inner core materials but also present enough reactivity and availability for secondary 
modification. As indicated from IR and zeta potential measurement, there are free amine groups 
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Figure. 4.10. XPS spectra of as-prepared TETA coated nanoparticles. 
 
 
Figure. 4.11. Colloidal solution of 7.4 nm as-prepared magnetite nanoparticles stored under 
ambient condition for 2 months a) water, b) Phosphate buffer, pH=5.8, c) DMSO 
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Table 4.2. Colloidal properties of different sized as-prepared magnetite nanoparticles 
Diameter (nm) Zeta Potential Hydrodynamic Radius (nm) Polydispersity 
7.4 45.2 14.5 0.105 
9.8 49.5 17.9 0.102 
11.9 55.7 19.8 0.116 
 
 
Figure. 4.12. a) TEM image of gold nanocrystals attached Fe3O4 NPs (inset: EDS scan of Au@ 
Fe3O4). b) upper left: dispersed QDs-Fe3O4 under UV light; upper right: QDs-Fe3O4 collected by 
a permanent magnet; bottom: collected QDs-Fe3O4 under UV light. c) TEM image of Fe3O4 NPs 
functionalized with PAA (inset: FT-IR spectrum of Fe3O4 NPs after functionalization with PAA). 
dangling near the surface of the TETA coated NPs, which provide possible reaction sites for 
further modification. We have adopted two pathways to study the surface reactivity. Previous 
studies have shown that amine-functionalized NPs can be used for noble metal NPs or quantum 
dots (QDs) attachment.28,33,36-39 Herein, negatively charged gold crystals with an average 
diameter of 3 nm were used. From TEM study (Figure. 4.12a), small gold nanocrystals are 
uniformly attached onto the surface of Fe3O4 NPs. The presence of gold was also confirmed by 
EDS study (Figure 4.11a inset), in which a clear Au peak appeared after the attachment of gold 
nanocrystals onto the Fe3O4 nanoparticles. No observable change was found in TEM study after 
a one hour sonication treatment, implying a strong affinity of gold to amine groups. Similarly, 
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QDs can also be decorated to the surface of NPs via their affinity with amines. As shown in 
Figure 4.12b, dispersed QD-Fe3O4 nanocomposites exhibit strong orange color fluorescence 
under UV light. Under a small permanent magnet, QD-Fe3O4 can be easily collected, and the 
precipitates still emit strong fluorescence. 
Besides their affinity with transition metal element, amine groups are also expected to be 
reactive in organic reactions. For example, under the activation of zero length linker EDC, 
biocompatible polymer polyacrylic acid (PAA) was coupled to the surface of magnetite NPs via 
amine side. The significant changes in the zeta potential values and weight percentage (87% of 
total mass coming from the core Fe3O4 before conjugation; only 40% of total mass coming from 
the core Fe3O4 after conjugation with PAA) in organic layer from ICP measurement suggest a 
successful coupling. Additionally, from FT-IR study (Figure 4.12c inset), the two intense peaks at 
1581 cm-1 and 1414 cm-1 are assigned to asymmetric and symmetric COO- stretching. The 
absorption peak corresponding to C=O of carboxylic group is located at 1704 cm-1, which also 
demonstrates that the conjugation between free amine group and PAA is achieved. TEM studies 
showed that this functionalization does not cause any effect on the shape or size of the NPs. 
Biocompatible polymer coating can prolong the circulation time and effectively reduce 
nonspecific interaction with protein and other biomolecules, which make the surface modified 
iron oxide NPs promising candidate as contrast agent in MRI.  
 
4.4. Conclusion 
In this chapter, we described a wet chemical synthesis procedure to prepare narrowly 
distributed, spherical shaped magnetite NPs with controlled size. Iron precursors and polyamine 
are the only two chemicals involved in the synthesis, which much simplifies the system and 
offers better control over the system. This synthesis method use inexpensive, commercial 
available polyamines as solvent, reducing and stabilizing agents at the same time to sufficiently 
minimize the consumption of solvents and chemical resources, which meets the principle of 
green chemistry by offering an economical and environmental friendly approach. The surface 
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moiety not only stabilizes nanoparticles in various polar solvents, they also provide functional 
groups that are available for either attachment of a different nanomaterial or biomolecule 
conjugation. It offers a fast, effective, reliable and economical approach to prepare magnetic 
nanoparticles with transcendent stability and excellent surface reactivity.  
 
* Part of this work was adapted with permission from DOI: 10.1039/c2jm15932e. Copyright 
(2012) The Royal Society of Chemistry. 
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Chapter V: The Bioapplications of Surface Functionalized Water-Soluble 
Magnetite Nanoparticles.* 
5.1. Bioseparation 
Magnetic nanoparticles can be immobilized with certain functionality which has affinity to 
specified molecules. When incubating the functionalized magnetic nanoparticles with molecules 
of interest, the surface moiety is able to captures them to the nanoparticles by interacting strongly 
with these molecules. Under an external magnetic field, target molecules can be isolated from a 
pool of irrelevant compounds or concentrated from a large volume of diluted solution. Because 
of the powerful magnetic properties, superparamagnetic behavior and large surface area, small 
iron oxide nanoparticles, particularly maghemite and magnetite, are of great values to 
magnetic-assist bioseparation in purification of proteins from plasma, antibodies from cell lysate 
and cells from tissue.  
The binding of biotin to streptavidin is one of the strongest noncovalent biological 
interactions known in nature.1 The strong and specific interaction has shown its important 
position in biotechnology such as cellular assays, DNA sequencing and oligonucleotide 
intracellular delivery.2,3 For instance, Bradley et al.2 covalently loaded streptavidin to amine 
functionalized, crosslinked, polystyrene microsphere and delivered biotin tagger DNA into cells. 
DNA molecules can be biotinylated on 5’ through polymerase chain reaction, captured by the 
streptavidin immobilized magnetic beads and sequenced at room temperature, which yields high 
quality sequence ladder and avoids time consuming conventional sequencing protocol.3 Based on 
same principle, Takashi et al.4 electrophoresed the complex of DNA and biotinylated probe in a 
gel and pass it through a streptavidin immobilized trap in order to purifying target DNA from 
various nontarget molecules.  
In this section, the powerful interaction between biotin and streptavidin was used as the 
model to test the separation ability of polyamine coated magnetic nanoparticles. By using 
fluorescence labeled streptavidin, it is possible to directly visualize the separation process. The 
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non-specific interaction was also investigated through incubation with irrelevant proteins or a 
mixture of several kinds of proteins. 
 
5.1.1. Experimental 
5.1.1.1. General Information. Synthesis medium triethylenetetramine and Fe(acac)3 were 
purchased from SIGMA and used as received. FITC conjugated streptavidin and normal mouse 
IgG conjugated by PE-Cy5 were purchased from Millipore and Santa Cruz Biotechnology, 
respectively. Other chemicals and solvent were purchased from SIGMA and Alfa Aesar and used 
without further purification. Surface composition was examined by Thermo Nicolet Nexus 670 
FT-IR machine in 650-4000 cm-1 region. Photoluminescence spectra were collected on a 
PerkinElmer LS 55 Fluorescence spectrometer. 
 
5.1.1.2. Preparation of amine terminated Fe3O4 nanoparticles. Under a flow of argon, 0.353g 
(1 mmol) of Fe(acac)3 was mixed with 20 ml of TETA. This mixture was first heated to 110 °C 
for 20 min to complete dissolved the solid. The resulting solution was gradually heated to 210 °C 
for two hours and then, heated to reflux for another 1 hour. After cooling to room temperature, 
the solid product was magnetically collected and washed with acetone for five times. The 
nanoparticles were dispersed in polar solvents such as water or alcohol. 
 
5.1.1.3. Preparation of biotin conjugated Fe3O4 nanoparticles. In a 10 ml flask, 100 mg of EDC, 
and 10 mg of biotin were subsequently added to 3 ml of buffer solution and stirred for 15 min. 
Separately, 10 mg of TETA coated iron oxide nanoparticles were dispersed in 2 ml of buffer by 
sonication and mixed with EDC activated biotin for 4 h at room temperature. The solid product 
was washed with ethanol for five times and dried under vacuum.  
 
5.1.1.4. Investigation of binding and separation of FITC-streptavidin with biotin-Fe3O4 
nanoparticles. An amount of 0.1 mg of biotin conjugated Fe3O4 nanoparticles were first 
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dispersed in 100 μl of PBS buffer solution. Then, 100 μl of FITC conjugated streptavidin (50 
μg/ml) or PE-Cy5 conjugated normal-mouse IgG was added to the nanoparticles dispersion. The 
mixture was incubated for 30 min with shaking. The nanoparticles were collected by a small 
permanent magnet and redispersed in PBS buffer solution.  
 
5.1.1.5. Investigation of binding and separation of FITC-streptavidin from a mixture of 
proteins with biotin-Fe3O4 nanoparticles. The separation of FITC-streptavidin from a mixture of 
proteins was carried out in a similar procedure. Briefly, an amount of 0.1 mg of biotin conjugated 
Fe3O4 nanoparticles were first dispersed in 100 μl of PBS buffer solution. Then, 100 μl of FITC 
conjugated streptavidin (50 μg/ml) and PE-Cy5 conjugated normal-mouse IgG (50 ug/ml) was 
added to the nanoparticles dispersion. The mixture was incubated for 30 min with shaking. The 
nanoparticles were collected by a small permanent magnet and redispersed in PBS buffer 
solution. 
 
Scheme 5.1. Purification of FITC-streptavidin from a mixture of proteins using Biotin-Fe3O4 and 
chemical conjugation of biotin to Fe3O4. 
 
5.1.2. Results and Discussion 
  Many studies have shown that magnetic NPs can be applied in separation of bio-related 
molecules. Here, the strong binding between biotin and streptavidin was chosen as a model to 
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test the potential of polyamine coated magnetite NPs in bioseparation. Scheme 5.1 describes the 
procedure of using functionalized magnetic nanoparticles in the separation of proteins. First, 
water-soluble polyamine coated Fe3O4 nanoparticles are prepared and the free amine groups on 
the surface are conjugated with biotin molecules through carboxyl terminal. Then, biotinylated 
Fe3O4 nanoparticles are incubated with either target proteins solely or a mixture containing 
proteins of interests and other irrelevant proteins. With the attraction force from a small 
permanent magnet, target proteins captured by magnetic separators are collected. The  
 
Figure 5.1. FT-IR spectrum of biotin conjugated Fe3O4 nanoparticles. 
conjugation between biotin and amine groups on the nanoparticle surface is performed under 
similar reaction condition as in PAA conjugation, in which EDC acts as a zero-length linker. 
FT-IR scan shows that a strong amide bond located at 1681 cm-1 (Figure. 5.1) appeared after the 
conjugation, indicating a successful linking. From TEM study, no obvious difference was 
observed after the coupling of biotin. To test their ability in bioseparation, the biotin conjugated 
NPs dispersion was first added to a PBS buffer containing FITC-labeled streptavidin. After 
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shaking for 30 min, the solid product was collected with a small permanent magnet and the 
solution was measured. As illustrated in the emission spectra (Figure. 5.2a), the fluorescent 
intensity dropped to only 4% of the initial intensity. In an ideal scenario, dye labeled proteins are 
captured through the strong binding affinity of biotin with streptavidin and magnetically 
collected, which leave very small amount of FITC-streptavidin in the supernatant. However, it is 
possible that proteins are absorbed onto the nanoparticles through non-specific interaction 
between charged groups on the surface of nanoparticles and proteins. In order to eliminate the 
doubts, a control test was performed, in which as-prepared Fe3O4 NPs without biotin conjugation 
were also incubated with FITC-labeled streptavidin for 30 min and collected with a magnet. The 
fluorescent intensity of the remaining solution still exhibited 80% intensity of the origin (Figure. 
5.2b), indicating that the sharp intensity drop must result from the effective binding of 
biotin-Fe3O4 NPs with streptavidin rather than chemical degradation or non-specific interaction 
with the proteins. After the separation, the biotin-Fe3O4 captured FITC-streptavidin was 
redispersed in PBS buffer and exhibited green color fluorescence. Another question arose after 
the control test: whether the biotin-Fe3O4 NPs interact solely with streptavidin or the 
 
Figure 5.2. Fluorescence spectra of (a) FITC-streptavidin solution before and after mixing with 
biotinylated Fe3O4 nanoparticles dispersion, (b) FITC-streptavidin solution before and after 
mixing with as-prepared nanoparticles dispersion. 
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Figure 5.3. Fluorescence spectra of Cy5-mouse IgG solution before and after mixing with 
biotin-conjugated nanoparticles dispersion. 
biotinylation causes the nanoparticles response to any proteins non-specifically? The biotinylated 
Fe3O4 NPs were mixed with Cy5 labeled normal mouse IgG and incubated for 30 min under 
same protocol. From photoluminescence measurement, 90% of the intensity remained after the 
separation (Figure. 5.3), implying a very limited non-specific interaction with irrelevant proteins. 
The conjugation of biotin consume a portion of amine groups which decrease the amount of 
positive charge on the surface of nanoparticles and lead to weaken electrostatic interactions. 
Therefore, the nonspecific interaction between protein and Fe3O4 nanoparticles is smaller when 
biotin is coupled to the surface. The fluorescent images of isolated NP dispersion under UV light 
(Fig. 5.4a) gave a direct-viewing of the efficient separation process. The supernatant are almost 
transparent under UV light when using biotin-Fe3O4 NPs for the separation, whereas no 
significant change in the fluorescence intensity are observed for as-prepared NPs and using 
biotin-Fe3O4 for the separation of Cy5-normal mouse IgG. 
145 
 
 
Figure 5.4. (a) Fluorescent images from the solutions 1: before and 2: after mixing with the 
nanoparticles. Left and middle: biotinylated and as-prepared Fe3O4 NPs with FITC-streptavidin. 
Right: biotinylated Fe3O4 NPs with Cy5-IgG,   (b) Fluorescence spectra from the mixture 
solutions of FITC-streptavidin and normal mouse IgG labeled by Cy5 before and after treating 
with biotinylated Fe3O4 NPs (Inset: fluorescent images showing the separation process. Left: 
before, middle: after treating with biotinylated Fe3O4, right: redispersed Fe3O4 NPs separated 
FITC-streptavidin). 
We also tested their separation ability in a mixture of different types of proteins. Under 
identical experimental condition, a mixture of Cy5 labeled normal mouse IgG and FITC-labeled 
streptavidin was incubated with biotin-Fe3O4 NPs. The separation process (Figure. 5.4b) caused 
only 13% decrease of fluorescent intensity in Cy5 while 91% of the FITC-labeled streptavidin 
was collected during the process. Meanwhile, the fluorescent color of the solution was changed 
from yellow to red during the separation, and redispersed NPs presented green luminescence, 
which implies that streptavidin are specifically separated by biotin-Fe3O4 NPs. 
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5.2. Controlled drug delivery 
In conventional chemotherapy for cancer, treatments are always accompanied with many 
adverse effects such as depression of the immune system, gastrointestinal distress, hair loss, etc.5 
Because most anti-cancer drugs work principally by impairing mitosis of cells, any fast-dividing 
cells including normal cells and cancer cells will be targeted during the treatment. The 
application of nano-sized carrier in cancer treatment has brought new hope in eliminating side 
effects of anti-cancer drugs and increasing their therapeutic effect. Among many potential drug 
carriers, dendrimer represent a unique class of polymers that possess many special properties that 
are valuable to drug delivery. PAMAM dendrimer, for example, is a hyperbranched 
monodispersed tree like macromolecules with three-dimensional structure, composed of an 
ethylenediamine or ammonia core and repeated amidoamine as branches. Due to their special 
synthesis in a step-wise manner from branched monomer units, they allow the precise control of 
size, shape, dimensions, density, polarity, flexibility, solubility and placement of functional 
groups by choosing desired building units and functional group chemistry. As a result, they 
combine typical characteristics of small organic molecules and polymers that result in special 
physical and chemical properties.6-8  
Higher generation of dendrimer molecules possess considerable amount of cavities that are 
able to entrap hydrophobic guest molecules. In addition, either half generation (carboxyl 
terminated) or full generation (amine terminated) dendrimer molecules have remarkable number 
of surface functional groups that are available for conjugation.9,10 Through these surface 
functionalities, not only drug molecules can be directly conjugated to dendrimer with very high 
efficiency, various targeting agents such as folic acid, transferrin and antibodies can also be 
immobilized to dendrimer surface to deliver drug molecules directly to target site. 
The unique structure of dendrimer makes it a very promising carrier for drug delivery. The 
molecules itself does not possess any targeting ability if no modification such as conjugation of 
targeting molecules is performed. On the contrary, magnetic iron oxide nanoparticles, which the 
core and the simple ligand shell are not able to hold guest molecules, can be guided and 
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concentrated at certain location under an external magnetic field. A hybrid nanomaterial 
composed of a magnetic core and dendrimer layer are capable for drug carrying and target 
delivery simultaneously. 
In this section we introduced a surface functionalization method to directly grow dendritic 
structure on the surface of magnetite nanoparticles. Ibuprofen was chosen as the model drug to 
test the loading capacity of dendrimer layer and their releasing behavior in aqueous solution. 
 
5.2.1. Experimental 
5.2.1.1. Fabrication of PAMAM dendrimer coated Fe3O4 nanoparticles. Building PAMAM 
dendrimer on the surface of magnetite nanoparticles followed the similar procedure as in neat 
PAMAM dendrimer.11,12 Typically, 5 mg of TETA coated magnetite nanoparticles was dispersed 
in 20 ml of methanol by sonication. A mount of 1 ml of methylacrylate was added to the 
dispersion and mixed under sitrring overnight. The solid part was magnetically collected and 
washed with methanol for 5 times and redispersed in 10 ml of methanol. This procedure 
produces G0.5 of dendrimer structure. Excessive ethylenediamine (EDA) was added and the 
dispersion was mixed for 48 h. After washed with methanol for 5 times, the solid part was dried 
under vacuum, which lead to G1 of dendritic structure. Higher generation of dendritic structure 
was prepared by repeating the cycle above. 
 
5.2.1.2. Hydrophobic drug loading using PAMAM dendrimer coated Fe3O4 nanoparticles. We 
performed the test on nanoparticles with G4 dendrimer. An amount of 1 mg of G4 
dendrimer-Fe3O4 was fully dispersed in 1 ml of DMSO. Ibuprofen (10 mg) was then dissolved, 
and the solution was stirred for 24 h. After that, the nanoparticles were separated with centrifuge 
at 14000 rpm for 20 min, washed with water for 3 times and dried under vacuum. The 
supernatant was diluted 20 to 50 times with neat DMSO and measured the absorbance (Varian 
Cary 500 UV-Vis spectrophotometer). The standard curve of ibuprofen was prepared as follow: 5 
mg of ibuprofen was dissolved in 5 ml of DMSO, and part of the solution was further diluted 
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with DMSO to the concentration of 0.5, 0.1, 0.05, 0.01, 0.005 mg/ml. The absorbance of 
standard solutions was measured in UV-Vis spectrophotometer in the range of 260 nm to 300 nm 
and the peak values at 265 nm were used. The fitted standard curve is A=0.026+1.49C, where A 
is the absorbance of solution at 265 nm, C is the concentration in mg/ml of sample solution.  
 
5.2.1.3. Drug releasing. The 0.1 mg of drug loaded nanoparticles was added to 2 ml of PBS 
buffer. The solution was transferred to a SnakeSkin dialysis bag (Thermo Scientific, MWCO 
7000) and then dialyzed against 300 ml of PBS buffer in a beaker. At designed interval, 1 ml of 
sample solution was taken out and measured for UV absorbance. And 1 ml fresh PBS was added 
to the beaker to compensate the volume change. The release lasted for 72 h. In a control test, 
pure ibuprofen was dissolved in PBS buffer and dialyzed against PBS buffer following the same 
procedure above. 
 
5.2.2. Results and Discussion  
    The modification process on the amine functionalized magnetite nanoparticles are 
performed according the synthesis of pure PAMAM dendrimer (Scheme 5.2).6,11 First, by adding 
excess methyl acrylate into a dispersion containing TETA coated nanoparticle, which defined as 
G0, the Michael addition between the amine groups on the surface of nanoparticles and the 
acrylate yield a ligand layer with methyl ester groups, which denoted as G0.5. Further addition of 
larger amount of EDA will lead to exhaustive amidation between methyl ester and one amine 
groups of EDA and produce G1. By repeating the cycle above, higher generation can be prepared. 
After the functionalization, TEM was used to check the effect of repeated reaction on the 
nanoparticles. Figure 5.5 showing the magnetite nanoparticles before and after building the 
dendrimer layer, suggest there was no observable change on the morphology. However, the 
number of minor aggregation, composed of less than ten nanoparticles, is increased, which can 
be explained by the possible amidation of ester groups from two nanoparticles with one EDA 
molecules. Based on calculation of more than 200 nanoparticles, the average size after the  
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Scheme 5.2. Surface modification on polyamine coated Fe3O4 nanoparticles to build dendrimer 
polymer layer. 
functionalization is 6.9 nm (SD=1.1 nm), which is insignificantly larger than the as-prepared 
nanoparticles (average size=6.7 nm, SD=1.0 nm). Nevertheless, dendrimer coated nanoparticles 
are able to easily dispersed in aqueous solution with no precipitate for several months at ambient 
condition. Magnetic measurement also supports the closed value of normalized saturation 
magnetization of nanoparticles before and after dendrimer coating, indicating that the 
nanoparticles were not harmed by the surface modification process. 
    FT-IR was used to investigate the surface composition of product after every modification. 
Figure 5.6a is a comparison between neat methyl acrylate and G0.5 nanoparticles. The peak at 
1733 cm-1 is assigned to the C=O bond of ester group, which lies in the same location as in pure 
methyl acrylate. The intense band at 1107 is contributed from the C-O stretching of ester group. 
The sharp peak located at 1633 in neat methyl acrylate, which is from the unsaturated C=C 
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Figure 5.5. TEM images of Fe3O4 nanoparticles (a) as-prepared, (b) dendrimer coated. Size 
statistics of Fe3O4 nanoparticles before and after the modification. 
stretching, disappeared after the modification, suggesting a possible Michael addition of alkene 
with amine groups. The spectrum of G0.5 nanoparticles was also compared with as-prepared 
TETA coated particles (Figure 5.6b). The spectra exhibit significant differences between two 
samples, indicating the surface composition was changed after the reaction with methyl acrylate. 
It is worth noting that G0.5 nanoparticles still present small peak at around 3400 cm-1 and  
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Figure 5.6. FT-IR spectra of (a) neat methylacrylate and G0.5 dendrimer coated Fe3O4 
nanoparticles, (b) G0.5 dendrimer and as-prepared Fe3O4 nanoparticles. 
 
Figure 5.7. FT-IR spectra of G0.5 and G1 dendrimer coated Fe3O4 nanoparticles. 
1600 cm-1, corresponding to N-H stretching and bending. This is probably coming from the N-H 
group of polyamine molecule backbones and unreacted secondary amine of cyclic TETA.  
The terminal ester groups of half generation products are not stable, which will undergo 
hydrolysis in water and turn into carboxyl group. Exhausted amidation necessitate an addition of  
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excess of EDA, which turn ester group into stable amide and transfer amine groups to the 
dendritic structure for further reaction cycle.13 From IR measurement (Figure 5.7), the spectrum 
of G1 is almost complete different from G0.5, where bands assigned to ester groups vanished 
with the emerging bands at 1640 cm-1 and 1560 cm-1, ascribed to the C=O stretching and N-H 
bending vibration of amide group, and bands at 1509 cm-1 and 1461 cm-1, which is due to the 
C-H bond vibration of methylene group. Additionally, peaks at 2800 cm-1 to 3000 cm-1 region, 
attributed to the characteristic C-H stretching of alkane, presented an obvious increasing in the 
intensity, implying the existence of abundant alkane functions.     
    Results from IR spectroscopy study indicated the successful reaction cycle which would 
lead to dendritic polymer coating on the surface of nanoparticles. However, due to the compact 
nature of ligand molecules of the surface of nanoparticles and intrinsic drawback in the divergent 
method that defects could be generated at higher generation because of steric resistance, whether 
the dendritic structure built by this method are able to hold hydrophobic guest molecules is  
 
Figure 5.8. UV-Vis spectra of ibuprofen solution before and after mixing with dendrimer coated 
nanoparticles. 
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unclear. Thus, ibuprofen was chosen as model drug to test the loading capacity and releasing 
behavior of the dendrimer coated Fe3O4 nanoparticles. Ibuprofen is a non-steroidal 
anti-inflammatory drug with poor solubility in water and relatively short half life, primarily for 
relief of pain or symptoms of arthritis or fever.14 The drug molecules were dissolved in DMSO 
and G4-dendrimer coated nanoparticles were then dispersed in the solution under sonication. 
Under such condition, the dendrimer layer is able to stabilize the particles in the solvents, and 
there is no-preferential affinity of DMSO with the inner or outer part of the dendritic structure, 
which means the drug molecule can move freely into the cavity of dendrimer layer. After the 
loading, the drug nanoparticle complex was first washed with deionized water to remove weakly 
absorbed drug molecules on the periphery of the dendrimer shell. From UV-Via measurement 
(Figure 5.8), the absorbance of supernatant after the drug loading process presents a drop in the 
intensity, indicating a portion of ibuprofen was trapped in the dendrimer coated nanoparticles. 
Based on the standard curve, the calculated loading efficiency is about 131 ug per gram of 
nanoparticles, which is considerably higher than many other hydrophobic drug delivery 
systems.15,16 
Besides the impressive hydrophobic drug carrying ability, dendrimer also exhibit great 
values in realizing controlled drug delivery, which drug molecules are slowly liberated instead of 
a burst release that can lead to a quick drug clearance by the body. Dendrimer molecules, 
especially higher generation, possess a hydrophilic out-layer with plenty of amine groups (full 
generation) and a hydrophobic cavity that can interact with hydrophobic guest molecules. When 
dispersed in aqueous solution, the surface amine groups protonate to carry positive charges and 
the oxygen atoms from amide group interact with water molecules and form hydrogen bonds, 
rendering water –solubility to the dendrimer. Because the surface amine groups are very compact 
at higher generation, they are able to act as gates that block part of the contact between aqueous 
solution and internal hydrophobic cavities, decreasing the possibility of drug molecules escaping 
from the cavities and prolonging the releasing time.  
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We adopted dialysis bag in buffer solution to mimic the releasing environment. The pore 
size of the dialysis has a molecular cutoff of 7000 which allow the free transportation of 
ibuprofen and no-permeation of nanoparticles. From Figure 5.9, more than 50% of the pure 
ibuprofen was found outside the dialysis bag only after two hours, indicating no sign of 
controlled release, whereas drug-dendrimer-Fe3O4 complex presented a much slower rate of 
releasing. Less than 20% of the drug molecule loaded in the dendrimer-nanoparticles structure 
was released into the environment after two hours, and the releasing percentage did not pass 50% 
even after 12 h, strongly suggesting a prolong drug release behavior of dendrimer coated Fe3O4 
nanoparticles. The entire drug release test lasted for 72 h, and we noted that releasing rate 
experienced a sharp drop after about 10 h. This is probably because the drug release from 
dendrimer is a physical process which relies on the mass action, and higher drug concentration 
outside the dialysis bag impedes the migration of drug molecules.   
 
Figure 5.9. (a) In vitro release of ibuprofen in G4 PAMAM dendrimer coated Fe3O4 
nanoparticles compared with the pure ibuprofen release behavior. (b) In vitro release of ibuprofen 
in G4 PAMAM dendrimer coated Fe3O4 nanoparticles up to 72 h. 
 
5.3. Conclusion 
In this chapter, we have demonstrated that the surface moiety of polyamine coated 
nanoparticles can be easily manipulated to immobilize different functionalities to nanoparticle 
surface. Both as-prepared and biotinylated TETA coated magnetite nanoparticles presented low 
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level of non-specific interaction with protein, whereas biotin modified nanoparticles have shown 
high efficiency in capturing streptavidin. In addition, the protein-nanoparticle complex can be 
easily collected by a small permanent magnet, suggesting their potential in the separation of 
many other biomolecules. Dendrimer coated nanoparticles, on the other hand, exhibited a 
remarkable loading capacity of hydrophobic drug and prolong releasing behavior, which could 
largely reduce the overall dosage for the treatment.  
 
* Part of this work was adapted with permission from DOI: 10.1039/c2jm15932e. Copyright 
(2012) The Royal Society of Chemistry. 
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Chapter VI: Summary 
 
Iron oxide magnetic nanoparticles hold a very important position in nanotechnology that 
can benefit applications in clinical areas. Due to their relative lower toxicity compared to other 
nanomaterials (quantum dots, MFe2O4 M=Mn, Co, Ni), high surface to volume ratio, and 
powerful magnetic properties, iron oxide (maghemite, magnetite) nanoparticles are expected to 
be a promising force for next generation nanomedicine. The preparation of iron oxide magnetic 
nanoparticles is an essential step in the development of magnetic nanoparticle based functional 
nanomaterials toward practical clinical applications. Simplicity, low cost, large scale and “green” 
production are always significant and decisive factors that determine the fate of a nanomaterial 
on its way from scientific research to commercialization. Coprecipitation, a conventional wet 
chemistry synthesis method, is exclusively used to prepare iron oxide magnetic nanoparticles for 
commercialized MRI contrast agents. However, low uniformity and poor colloidal stability of the 
product are the major issues that limit their practical applications. Thermal decomposition 
methods in non-polar solvents are able to produce mono-dispersed iron oxide magnetic 
nanoparticles in a very large scale. However, their hydrophobic nature is not suitable for direct 
biological purpose. A facile, fast and large scale preparation method that meets the standard of 
green chemistry by using low cost and non-toxic chemicals and is able to directly produce 
uniform water-soluble iron oxide magnetic nanoparticles with reactive surface functionalities has 
been pursued. 
Polyol mediate synthesis is a rather effective way to directly prepare water-soluble 
nanostructured materials. Polyalcohols can dissolve a variety of precursors and are able to 
chelate with transition metal ions so as to assist the nucleation and growth of the nanoparticles, 
leading to better control over the size and morphology of the materials. The surface compositions 
of materials prepared in polyols are very simple, which requires further modification for 
applications. However, the room temperature ligand exchange method is slow and low in yield. 
We have successfully solved the problems that exist in the room-temperature method by using 
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in-situ functionalization. Ligand molecules that bear desired functionalities (chelating groups, 
active functional group such as amine, carboxyl, hydroxyl, etc.) are quickly introduced to the 
synthesis system at elevated temperature and induce a rapid and highly efficient ligand exchange. 
Because the ligand exchange is performed after the nanoparticles are fully developed, the 
morphology, size and uniformity of the product are mainly determined by the synthetic 
conditions before the ligand exchange. Almost any functionality can be introduced to the surface 
of nanoparticles by simply selecting appropriate molecules to be capping ligands. Thus, 
nanomaterials that are composed of the same core but differ only in the surface composition can 
be prepared. Additionally, if several types of ligand molecules that bear different functions are 
introduced at the same, magnetic nanomaterials with versatile surface functionalities that are 
suitable for multiple applications can be designed 
Although there are other reports on the direct synthesis of water-soluble iron oxide magnetic 
nanoparticles, the reactivity and availability of the surface functional groups are always issues 
that directly determine the possibility of further modification. As an analog to polyalcohol, the 
potential of polyamines in the preparation of water-soluble magnetic nanoparticles with surface 
reactivity has not previously been reported. In fact, polyamines possess many similar properties 
to polyalcohols, such as hydrophilicity, high boiling, chelating ability and reducing properties. 
Additionally, polyamine molecules provide amine groups, a popular reaction site in 
bioconjugation chemistry, which is readily available for subsequent reactions. We have 
developed the first one-pot polyamine mediated large-scale synthesis to prepare water-soluble 
magnetic nanoparticles that have numerous amine groups on the surface. The iron precursor and 
triethylenetetramine (which acts as solvent, reducing agent and capping ligand) are the only two 
starting materials indicating a rather simplified system. The resulted nanoparticles presented 
much narrower size deviation than other polar solvents mediated synthesis methods and the size 
can be easily tuned from 7 nm to larger than 20 nm by using a seed-mediated synthesis strategy. 
The surface amine groups are highly reactive toward functionalization and the nanoparticles 
show a strong potential for applications in bioseparations and drug delivery. With appropriate 
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coating, nanoparticles prepared by this method are also expected to be a powerful probe in 
fluorescent and magnetic resonance imaging. 
Hybrid nanocomposites that consist of two or more functional parts such as gold attached 
magnetite, are of great value to many applications because they integrate attractive properties 
from different materials. Non-crystal silica nanostructures, especially silica nano/micro spheres 
are widely chosen as the support to assembly various nanomaterials onto their surface. The silica 
itself can be either mesoporous to be able to hold guest molecules for drug delivery or doped 
with dye molecules to be fluorescent. The fabrication of such multifunctional platforms is 
usually realized in a step wise manner which requires the preparation of each constituent part 
separately. Followed with proper modification, the parts can be then loaded onto the support 
respectively. Magnetite nanoparticles were successfully assembled onto several types of silica 
nanospheres in this way, and the prepared materials present profound activity in MRI. However, 
the fabrication process is obviously time consuming, ascribed to the synthesis and surface 
modification of both magnetite and silica. We have developed a novel in-situ method to directly 
embellish any non-crystal silica structure with water-soluble magnetite nanoparticles with 
excellent efficiency. In the polyol system, magnetite nanoparticles attach directly to the silica 
surface, and the materials can be dispersed in aqueous solution without any post-synthetic 
treatment. The ligand layer of the material is also able to participate in many conjugation 
reactions allowing further functionalization. By using mesoporous silica and doping the materials 
with dyes, it is possible to fabrication a multifunctional platform for drug delivery, fluorescent 
imaging and MRI simultaneously.   
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